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Background: Communicating the diagnosis and prognosis of cancer is widely documented as a 
challenging task. Furthermore, ensuring that patients understand their treatment options is considered 
good practice; however literature in this regard tends to be limited. Performing these tasks in cross-
cultural clinical settings complicates patient-provider communication. This study focused on Zulu patients 
diagnosed with osteosarcoma and was conducted at a tertiary (training) hospital in the province of 
KwaZulu-Natal (KZN), South Africa. The primary motivation for undertaking this research stemmed 
from observations in clinical practice that Zulu cultural beliefs and practices play a significant role in the 
management of osteosarcoma and hence culturally competent communication was an essential 
requirement at this site. In addition, patients typically present at the study site with locally advanced or 
metastatic disease. The late presentation of patients and further delays stemming from patients’ 
preferences to fulfil cultural practices results in treatment limitations and very poor prognosis. Healthcare 
providers in this setting are therefore expected to simultaneously inform patients of the diagnosis of 
osteosarcoma, the significant limitations with regard to treatment options, and prognostic considerations 
in a culturally sensitive manner that engenders cooperation in the patient while allowing them the 
opportunity to fulfil their cultural obligations.  
 
Aim and Objectives: This study aimed to develop an evidence-based practice guideline with 
recommendations for engaging in culturally competent communication with adult Zulu patients regarding 
the diagnosis, treatment and prognosis of osteosarcoma. Four objectives were devised in order to meet the 
aim of the study. 
Objective 1: Conduct an integrative literature review to gather evidence from previous research.  
Objective 2: Gather evidence from healthcare providers about the approach taken when they discuss 
osteosarcoma, its treatment and prognosis with Zulu patients as well as the cultural aspects considered 
during these discussions.  
Objective 3: Gather evidence from Zulu patients by exploring their understanding of the osteosarcoma 
diagnosis, its treatment and prognosis, and their experience of patient-provider communication 
throughout the illness experience was conducted. Patients’ cultural descriptions related to the 
management of osteosarcoma were also elicited.  
Objective 4: Develop an evidence-based practice guideline for culturally competent patient-provider 




Methods: Objective 1: Whittemore and Knafl’s approach to conducting an integrative literature review 
was used. A number of databases were systematically searched and a manual search was also conducted. 
Specific inclusion and exclusion criteria were set and documents were critically appraised independently 
by two reviewers. Thirty-five documents were included following these processes. Data extraction and 
synthesis followed and were also independently verified.  
Objective 2: We used an exploratory descriptive contextual study design and conducted focus group 
interviews with professional nurses, allied health professionals, and orthopaedic physicians. Three focus 
groups with a total of twenty-three participants were conducted. Focus group interviews were audiotaped 
and transcribed verbatim. We thematically analysed the interview transcripts using Guba’s Model of 
Trustworthiness to ensure rigour. 
Objective 3: We used a qualitative case study approach with in-depth interviews that were conducted in 
isiZulu, audiotaped and transcribed verbatim. The transcripts were translated into English and back 
translated. Transcripts were then analysed thematically. Data were verified using Guba’s model of 
trustworthiness. 
Objective 4: The AGREE II (Appraisal of Guidelines, Research and Evaluation) appraisal instrument was 
used as a guide for developing the evidence-based practice guideline. The AGREE II is a 23 item tool 
comprising six domains, five of which were considered in developing the guideline.  
 
Results: The integrative literature review provided directives on how to deliver culturally competent 
communication to cancer patients. The review also highlighted the grave need for scientifically rigorous 
research in the field of culturally competent communication in the management of cancer. Our research 
with the healthcare providers produced a number of strategies for communicating with Zulu patients 
about the diagnosis, treatment and prognosis of osteosarcoma. These strategies also addressed cultural 
considerations and provided detailed information on the cultural factors that have to be taken into account 
when managing Zulu patients diagnosed with osteosarcoma. Challenges encountered with regard to 
discussing diagnosis, treatment and prognosis also emerged. In addition to revealing strategies and 
challenges that are confirmed in the literature, this study also unearthed unique strategies and challenges 
peculiar to this cross-cultural clinical setting. Despite the uniqueness of some of these strategies, they 
could be useful in other cross-cultural clinical settings where patients belong to collectivistic cultures, and 
observe traditions and other practices that are significantly different to Western medical approaches. Our 
findings also emphasised the importance of training healthcare providers on communication of sensitive 
information in cross-cultural clinical settings. Our research with Zulu patients diagnosed with 
osteosarcoma revealed that these patients had extensive understanding of the diagnosis of osteosarcoma, 
diagnostic procedures, the treatment options applicable to treating osteosarcoma and the side-effects of 
ix 
 
chemotherapy. These findings also revealed patients’ varied perceptions of and emotional responses to 
diagnosis and treatment and exposed difference in healthcare provider and patient perceptions of 
amputation. A significant contribution of the patient study is embedded in Zulu patients’ descriptions of 
their cultural and health beliefs and practices. Specific rituals that are performed to ensure successful 
outcome of medical procedures, to cleanse patients from bad luck and to address the issue of witchcraft 
were outlined. Consultation with a reputable traditional healer was flagged as an important cultural 
practice. However, patients varied in their adherence to traditional belief systems, participation in rituals 
and the extent to which they deferred decision-making to the familyreinforcing the importance of not 
stereotyping based on pre-existing knowledge of a cultural group. The evidence-based practice guideline 
was developed based on the findings from the integrative literature review and the studies conducted with 
the healthcare providers and the Zulu patients. These three sources of evidence facilitated the 
development of a guideline that presents generic requirements and recommendations for culturally 
competent communication, and denotes specific strategies for communicating diagnosis, treatment, and 
prognosis to Zulu patients diagnosed with osteosarcoma. The evidence-based practice guideline also 
explicates areas that require further research and refinement. 
 
Conclusions: The obvious contribution of this research is represented in the evidence-based practice 
guideline. However, each of the objectives makes a significant contribution to knowledge and practice. 
This study breaks ground and alerts to the magnitude of research that is required in cross-cultural clinical 
settings, especially in the South African context as literature in this context with regard to culturally 
competent communication is very limited. The need for training our healthcare providers in 
communication of sensitive information in cross-cultural clinical settings strongly emerged from the data. 
Policy directives that support culturally competent patient-provider communication at a healthcare 
systems level could significantly contribute to addressing resource constraints and creating clinical 
environments that are conducive to culturally competent communication.  
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Chapter 1: Introduction 
1.1 Chapter Overview 
The purpose of this chapter is to provide an overview of the study. The problem statement is outlined 
and the rational and purpose of the study are explicated. The study setting and its associated 
challenges are specified. The aims and objectives of the research are discussed and the structure of the 
thesis is explained.  
 
1.2 Statement of the Problem 
Osteosarcoma is the most frequent primary solid malignancy of bone and is derived from primitive 
mesenchymal cells. Untreated osteosarcomas can result in local and/or metastatic disease 
progression.
1
 Despite advances in treatment of osteosarcoma, survival is dependent on diagnosis prior 
to progression beyond localised disease.
2
 The majority of patients presenting at the study site already 
have locally advanced or metastatic disease thus negatively affecting treatment options and outcomes 
for survival.
3
 Treatment options include chemotherapy and surgery which can include either limb 
salvage or amputation.
4
 Limb salvage is not always an option in patients with advanced local disease, 
meaning that amputation, often more as a palliative and quality of life measure is frequently the only 
surgical option at the study site.  
 
The late presentation of patients at the study site can be partially attributed to misdiagnosis at 
community health centres or district hospitals.
3
 However, observations in clinical practice highlighted 
the significant role that culture plays in the management of osteosarcoma and also indicated that 
patients may be in denial about or underestimate the seriousness of their condition. Zulu cultural 
practices including extensive familial, ancestral and/or traditional healing consultations and rituals 
before agreeing to certain treatment options may contribute to late presentation of patients and 
subsequent delays in treatment following diagnosis. It is therefore important for healthcare providers 
to communicate an understanding of these cultural beliefs while at the same time communicating the 
urgency of treatment and the negative effect of delay on survival. This requires the skill of 
communicating with Zulu patients in a culturally sensitive manner that engenders cooperation in the 
patient while allowing them the opportunity to fulfil their cultural obligations. The purpose of this 
study was therefore to develop an evidence-based practice guideline for culturally competent patient-
provider communication with Zulu patients regarding the diagnosis, treatment, and prognosis of 
osteosarcoma. Although literature regarding culturally competent communication in international 
settings is readily available, African literature on the subject is sparse.
5-13
 This study breaks ground in 
that it addresses the problem of culturally competent communication with an identified group of 




1.3 Literature Review and Motivation  
The primary motivation for undertaking this research stemmed from observations in clinical practice 
that Zulu cultural beliefs and practices play a significant role in the management of osteosarcoma and 
that these beliefs and practices need to be acknowledged when communicating with Zulu patients 
about the diagnosis, treatment and prognosis of osteosarcoma. In addition, research conducted at this 
study site
3
 indicated that patients diagnosed with osteosarcoma often present for treatment when the 
disease has already metastasised. According to the literature, patients present late for treatment partly 
due to misdiagnosis at community health centres (CHCs) or district hospitals.
3
Observations in 
practice indicated that late presentation could also be partially attributed to Zulu patients’ preference 
to exhaust all traditional healing options before seeking Western medical assistance. A delay in 
diagnosis and treatment significantly affects prognosis. This study gathered existing evidence from 
the literature by conducting an integrative literature review, accessed provider practices with regard to 
their interactions with Zulu patients about osteosarcoma, and gained insight into Zulu patients’ 
accounts of the medical communication process, with the ultimate outcome of an evidence-based 
practice guideline for culturally competent patient-provider communication. The evidence-based 
practice guideline that was developed as well as the studies that were conducted in order to develop 
the guideline had not been done in the South African context before. The issues of patient-provider 
communication, culture and cancer and associated concepts are now unpacked. 
 
1.3.1 Patient-provider Communication  
Communicating with cancer patients presents the healthcare provider with unique challenges due to 
the life-threatening nature of the illness. Despite advances in treatment, cancer is still commonly 
associated with negative emotions such as fear and anxiety.
14
 Communicating the diagnosis, treatment 
and prognosis of cancer with patients is commonly viewed as an unpleasant and complex task.
15
 
Healthcare providers generally regard communicating about cancer and coping with the emotional 
responses of patients resulting from such news as stressful.
16
 Providers’ communication skills have a 
significant effect on both the patient and the provider. The link between effective patient-provider 
communication and patient satisfaction, compliance with treatment, quality of life and health 
outcomes is well-documented.
16-18
 Effective patient-provider communication can also positively 
influence provider burnout, professional satisfaction and decrease litigation.
19
 For the cancer patient, 
effective provider communication can affect the psychological well-being of patients receiving a 
cancer diagnosis and increase their sense of control and involvement in their care.
20
 However this 
benefit is reciprocal as providers are equally dependent on good patient-provider communication in 







1.3.2 Culture and Patient-provider Communication 
Culture can be defined as “a system of beliefs, values, rules and customs that is shared by a group and 
is used to interpret experiences and direct patterns of behavior”.
22
 Culture is an important 
consideration in clinical care as it plays a significant role in how patients’ health-related values, 
beliefs and behaviours are shaped.
22
 Cultural diversity in South Africa essentially means that patients 
are more often than not treated by a provider from a different culture to their own. Managing cancer in 
a multicultural context further complicates the patient-provider relationship.
5 
Healthcare providers 
have to develop an understanding of patient preferences for communication, accommodate the use of 
nonverbal communication and anticipate the psychosocial impact of terminologies used.
6,7 
Understanding all these facets does by no means intimate that providers can adopt a ‘one size fits all’ 
approach when addressing individuals from certain cultural backgrounds, as various factors such as 




Culture affects patients’ and communities’ interaction with cancer, patients’ approaches to its 
treatment and trust in providers and institutions.  Similarly culture has been shown to affect individual 
professionals’ and institutions’ approach to minority patients.
8
 While it is well-known that cultural 
factors are crucial to diagnosis, treatment and efficient management of illness, overemphasis on 
culturally categorising patients may result in stereotyping.
9
 The other side of this pertains to 
providers’ awareness of their own cultural backgrounds and contexts
19
 and of how this interacts with 
that of the patient as well as the culture of medicine.
9,10
 Disparities in healthcare particularly those 
related to race and ethnicity, are well-documented and significantly influence access to and optimal 
use of healthcare services.
11,17,23-25
 However, the concept of culture, as earlier defined, is not solely 
associated with race and ethnicity.
26
 It is noteworthy that South Africa presents with disparities in 
health and wealth that are amongst the highest in the world.
25
 Despite post-apartheid South Africa 
awarding high priority to health equity, a 2008 study by Kon and Lackan showed that Black and 
Coloured (preciously disadvantaged race groups in South Africa) South Africans were still 
underserved and disadvantaged especially with regard to health care.
27,24
 Health disparities have 
multiple complex causes including genetics, poverty, access to health care, behaviour, and 
environmental factors.
23
 The complex interactions of political and racially motivated policies such as 
the South African apartheid policies as well as globally documented causes of health disparities such 
as low socioeconomic status, unemployment, lower levels of education, and occupations and living 
environments that expose individuals to hazards requiring intervention at many levels.
25,28
 While large 
scale interventions on the policy and institutional level may be required, literature increasingly points 








1.3.3 Cultural Competence and Evidence-based Practice 
Cultural competence has varied definitions
30-38
 but seems to require the acquisition, integration and 
application of awareness, knowledge, skills and attitudes regarding cultural differences in order to 
effectively deliver expert care that meets the unique cultural needs of patients; to manage and reduce 
cross-cultural misunderstanding in discordant medical encounters; and to successfully negotiate 
mutual treatment goals with patients and families from different cultural backgrounds. Surbone 
described cultural competence in medicine as complex and multi-layered.
39
 Cultural competence can 
be achieved via organisational, structural and clinical cultural competence interventions.
29
 On the 
organisational level this refers to ensuring that the leadership and staff compliment of a health care 
delivery system is diverse and representative of its patient population. Structural cultural competence 
interventions address structural processes that limit access to quality health care. Clinical cultural 
competence interventions address provider knowledge of the interaction between sociocultural factors 
and health beliefs and behaviours as well as equipping providers with the skills to manage these 
culturally complex interactions. The overall aim of this research is the development of an evidence-
based practice guideline for culturally competent patient-provider communication with regard to 
osteosarcoma diagnosis, treatment and prognosis. This study will address the issue of culturally 
competent patient-provider communication and therefore falls in the domain of clinical cultural 
competence interventions. Culturally competent patient-provider communication can be defined as the 
ability to communicate with awareness and knowledge of how sociocultural factors contribute to 
healthcare disparities, how cultural factors influence health beliefs and behaviours and in addition 
possessing the skills to manage these factors effectively in cross-cultural patient-provider contexts.
40 
 
Inherent in the concept of cultural competence as described above is the patient-centered approach to 
medicine. This approach, in line with the concept of cultural competence, expects that the provider 
takes the patient’s needs and preferences into account
41
 and allows for differences among patients 
with the same diagnosis and/or from the same ethnic group.
26
 Bensing argued that patient-centered 
medicine and evidence-based medicine are on opposite ends of the continuum as the former purports 
humanism and a biopsychosocial approach and the latter denotes positivism and a biomedical 
approach.
41
 Both paradigms are deemed relevant and essential, and on close inspection can be 
practised at the same time despite them housing completely opposite paradigms. Bensing described 
communication as absolutely key to patient-centered medicine and intimated that strengthening the 
evidence base of patient-centered medicine lies in conducting communication research.
41
 This author 
firstly calls for research that links communication to health outcomes and also appeals for greater 
efforts in synthesising the evidence in order to develop evidence-based practice guidelines and 
protocols. This study is in line with the latter plea with specific emphasis being placed on culturally 
competent patient-provider communication with Zulu patients diagnosed with osteosarcoma. 
Although much has been written on the concept of cultural competence, there is a lack of agreement 
16 
 
with regard to how to best implement this at the individual patient care level.
41
 The aim is that a 
review of the evidence from existing literature as well as the generation of new evidence from 
providers and patients will result in an evidence-based practice guideline for this specific population 
group. The approach taken in this research therefore reflects the general consensus in the literature 
that evidence-based practice typically includes three key components namely, research-based 




The benefits and purpose of evidence-based practice guidelines are to summarise and synthesise 
knowledge and innovations in medicine; to reduce variation in practice; and to improve quality of 
patient care.
44,45 
Evidence-based practice guidelines are developed in a transparent and structured 
manner and reviews, rates and synthesises a large body of evidence resulting in a series of 
recommendations that can improve provider practice and patient outcomes simultaneously. This study 
concludes with the developed guidelines being reviewed by an expert panel consisting of people with 
expertise in clinical content; experts in literature reviews or guideline development, or both; and 




1.4 Background and Study Setting 
This study focused on Zulu patients diagnosed with osteosarcoma and was conducted at a tertiary 
(training) hospital in the province of KwaZulu-Natal (KZN), South Africa. The primary motivation 
for undertaking this research stemmed from observations in clinical practice that Zulu cultural beliefs 
and practices play a significant role in the management of osteosarcoma and hence culturally 
competent communication was an essential requirement at this site. KwaZulu-Natal has a population 
of 10.9 million people of a total South African population of 54 956 900 million.
47 
More than half of 
the province is rural, unemployment rates are high and literacy has been observed as a challenge in 
some of the patients presenting at this tertiary facility.
48,49 
Regarding poverty levels, 56.6% of the 
KZN population live below the upper-bound poverty line (R620 per capita per month in 2011 
prices).
48 
The majority of the KwaZulu-Natal population is classified as Zulu. The Zulu people are 
indigenous to South Africa and speak isiZulu, one of South Africa’s 11 official languages. Zulu 
patients also typically engage in cultural health beliefs and practices that are in contrast to the Western 
medical model within which medical training is housed. They may conceptualise illness as resulting 
from displeasing the ancestors, witchcraft or troublesome social relationships.
50,51 
Rituals are often 
used to communicate with God and the ancestors in order to achieve healing. Zulu patients may also 
consult traditional healers who are viewed as a medium between the ancestors and God and who treat 
the patient holistically taking into account the physical, psychological, spiritual and social.
52,53 
Depending on the type of traditional healer consulted – sangoma (diviner), inyanga (traditional doctor 






The study site forms part of the national public health system that serves more than 80% of the South 
African population. The national public health system provides care to patients who do not have 
sufficient economic resources to access private healthcare.
25,54 
The healthcare system in KZN uses a 
referral system and specific referral patterns are followed. Patients may present at the local clinic or 
district hospital and may then be referred to a regional or tertiary hospital depending on the nature of 
the presenting problem. The KZN Department of Health has a transport system which brings patients 
from the local hospital to the tertiary facility. However, patients still have to transport themselves 
from home to their local hospital in order to access the hospital transport. Patients may travel as far as 
450 kilometres to receive tertiary services. The hospital where the study was conducted is a tertiary 
referral hospital and provides specialised consultative health services to Western KZN. This facility 
serves a population of approximately 3.5 million. The Tumour Sepsis and Reconstruction (TSR) Unit, 
which forms part of the Orthopaedic Surgery Department is dedicated to the treatment of 
musculoskeletal tumours and due to its specialisation, receives referrals from areas within KZN and 
outside the province that are not part of the referral system. The unit uses a multidisciplinary team 
(MDT) approach to managing patients diagnosed with osteosarcoma. The MDT consists of 
orthopaedic consultants and registrars; nurses from the orthopaedic and oncology outpatient clinics 
and wards; and allied health professionals including dieticians, occupational therapists, 
physiotherapists, social workers, and clinical psychologists. Medical encounters are largely culturally 
discordant at this tertiary hospital. HCPs receive medical training mostly in English or at some 
universities in Afrikaans and the majority of healthcare professionals are not of Zulu origin.  
 
1.5 The Aim and Objectives of the Study 
1.5.1 The Aim of the Study 
The overall aim of the study was to develop an evidence-based practice guideline for culturally 
competent patient-provider communication with Zulu patients with regard to osteosarcoma diagnosis, 
treatment and prognosis.  
 
1.5.2 The Objectives of the Study 
Objective 1: This objective focused on obtaining research-based evidence from the literature. An 
integrative literature review was conducted to gather this evidence. The integrative literature review 
allows for the inclusion of studies with diverse methodologies.
55
 It comprises a number of key stages: 





Objective 2: This objective accessed clinical expertise pertaining to current practices in this cross-
cultural setting. An exploratory descriptive contextual study of the approach taken by healthcare 
providers when discussing osteosarcoma, its treatment and prognosis with patients as well as the 
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cultural aspects considered during these discussions was conducted. A focus group interview guide 
consisting of semi-structured questions was used to elicit information regarding the process and 
content that multidisciplinary team members follow when discussing osteosarcoma with Zulu 
patients. 
 
Objective 3: This objective focused on obtaining information about patient experiences and 
preferences. An exploratory descriptive contextual study of patients previously treated for 
osteosarcoma to explore patient understanding of the osteosarcoma diagnosis, its treatment and 
prognosis, and patient experience of patient-provider communication throughout the illness 
experience was conducted. Qualitative in-depth semi-structured interviews were conducted to gather 
this information. Trained fieldworkers conducted the interviews in Zulu. 
 
Objective 4: This objective integrated the evidence collected in Objectives 1, 2 and 3 in order to 
develop an evidence-based practice guideline for culturally competent patient-provider 
communication with Zulu patients diagnosed with osteosarcoma. The AGREE II (Appraisal of 




1.6 Research Design and Methods 
The research design and methods for each of the objectives is briefly outlined. 
1.6.1 Objective 1: Conducting the integrative literature review 
Whittemore and Knafl’s approach was used to conduct the integrative literature review.
55
 This 
approach comprises the following key stages: problem identification, literature search, data 
evaluation, data analysis and presentation. 
Problem identification: The review question was formulated using the PICO guide. The following 
review question was formulated: How is culturally competent patient-provider communication best 
delivered to adult Zulu patients diagnosed with osteosarcoma? 
Literature search: An experienced librarian assisted the primary author with selecting the keywords 
and databases, and with conducting the search. In the period February to May 2015, various electronic 
databases and evidence-based practice guideline websites were searched. A manual search was also 
conducted. Inclusion and exclusion criteria were set for the search. An independent reviewer was used 
to minimise bias in the selection of studies.
57 
Data evaluation: The data was evaluated using a comprehensive and frequently used hierarchy 
system depicting seven levels of evidence.
58 
Critical appraisal tools were used to “carefully and 
systematically examine the documents in order to judge the trustworthiness, value and relevance in a 
particular context”.
59





Data analysis: The goals of this stage are a thorough and unbiased interpretation of primary sources 
as well as an innovative synthesis of the evidence.
55 
Data relevant to the review question were 
extracted from the included records. The primary investigator conducted the data extraction and coded 
and content analysed the extracted data. An independent reviewer verified both processes in order to 
improve the rigour of the data analysis. Data display matrices were developed to facilitate data 
comparison and synthesis. The researchers employed an iterative process by repeating the data 
extraction and synthesis numerous times, in order to ensure the verification of the results.  
Data presentation: The data is presented in the form of tables and text as is outlined in Chapter 2.  
 
1.6.2 Objective 2: Focus groups with health professionals 
Research design and method: A qualitative exploratory descriptive study design using semi-
structured focus group interviews were used to gather data. The interview schedule was piloted to 
ensure that a broad range of data was being elicited for the purposes of the study. Three focus groups 
comprising three distinctive groups; orthopaedic consultants and registrars, nurses and allied health 
professionals, were conducted. 
Participants and sampling: Census sampling was used as all members of the MDT were approached 
for participation in the study. Five health professionals could not participate due to scheduling 
difficulties. The three focus groups comprised a total of twenty-three health professionals. 
Data collection: An expert in focus group interviewing and qualitative research conducted the 
interviews. She had no prior contact with the participants. Focus groups were arranged at the hospital 
as participants work in a high pressured, resource-constrained environment and had to be on hand in 
the case of emergencies arising.  
Data analysis: The data were analysed using thematic analysis which is a data analysis technique 
commonly employed in qualitative research for identifying, analysing, and reporting patterns within 
data.
60 
There are a number of steps in thematic analysis: 
1 The first step involves familiarising yourself with your data. This entails transcribing data (if 
necessary), reading and rereading the data, and noting down initial ideas. 
2 The researcher then generates initial codes. This requires the researcher to code interesting 
features of the data in a systematic fashion across the entire data set, collating data relevant to 
each code. 
3 The researcher then searches for themes by collating codes into potential themes, gathering all 
data relevant to each potential theme. 
4 Themes are then reviewed and refined by checking the collated extracts for each theme and 
observing whether they form a coherent pattern (Level 1). Extracts that do not fit into a theme 
could be an indication that the theme is problematic and needs to be reworked or could mean that 
a new theme(s) has to be created for those extracts or alternatively that extracts have to be 
discarded. A thematic map is now generated of the themes and the researcher can move to Level 2 
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of this step which involves considering the validity of individual themes in relation to the entire 
data set. 
5 Themes are then defined and named. This entails ongoing analysis to refine the specifics of each 
theme, and the overall story the analysis tells thereby generating clear definitions and names for 
each theme. 
6 The researcher then selects vivid, compelling extract examples, relating these back to the research 
question and literature and presenting a discussion of the findings.
60
 
Trustworthiness: Guba’s model of trustworthiness with its four criteria was utilized to ensure rigour 
in the qualitative research process.
61
 With regard to the criterion of credibility, research methods that 
are well-established in the qualitative genre were used. The researchers were suitably qualified and 
had the relevant experience required for the research project. Data verification entailed the processes 
of independent coding by the focus group interviewer; two rounds of peer review of the themes by 
two independent qualitative researchers; and a final theme discussion by the principal investigator and 
the focus group interviewer. Contextual credibility was addressed in that the principal investigator has 
in-depth knowledge of the participating organisation and ensured that the focus group interviewer had 
a good understanding of the approach taken in the management of osteosarcoma patients at the study 
site. The focus group interviewer employed iterative questioning and probing to elicit rich data and 
verify information. Guba’s transferability and dependability was addressed by providing a detailed 
description of the research context and research procedures followed so that readers are able to decide 
on the transferability of the findings for their context and to facilitate the future repetition of the 
research. Dependability was further addressed by providing an operational description of the research 
design and methods. The confirmability criterion relates to ensuring that the findings reflected the 
experiences and opinions of the participants and not those of the researcher.
62
 The principal 
investigator works at the study site, hence an experienced independent researcher whom has had no 
prior contact with the participants conducted the focus groups. The process of bracketing
63
 was used 
while analysing the data and the themes were verified by independent qualitative researchers.  
 
1.6.3 Objective 3: In-depth interviews with Zulu patients 
Research design and method: A qualitative descriptive case study design was used. Semi-structured 
in-depth interviews were conducted by a Zulu-speaking fieldworker. The interview schedule was 
piloted to ensure that the appropriate data would be elicited for the purposes of the study.  
Participants and sampling: Convenience sampling was used to obtain participants for the study. 
Data collection: Zulu patients were contacted telephonically by Zulu-speaking fieldworkers and 
invited to participate in the study. Those that agreed to participate travelled to the hospital for the 
interviews. Where patients already had hospital appointments booked, interviews were scheduled for 




Data analysis and trustworthiness: The data were analysed using thematic analysis.
60 
A qualitative 
research expert independently coded the data following which a data discussion was held to finalise 
the themes. The research methods are discussed in detail in Chapter 6 and allows for replicability of 




1.6.4 Objective 4: Developing the evidence-based practice guideline 
The AGREE II (Appraisal of Guidelines, Research and Evaluation) appraisal instrument was used as a 
guide for developing the evidence-based practice guideline.
64
 The purpose of the AGREE II 
Instrument is to provide a framework for assessing the quality of guidelines; provide a methodological 
strategy for the development of guidelines; and inform what information should be reported in 
guidelines and in what manner.
56
 The AGREE II is a 23 item tool comprising six domains, five of 
which were used for developing the guideline. The domain, applicability which refers to the likely 
barriers and facilitators to implementation, strategies to improve uptake, and resource implications of 
applying the guideline was beyond the scope of this study. Implementation of the guideline will 
require training of healthcare providers. 
Domain 1: Scope and Purpose: This domain is concerned with the overall aim of the guideline, the 
review question, and the target population. 
Aim of the guideline: Present healthcare providers treating Zulu patients diagnosed with osteosarcoma 
with evidence-based recommendations that can facilitate culturally competent communication 
regarding the diagnosis, treatment and prognosis of osteosarcoma.   
The review question: How is culturally competent patient-provider communication best delivered to 
adult Zulu patients diagnosed with osteosarcoma? 
Target group: Adult Zulu patients diagnosed with osteosarcoma.  
Domain 2: Stakeholder Involvement: This domain focuses on the extent to which the guideline was 
developed by the appropriate stakeholders and represents the views of its intended users. The 
guideline was developed by one of the members of the multidisciplinary team working with Zulu 
patients diagnosed with osteosarcoma. Healthcare providers working in a multidisciplinary team 
context with Zulu patients diagnosed with osteosarcoma participated in focus groups. Zulu patients’ 
views and preferences were investigated using in-depth interviews.  
Domain 3: Rigour of Development: This domain relates to the process used to gather and synthesize 
the evidence, the methods to formulate the recommendations, and to update them. 
Gathering and synthesising the evidence: An integrative literature review was conducted to review the 
existing evidence. Focus groups with healthcare providers and in-depth individual interviews with 
Zulu patients were conducted in order to contextualise the guideline.  
Formulating the recommendations: The recommendations were formulated following careful review 
of the results of the integrative literature review, the focus group interviews and the patient interviews. 
Duplicate recommendations across these three sources were grouped together. Generic 
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recommendations were grouped together and recommendations specific for the communication of the 
diagnosis, treatment and prognosis of osteosarcoma with Zulu patients were presented separately. The 
guideline was reviewed by an expert panel. The guideline development process was supervised by 
experienced researchers and clinicians.  
Domain 4: Clarity of Presentation: This domain deals with the language, structure, and format of the 
guideline. Care was taken to develop clear and unambiguous recommendations. Headings and 
subheadings clearly demarcate the different sections of the guideline.  
Domain 5: Editorial Independence: This domain is concerned with the formulation of 
recommendations not being unduly biased with competing interests. There are no competing interests 
to report. 
 
1.7 Ethical Considerations 
A number of ethical considerations were important for the purposes of this study. 
1.7.1 Informed consent 
Informed consent was ensured in this study in that each participant received an information sheet (see 
Appendix C and D) explaining the nature and purpose of the study, who the researcher is, the issues 
of confidentiality and anonymity and a contact number should any questions arise. The 
researcher/fieldworkers collecting the data provided a detailed explanation of the research, its duration 
and the issues of confidentiality and anonymity. The information sheet also contained the contact 
details for BREC should the participants be concerned that ethical violations occurred during the 
research. The information sheet for patients was translated into Zulu.   
 
1.7.2 Coercion 
Participants were informed of their right to voluntary consent and their right to withdraw from the 
study at any time. Patient participants were also reassured that their decision regarding participation in 
the study did not affect their access to healthcare in any way. 
 
1.7.3 Privacy and confidentiality 
An independent qualitative expert that had no prior knowledge of the participants conducted the focus 
groups. Fieldworkers contacted the Zulu patients and invited them to participate in the study. 
Although the researcher has knowledge of the identities of the participants gleaned from the consent 
forms that were completed, these are securely stored and anonymity and confidentiality in reporting of 
the findings was maintained at all times. Furthermore, transcriptions of the tape recorded focus groups 
were conducted by an independent transcriber with no prior knowledge of the participants. 
Anonymity was further ensured through de-identification using codes.  
 
1.7.4 Risk of Harm to Patients 
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Zulu patients diagnosed with osteosarcoma were approached for participation in the study. Patients 
were asked about their illness as well as their experience of the healthcare system. There was a 
concern that retelling their stories could evoke negative emotional responses. Counselling was made 
available in the event that a participant may have required this. However, osteosarcoma patients are 
referred to the Clinical Psychology Department before final diagnoses are made. These patients 
therefore receive ongoing psychological intervention from the time of diagnostic work-up and 
throughout the treatment process should they agree to this service. In addition, many of these patients 
receive services from the Social Work Department as well. The risk of harm noted was therefore 
minimal but was taken into account nonetheless. None of the participants requested counselling 
following participation in the study. 
 
1.7.5 Ethics Approval 
Ethics approval to conduct the study was obtained from the UKZN Bioethics Research and Ethics 
Committee (BREC) and permission to conduct the study at the institution was obtained from the CEO 
of Grey’s Hospital as well as KZN Health Research and Knowledge Management (Appendix G). 
 
1.8 Structure of the Thesis 
The thesis is divided into four parts which are directly linked to the four objectives of the study. Parts 
one, two and three culminate in Part 4. As stated, evidence-based practice should comprise evidence 
from 1) research, 2) clinical expertise, and 3) patient preferences.
42,43
 Parts one, two and three speak to 
these three components.  
Part 1 comprises the integrative literature review and consists of Chapter 2 entitled: Culturally 
competent communication in the management of cancer: An integrative literature review. 
Part 2 covers the second objective and relates to the focus groups conducted with the healthcare 
providers. This section comprises three chapters. Chapter 3 entitled: Strategies and challenges for 
communicating the diagnosis of cancer in cross-cultural clinical settings—Perspectives from South 
African healthcare professionals, covers the topic of discussing the diagnosis of osteosarcoma with 
Zulu patients. Chapter 4 entitled: Communicating about treatment of osteosarcoma in cross-cultural 
clinical settings: A qualitative review of content, process, challenges, and strategies, details the 
treatment discussion as well as the cultural considerations in this regard. Chapter 5 entitled: 
Communicating about prognosis with regard to osteosarcoma in a South African cross-cultural 
clinical setting: strategies and challenges, highlights the prognostic discussion with Zulu patients from 
the healthcare providers’ perspectives.  
Part 3 relates to the third objective and comprises Chapter 6 entitled: Communication across the 
osteosarcoma disease trajectory: Patients’ factual, emotional and cultural accounts. This chapter 
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explores how the diagnosis, treatment and prognostic aspects of osteosarcoma is communicated to 
patients, their understanding of the diagnosis and treatment of osteosarcoma as well as their 
experience of the communication of these components. Participants’ descriptions of the role of culture 
in the management of this life-threatening illness are also reported on.  
Part 4 outlines the evidence-based practice guideline that was developed based on the data discussed 
in Parts 1, 2 and 3. Part 4 contains Chapter 7 and is entitled: Culturally competent patient-provider 
communication with Zulu patients diagnosed with osteosarcoma: An evidence-based practice 
guideline. 
Part 5 outlines the synthesis and discussion of the study. Chapter 8 provides a summary of the main 
findings and highlights the original contribution of the work. Strengths and weaknesses of the study 
are discussed; practice implications as well as directions for future research find their home in this 
section.  
1.9 Chapter Conclusion 
This chapter outlines the significance of the problem to be studied and provides a substantive 
background and motivation for the study. The research design and methods is outlined in order to 
orientate the reader to the methods used to achieve the aim of an evidence-based practice guideline. 
Patients typically present late for treatment at the study site and the majority of the patients treated at 
this tertiary facility are Zulu. The poor prognostic outcomes resulting from late presentation and 
possible further delays as a result of cultural practices poses a number of challenges to healthcare 
providers with regard to communicating with Zulu patients. Cultural competence therefore has a 
significant role to play in mediating these challenges and ensuring that health outcomes are 
maximised. The evidence-based practice guideline therefore offers recommendations for navigating 
the cross-cultural clinical terrain within which these patients are treated.   
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Part 1: Conducting the Integrative Literature Review 
 
There is general consensus in the literature that evidence-based practice generally includes three key 
components, namely research-based evidence available from the literature, clinical expertise and 
patient preferences.
1,2
 The first part of this study entailed conducting an integrative literature review 
detailing the existing evidence for culturally competent patient-provider communication in the 
management of cancer. Specific literature on osteosarcoma was not available hence the decision to 
focus on cancer while conducting the integrative literature review. Chapter two provides a detailed 
account of the methods used to conduct the integrative literature review. The review highlighted the 
grave need for scientifically rigorous research in the field of culturally competent communication with 
cancer patients. However, the results provide clear directives on how culturally competent patient-
provider communication can be delivered to adult patients diagnosed with cancer.  
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Summary of Findings  Level of 
Evidence 
Atkin et al. 2014 Qualitative 
study 
Practitioners, despite a commitment to sensitive care, struggle to reconcile individual 
behaviour with what they think they know about South Asian cultures which creates 
misunderstandings, leading to poor practice. Strategies for cultural competence: self-
awareness; awareness of cultural practices; demonstrating sensitivity; integrating cultural 
competence into clinical practice; challenging beliefs about cultures. 
Level VI 
Barclay et al. 2007 Literature 
study 
Reported on the following strategies: awareness of a possible need for the provider to take 
a more directive role, of patient demographics in service area, of own health belief system 
and own cultural biases; accommodating patients that require family involvement; 
knowledge of own cultural biases. Urged active exploration of cultural issues with patients 
and preferences for truth disclosure. Proposed demonstrating respect; recognising patients' 
health beliefs; and using professional translators. 
Level VII 
Beyene 1992 Case study Key strategies reported: understand and accommodate the role of the family; allow family 
participation in care if required by culture; do not misjudge level of acculturation with 
dominant culture; demonstrate warmth; be culturally sensitive to beliefs and practices; use 
professional translators. 
Level VI 
Chambers 2008 Book chapter Strategies reported included: awareness of dominant cultural narratives and of patients’ 
tendency to mix allopathic and traditional medicine; knowledge of own culture; 
knowledge of the community’s clinical experience; openness about own cultural frame; 









Summary of Findings  Level of 
Evidence 
Chaturvedi et al. 2014 Case study Highlighted importance of awareness of patient education levels and the role of culture in 
health belief systems. Emphasised that culture shapes patients’ interaction with the 
healthcare system. Strategies included: effective communication; explore patient and 
family perspectives; respect religious beliefs; enhance patient trust; treat patients equally; 
simplify information. 
Level VII 
Cohen & Palos 2001 Literature 
study 
 
Defined key concepts and summarised available guidelines to assist with providing 
culturally competent nursing care. Concluded that becoming culturally competent begins 
with understanding terms and concepts that are essential in developing cultural awareness, 
knowledge and skills. Emphasised sensitivity to language and the history of the 
development of some labels, assessing communication needs and conducting cultural 
assessments. 
Level VII 
Coughlin 2014 Literature 
study 
Reported on the roles of cultural competency, patient trust, and health literacy in the 
oncology setting. Highlighted the need for culturally competent lung cancer patient 
navigators from the point of diagnosis to the initiation and completion of treatment, 
including cancer staging. 
Level VII 
Dein 2006 Book chapter Emphasised the importance of: awareness of own culture, interaction of patient and 
provider culture, own stereotypes; providing culturally and linguistically sensitive 
services. 
Level VII 
Die Trill & Holland 
1993 
Case study Cancer was used as a model to highlight major cultural issues that should be considered in 
order to increase cultural sensitivity in the medical setting: family function, sex roles, 
language, disclosure of disease-related information, pain, attitudes towards illness and 
health practices, immigration, region, autonomy versus dependency, and death and 
bereavement. Emphasised avoiding cultural stereotyping when being culturally sensitive 








Summary of Findings  Level of 
Evidence 
Epner & Baile 2012 Case study Argued that the categorical or multicultural approach to cultural competence results in 
stereotypical thinking. The cross cultural approach focuses on foundational 
communication skills, awareness of cross-cutting cultural and social issues, and health 
beliefs that are present in all cultures and offers a patient-centred alternative. Highlighted 
various models of effective cross-cultural communication and negotiation and the key 
elements of patient-centred care.  
Level VII 
Huang et al. 2009 Qualitative 
study 
Explored the social construction of cultural issues and found that previous experiences 
with people from other cultures and organisational approaches to culture and cultural care 
often influenced nurses’ views and understandings of culture and cultural mores and their 
beliefs, attitudes and behaviours in providing cultural care.  
Level VI 




Proposed strategies for reducing heath disparities in cancer care included: acknowledging 
own personal assumptions and biases; gaining an understanding of the cultural meaning of 
cancer; recognising culture of both patient and provider; awareness of cultural variations 
within cultures; integrating cultural knowledge into communication; providing 
information in a respectful manner to the designated receiver; using culturally appropriate 
nonverbal communication etiquette; engaging in congruent verbal and nonverbal 
communication; integrating community resources into cancer care; using professional 
translators; providing ethnic-specific services.  
Level VII 
Kagawa-Singer 2013 Book chapter Proposed cultural competence as a critical skill set for improving quality of health care, 
improving equity in the availability of healthcare and eliminating health disparities among 
population groups with regard to cancer care. Defined culture and cultural competency 
and discussed culturally based communication strategies to facilitate building trust 
between patient, family and provider with a view to negotiating mutually agreed upon 








Summary of Findings  Level of 
Evidence 
Kreps 2006 Literature 
study 
Provided an overview of cancer-related health disparities in the US and outlined 
communication strategies for reducing health disparities: minimise bias; demonstrate 
respect; make patients active participants; sensitive and adaptive communication to 
overcome health literacy barriers; use appropriate language; check patient understanding; 
use culturally sensitive print, audiovisual and electronic communication; formulate and 






Acknowledged the critical role of culture and the importance of establishing guidelines for 
culturally competent medical care. Advocated having knowledge of: health-related 
cultural factors; the incidence and prevalence of diseases in the population; treatment 
outcomes peculiar to that population. Cautioned against blanket racial classifications; 
advocated integrating knowledge of diverse population health into clinical practice and 
converting an awareness of disease prevalence into practices and policies. 
Level VII 
Lichtveld et al. 2012 Book chapter Focused on the role of cultural competence in addressing health disparities and proposed 
strategies for creating a culturally competent cancer workforce.  Highlighted being aware 
of phases of acculturation and advocated knowledge of: the patient’s culture, ethnic and 
geographic differences; processes of decision-making in different cultures; role of culture 
in health belief systems. Emphasised the significance of first medical encounters and the 
role and effectiveness of patient navigators. 
Level VII 
Longo & Slater 2013 Case study Illustrated the challenges of providing culturally-competent. Proposed strategies for 
culturally competent care included: recognition of spiritual and cultural needs; 
understanding that patients and families may respond differently to the dominant cultural 
expectation; conducting cultural and spiritual assessments of patients and families as part 
of the psychosocial assessment; maintaining open communication; providing family with 














Proposed practices for reducing health disparities and improving cultural competence 
included: awareness of personal biases and stereotypes; cultural knowledge of health-
related needs; knowledge of own belief system, own culture and patients’ culture, own 
stereotypes and biases, cultural variations within cultures; knowledge of the impact of 
sociocultural differences on patient-provider interactions; effective assessment and 
communication skills; responsiveness to individual needs; effective patient-centred 
communication; respect for cultural differences; need for policies. 
Level VII 
Mitchell 1998 Literature 
Study 
Reported on the cross-cultural aspects of cancer disclosure. Strategies: awareness of 
culturally constructed myths about cancer; explore patients’ disclosure preferences before 
diagnostic testing; ensure that MDT is aware of disclosure preferences; be sensitive 
regarding terms used when discussing cancer. 
Level VII 
Moore et al. 2012 Quantitative 
study 
Found that: interpersonal treatment explained the greatest amount of patient satisfaction; 
adequate communication that addresses relevant patient needs and concerns during all 
medical encounters improves patient satisfaction; patient-centred care can build trusting 
relationships. Recommended respectful communication. 
Level IV 
Mullin et al. 1998 Case study Focused on cross-cultural patient-provider difficulties and how this interfered with quality 
of care. Recommendations to improve quality of treatment in cross-cultural settings 
included learning the patient’s language or developing a vocabulary of terms that are 
familiar to patients, not stereotyping, using professional translators. 
Level VII 
Muñoz-Antonia 2014 Conference 
paper 
Proposed that culturally competent care should become the mandate of all providers and 
specifically urged oncology providers to become more familiar with disease patterns and 
cultural health belief systems that impact cancer care. Highlighted awareness of cultural 








Summary of Findings  Level of 
Evidence 
Murphy et al. 2010 Literature 
study 
Communication between provider and patient is proposed as important for reducing 
cancer care disparities along the disease trajectory especially as research cited in the 
article demonstrated that there is a disconnect between how providers think they are 
interacting and how patients are perceiving the interaction. Specific strategy - patient 
navigation. 
Level VII 
Ngo-Metzger 2006 Literature 
study 
Reviewed the literature focusing on the following five domains of culturally competent 
care: patient-provider communication, respect for patient preferences and shared decision-
making, experiences leading to trust or mistrust, experiences of discrimination, linguistic 
competency. Advocated culturally competent care as a strategy for reducing or eliminating 
ethnic and racial health disparities.    
Level VII 
Pârvu et al. 2013 Qualitative 
study 
Reported that participants had particular explanations and meanings of illness which 
sometimes negatively affected coping. Suggestions for culturally competent practice: 
awareness of personal biases and socio-cultural factors; knowledge of cultural approaches 
to illness and treatment; ability to determine key decision-makers, avoid generalizations. 
Providers should take responsibility for: cultural aspects of health and illness, combating 
discrimination in healthcare settings and be culturally sensitive and respectful of cultural 
values 
Level VI 
Pesquera et al. 2008 Literature 
study 
Reported on cancer health disparities in the US and the role of culturally competent care in 
reducing these disparities. Detailed strategies for improving cultural competence with 
specific reference to building cultural awareness, knowledge and skills are outlined. 
Discussed cultural competence standards and improving cross-cultural communication. 
Level VII 
Pierce 2008 Literature 
study 
Proposed culturally competent practice strategies included: being self-aware; having 
knowledge of different cultures, own culture, patient's culture, patient’s health belief 
system, socio-political barriers to accessing healthcare; recognising inherent power 









Summary of Findings  Level of 
Evidence 
and family trust; avoiding stereotyping /generalisations; clear and accurate 
communication; communicating with the patient’s extended family; congruent verbal and 
nonverbal communication; gaining access to and using patients' natural support systems to 




Rollins & Hauck 2015 Case study Described the impact of culture on delivering bad news to patients and proposed a patient-
centred approach to delivering bad news. Reported that patients vary in the preferences for 
receiving bad news both within and across cultures. Authors combined the SPIKES and 
Kleinman’s ethnographic models and these models’ inherent strategies to address these 
preferences.   
Level VI 
Shahid et al. 2013 Qualitative 
study 
Reported on communication challenges between health professionals and Aboriginal 
people with cancer. Found that Aboriginal people are marginalised and mistrust the health 
system. Proposed improving communication by heeding language, communication style, 
use of medical terminology and cross-cultural differences in time. Strategies included: 
avoid medical jargon, repeat explanations, use professional translators, use images to 
explain cancer.   
Level VI 
Song et al. 2014 Quantitative 
study 
Found that socio-cultural factors are associated with patient–provider communication. 
Reported that providers need to be aware of patient education levels, engage in behaviours 
that enhance trust, treat patients equally, respect religious beliefs, and reduce the difficulty 
level of the information. 
Level IV 
Surbone 2004 Editorial Focused on culture and cultural competence in oncology. Defined culture and argued the 
important role of culture in defining our identity. The complexity of cultural competence 
and the acquisition of knowledge, skills and attitudes to facilitate effective cross-cultural 








Summary of Findings  Level of 
Evidence 
Surbone 2008 Literature 
Study 
Emphasised the role of culture in oncology communication. Proposed that cultural 
competence can improve therapeutic outcomes and decrease health disparities. Outlined 
the knowledge, skills, cultural aspects providers need to be aware of and attitudes required 
in cross-cultural oncology settings.  
Level VII 
Surbone 2010 Editorial Emphasised cultural preferences for truth-telling and the changing landscape in this 
regard. Proposed cultural competence as a skill set that reduces the likelihood of cross-
cultural misunderstanding; that enables negotiation of mutually acceptable goals of 
treatment with patients and families cross-culturally, and facilitates relationships built on 
trust and mutual respect.  
Level VII 
Surbone & Baider 2013 Case study Discussed the ethical value and issues that can arise in the cross-cultural medical setting 
such as diverse attitudes and practices of truth-telling, family roles, end-of-life issues and 
caregiving practices. Defined and discussed cultural competence and its components. 
Level VI 
Thomas et al. 2010 Book chapter Proposed communication strategies included: be aware of nonverbal communication 
differences, gender, religious issues; build trust; build rapport; use print or visual media; 
attend to the patient’s expectations, feelings and concerns; make patients active 








Part 2: Conducting Focus Groups with the Healthcare Providers 
 
The second part of this study addresses the second requirement for evidence-based practice, namely 
that of accessing clinical expertise. Following the integrative literature review, it was important to 
gather information from the healthcare providers who treat Zulu patients. Focus groups were 
conducted with the healthcare professionals. The purpose of these focus groups was to gather data 
concerning the approach that healthcare providers take when discussing the diagnosis, treatment and 
prognosis of osteosarcoma with Zulu patients. The focus group interview questions also accessed the 
cultural aspects of involved in the management of osteosarcoma. Part two consists of three 
manuscripts. The data gathered from the focus groups interviews were rich and provided thick 
descriptions that could not be housed in one paper. Following consultation with qualitative research 
experts, it was decided that the data was too much for one paper and hence three papers were 
developed. Two of these papers have been submitted for publication and the third paper will be 
submitted once these have been accepted for publication.  
 
Chapters three, four, and five cover three distinct areas of communication. Chapter three highlights 
the strategies used and the challenges experienced when communicating the diagnosis of 
osteosarcoma to Zulu patients. Chapter four focuses on discussing treatment of osteosarcoma with 
Zulu patients and highlights the cultural factors that are to be considered during this discussion. 
Strategies for responding to these cultural factors are also explicated in this chapter. Chapter five 
provides an account of the strategies used and the challenges experienced when communicating about 
prognosis to Zulu patients. This part of the research project addresses the limitation of low level 
evidence highlighted in Chapter two. The evidence derived from the focus group interviews can be 
classified as Level VI evidence. The chapters are presented in the format of the journal that the work 




Chapter 3: Strategies and challenges for communicating the diagnosis of 
cancer in cross-cultural clinical settings—Perspectives from South African 
healthcare professionals 
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Strategies and challenges for communicating the diagnosis of cancer in cross-cultural 
clinical settings—Perspectives from South African healthcare professionals 
 
Abstract 
Communicating the diagnosis of cancer in cross-cultural clinical settings is a complex task. 
This qualitative research article describes the content and process of informing Zulu patients 
in South Africa of the diagnosis of cancer, using osteosarcoma as the index diagnosis. We 
used a descriptive research design with census sampling and focus group interviews. We used 
an iterative thematic data analysis process and Guba’s model of trustworthiness to ensure 
scientific rigour. Our results reinforced the use of well-accepted strategies for communicating 
the diagnosis of cancer. Additionally, new strategies emerged which may be useful in other 
cross-cultural settings. These strategies included using the stages of cancer to explain the 
disease and its progression and instilling hope by using a multidisciplinary team care model. 
We identified a number of patient, professional and organisational factors that complicate 
cross-cultural communication. We conclude by recommending the development of protocols 
for communication in these cross-cultural clinical settings.  
 
 









Communicating the diagnosis of cancer is a daunting (Baile et al. 2000; Bennett & Alison, 
1996; Fallowfield & Jenkins, 2004; Walsh, Girgis, & Sanson-Fisher, 2010) and critical 
communication task as it sets the stage for the patient’s cancer journey (Thorne et al., 2009). 
Performing this task in cross-cultural clinical settings adds to its complexity (Gao, Burke, 
Somkin, & Pasick, 2009). As culture shapes health-related values and help-seeking 
behaviours (Dein, 2004; Kagawa-Singer, Valdez Dadia, & Surbone, 2010); an awareness of 
its influence must be integrated into this communication when navigating cross-cultural 
barriers. The skills of culturally competent communication are a necessity for healthcare 
professionals (HCPs) working in situations where differences in languages and cultural 
contexts abound, and where the need to bridge medical and traditional health belief systems 
is a daily reality. 
 In this study, we explored communicating the diagnosis of cancer in a South African 
context, specifically with the Zulu people from the predominantly rural South African 
province of KwaZulu-Natal (See Figure 1: Map of South Africa). The Zulu ethnic group 
consists of indigenous people who speak isiZulu, one of South Africa’s 11 official languages. 
This province has an overall population of 10.9 million (of a total South African population 
of 54 956 900 million), the majority of which is classified as Zulu (Statistics South Africa, 




Figure 1: Map of South Africa 
 
 We chose to focus our investigation on communication between HCPs and Zulu 
patients with one index cancer diagnosis: osteosarcoma. Osteosarcoma is the most common 
primary cancer of bone (Ritter, 2010), and the complexity of its treatment necessitates a 
multi-disciplinary approach. Previous studies from our centre have found that patients with 
osteosarcoma typically present late for treatment due to misdiagnosis at community health 
centres (CHCs) or district hospitals (Ferreira & Marais, 2012). Furthermore, observations 
from clinical practice suggested that patients used several psychological coping strategies 
including denial and underestimation of the seriousness of the condition. These observations 
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also highlighted Zulu patients’ preference to exhaust traditional healing options before 
seeking Western medical assistance. In addition, an integrative literature review highlighted 
the need for scientifically rigorous research with regard to culturally competent 
communication regarding cancer.  
 Our first aim of the study was to provide an account of the content and process of 
informing Zulu patients of a diagnosis of osteosarcoma. The second aim was to investigate 
how this account may inform improved practice when HCPs communicate the diagnosis of 
cancer to Zulu patients. The third aim was to explore whether this investigation might add to 
the body of knowledge regarding communication of sensitive information in cross-cultural 
clinical settings. This study is part of a larger project and patients will also be interviewed to 
gather their perspectives of the communication processes. 
 
Method 
Research Design and Method 
Ours was a qualitative descriptive study using semi-structured focus group interviews to 
gather data. The interview schedule was piloted to ensure that a broad range of data was 
being elicited for the purposes of the study. Additionally, iterative questioning and probing 
contributed to eliciting rich data and verifying information. Interview questions focused on -
approaches that HCPs take when discussing osteosarcoma diagnoses with Zulu patients and 
the cultural considerations pertaining to this discussion.  
 
Participants, Sampling, and Data Collection 
We conducted our study at a tertiary hospital in Western KwaZulu-Natal. The hospital forms 
part of the national public health system that serves more than 80% of the South African 
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population. This system provides care to patients who do not have sufficient economic 
resources to access private healthcare (Benatar, 2013; Keeton, 2010). 
 The hospital’s Tumour, Sepsis and Reconstruction Unit (TSR), dedicated to the 
treatment of musculoskeletal tumours, employs a multidisciplinary team (MDT) approach to 
managing patients diagnosed with osteosarcoma. The MDT consists of orthopaedic 
consultants and registrars; nurses from the orthopaedic and oncology outpatient clinics and 
wards; and allied health professionals including dieticians, occupational therapists, 
physiotherapists, social workers, and clinical psychologists. All these members of the MDT 
were invited to participate in the study. All those that were available when the focus group 
interviews were conducted participated—a total of 23 HCPs—hence census sampling was 
used. Three nurses, a social worker and a clinical psychologist were not able to participate 
due to other demands. Participation was voluntary, and written informed consent was 
obtained from all participants. Demographic information regarding participants is presented 
in Table 1. Four Zulu healthcare professionals participated in the study. That the majority of 
the participants were not Zulu is an accurate reflection of the fact that patient-provider 
encounters are largely culturally discordant at this tertiary hospital.  
 The second author (a PhD-level social worker experienced in qualitative data gathering 
who previously had no prior contact with the participants) conducted three focus groups at 
the hospital study site; these interviews ranged in duration from 54 to 95 minutes. Due to 
scheduling conflicts and for the purposes of eliciting discipline specific information, the 
distinctive groups of professionals were interviewed separately. Each focus group discussion 
was tape recorded and transcribed verbatim by an independent transcriber with no prior 





Table1: Focus group demographic information (n=23) 
 
Orthopaedic consultants and registrars n=9 
Registered nurses from orthopaedic wards, orthopaedic clinic, oncology 
clinic and pain service 
n=5 
Allied health professionals (physiotherapists, occupational therapists, 
dieticians, social worker) 
n=9 
Gender 
     Males 




Ethnic Group (South Africa) 
     White 
     Indian 
     African (Zulu) 







Data Analysis and Trustworthiness 
We approached the data using a well-established form of thematic analysis that consisted of 
identifying, analysing, and reporting patterns (Braun & Clarke, 2006). We used Guba’s four-
criterion model of trustworthiness (Lincoln & Guba, 1985; Shenton, 2004; Whittemore, 
Chase, & Mandle, 2001) to ensure rigour.  
 
Ethical Approval 
Ethical approval was obtained from the Biomedical Research Ethics Committee at the 





The data suggested that HCPs use 5 distinct strategies to communicate the diagnosis of 
cancer, in this case osteosarcoma, to Zulu patients. They also noted that several factors 
complicate communicating the diagnosis of osteosarcoma to Zulu patients. Several 
participants reported that they experienced the focus group participation as transformative 
(De Laine, 2000) as they were able to reflect on their current practice, share challenges with 
and learn from fellow participants. 
 
Strategies for communicating the diagnosis of osteosarcoma 
The strategies for communicating the diagnosis of osteosarcoma to Zulu patients are outlined 
in Table 2. 
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Table 2: Strategies for communicating the diagnosis of osteosarcoma 
Sub-theme Strategies  
Set the stage for truth-telling  Start discussion right from the beginning 
Assess how much the patient knows 
Ask patients about their disease process 
Warn patients a few times about possible cancer diagnosis 
Give patients incremental information as the diagnostic process unfolds 
Inform patients of the reasons for diagnostic tests 
When diagnosis is confirmed, warn patient before communicating the diagnosis 
Warn patient by reminding patient of earlier conversations of possible diagnosis 
Confirm diagnosis only once patient has been warned 
Maintain hope 
Engage in patient-centred communication Build a relationship with the Zulu patient 
Spend time with the patient  
Offer the patient support 
Demonstrate a personal interest in the patient 
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Sub-theme Strategies  
Assess and address patient needs, fears and concerns, and coping 
Respond to patient questions about the diagnosis 
Gauge patients’ reactions  
Manage denial by 
     acknowledging that the diagnosis is difficult to accept  
     reinforcing the diagnosis  
     helping patients to accept the diagnosis 
Engage in culture-centred communication Take responsibility for improving communication 
Include some basic isiZulu phrases in conversations 
Demonstrate an understanding of Zulu cultural health beliefs 
Reassure patients that their diagnosis is 
     not due to anything that they have done  
     not a punishment 
     not due to bewitchment 
Demonstrate a genuine interest in patients’ culture  
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Sub-theme Strategies  
Ask patients questions about  
     their cultural and religious practices 
     their understanding of the aetiology of the condition 
     how they want to manage the condition  
     their cultural health beliefs 
Offer patients the best care possible regardless of language discordance 
Facilitate understanding of the diagnosis using 
visual aids 
Use images, pictures and information brochures 
Facilitate understanding by using the stages of 
cancer  
Educate patients regarding their stage of the disease  
Educate patients about the effects of cancer in every stage 
Facilitate understanding of the diagnosis using 
metaphors 
Use metaphors to explain concepts like cells, organs, tumours and metastases 
Use patient-initiated metaphors 
Check patient understanding Repeat information several times 
Check what patients remember from previous explanations  
Address language barriers Use language that patients can understand  
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Sub-theme Strategies  
Avoid using medical jargon 
Use professional or experienced translators 
Instil hope through MDT involvement Reassure patients of continued involvement of the multidisciplinary team 
Differentiate the different problems that would be addressed  
Explain how the different problems would be addressed 
Maintain hope regardless of disease stage 
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 Set the stage for truth-telling. 
HCPs suggested that the diagnosis discussion should be started right at the beginning in order 
to assess how much patients know. This assessment entailed asking patients about their 
disease process. 
 
So it often means having to break down what that means and starting right at the 
beginning: when did you first get sick, how did it progress, where did you go for 
treatment and this is what cancer means firstly a... So it is a discussion that we 
start on first contact with patient...  
 
 HCPs proposed that patients should be warned on multiple occasions regarding the 
possibility of a cancer diagnosis during the diagnostic work-up. Information should be 
provided incrementally as the diagnostic process unfolds to reduce patients’ emotional shock. 
Patients should be informed of the reason for diagnostic tests. Before confirming the 
diagnosis, patients should be warned by reminding them of earlier conversations regarding 
diagnostic possibilities. HCPs emphasised maintaining hope while setting the stage for truth-
telling.  
 
...what I think is important is that they are part of the planning process from the 
beginning… I think that the idea of cancer or malignancy should be put into their 
minds from an early stage, that that is something that you are working up or 
considering as part of the diagnosis so it's not a shock if it does come along…  So 
you say this and this are the possible diagnoses that you may have, and that is 
why we are doing these tests, and you should be aware that that [cancer] might 
be a possibility.   
66 
 
 Engage in patient-centred communication. 
HCPs emphasised building a relationship with Zulu patients by spending time with each 
individual patient and family, offering support and demonstrating personal interest.  
 
…some of them cry, we give that support and we give them the tissues and we let 
them cry out, so that at least we are there for them. 
 
 HCPs also advocated assessing and addressing patient needs. Some emphasised 
observing what patient needs were and attending to these needs without patients having to 
ask. Others proposed assessing patient concerns from the beginning by asking patients about 
their concerns and fears, and then gauging their coping abilities regardless of whether they 
knew the diagnosis. Responding to patients’ questions about the diagnosis was 
recommended.  
 
If the doctor has not yet told the patient about the diagnosis then we avoid 
discussing it but we look at what the patient’s concerns are, what do they think is 
wrong, what are they afraid of... 
 
 HCPs highlighted being sensitive to patients’ varied reactions to the diagnosis. 
Proposed strategies for managing patients’ denial included acknowledging that the diagnosis 
is difficult to accept, reinforcing the diagnosis and helping patients to accept the diagnosis.  
 
If the diagnosis has been made and the patient has been informed but still says I 
didn’t know, no one told me, then we do reinforce that information because 
denial is evident in most of our patients... 
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 Engage in culture-centred communication. 
HCPs advocated taking responsibility for improving communication as patient-provider 
encounters at the study site are largely language discordant. One proposed strategy involved 
including some basic isiZulu phrases in conversations.  
 HCPs proposed demonstrating an understanding of Zulu cultural health beliefs by 
reassuring patients that their diagnosis was neither due to anything that they had done, nor 
punishment or bewitchment (common explanatory models among Zulu patients). They 
encouraged expressing a genuine interest in patients’ culture by enquiring about their cultural 
and religious practices, their understanding of the aetiology of the condition, how they 
wanted to manage the condition, and their health beliefs. HCPs championed offering patients 
the best care possible regardless of language discordance. 
 
…we always ask what religion are they, what are the traditions that they practice. 
If it is a cancer diagnosis I am going to ask, “where do you think the cancer came 
from, were you bewitched?” And sometimes the patients will laugh because they 
thought that but they didn’t realise that I would have known. So they didn’t want 
to mention it on their own and then they will tell the story of who they think 
bewitched them and what they did… 
 
 Facilitate understanding of the diagnosis using visual aids. 
HCPs highlighted the importance of explaining the meaning of cancer to patients. The use of 
images was recommended, as patients can easily recognize on plain radiographs that bone 
with osteosarcoma is different from the normal bone and distinguish a healthy limb from a 




...they see the x-ray, it looks odd, it’s different from the normal size, they can see 
there’s something. 
 
 HCPs also recommended the use of pictures and giving patients the unit’s osteosarcoma 
brochure.  
 
 Facilitate understanding of the diagnosis using the stages of cancer. 
HCPs suggested using the stages of cancer to educate patients regarding their stage of the 
disease and the effects of cancer in every stage, including the occurrence of metastases.  
 
When I discuss diagnosis I always discuss stages. From the very beginning the 
patients will know which stage they are in and as that changes ideally we should 
explain to the patient that there is mets (metastases) here... 
 
Facilitate understanding of the diagnosis using metaphors. 
HCPs proposed the use of metaphors to explain concepts like cells, organs, tumours and 
metastases and indicated that patients seemed to understand the “house” metaphor best. 
 
So I often use a house… building blocks of a house, each block is a cell and they 
group together in a certain way to form a different part of the house. And each 
part then has a different function and I think it is more tangible so patients can 
understand that. So the tumour then is a lump which grows so that part of the 
wall of the house for example is not strong enough to do its job. For metastasis 
then we say some of those blocks have broken off, they float to other parts of the 
house and now they are making a lump there. 
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 Participants indicated that patients may also use metaphors to demonstrate their own 
understanding of their illness and suggested that HCPs use these patient-initiated metaphors 
when discussing their condition. 
 
 Checking for patient understanding. 
HCPs highlighted repeating information and checking patient understanding and emphasised 
checking what patients remembered from previous explanations. 
 
What I do find is that all of that information does not generally get absorbed, so 
you generally have to repeat. 
 
…at the next interview check how much they remember and understand… 
 
 Address language barriers. 
HCPs recommended using language that patients understand, avoiding medical jargon and 
using interpreters who share the information correctly. They advocated using professional 
interpreters.  
 
...I think we need to maybe try harder and improve communication. I think that is 
really important… we mostly all English speakers here but majority of our 
patients are Zulu, mother tongue Zulu speakers. 
 
 Instil hope through MDT involvement. 
HCPs reported that patients inevitably feel abandoned at some point; they therefore reassured 
patients of the continued involvement of the MDT, regardless of diagnosis and outcome. 
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They explained the role of all team members coupled with a differentiation of the various 
aspects of care and how they would be addressed. Maintaining hope was advocated 
regardless of disease stage. 
 
…this is just one sphere of your management here, you are still going to be seen 
by an oncology team, there is a psychologist, there is a social worker that's going 
to help you, you are not going to be left alone at this time… we are going to help 
you in different areas of your life… 
 
Complicating factors in communicating with Zulu patients 
Patient, healthcare professional and organisational factors that complicate communicating the 

















Table 3: Complicating factors in communicating with Zulu patients 
Subthemes Factors that complicate breaking bad news 
Patient factors Cultural health beliefs 
     cancer diagnosis is viewed as a punishment 
     cancer diagnosis may be attributed to being  bewitched 
     cancer diagnosis is associated with a poor prognosis 
Zulu word for cancer is associated with poor prognosis 
Lack of clarity regarding how much patients understand about the 
diagnosis 
Patients understand consequences of the diagnosis and not the 
actual diagnosis 




Lack of training 
Perceived lack of competence  
Tendency to use medical jargon 
Organisational factors Disjointed MDT functioning 
     unclear documentation in the medical file 
     delays in patient needs being addressed 
Resource constraints  
     attendance and scheduling of MDT forums 
     lack of access to professional translators 
     nursing time constraints  
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 Patient factors. 
HCPs reported that Zulu patients generally viewed a cancer diagnosis as an ancestral 
punishment or believed that they were being bewitched. Culturally, a cancer diagnosis was 
associated with a poor prognosis, often due to Zulu patients being socialised to believe that 
cancer kills. 
 
Zulu patients, most of the time they’ll say they have been bewitched. 
 
 Participants reported that the isiZulu word for cancer is umdlavuza, meaning 
‘something that ravages, something that destroys everything, something that cannot be 
stopped’. For Zulu patients umdlavuza is cancer, and it cannot be mistaken for another 
illness. HCPs viewed the term as problematic for cancers that can be cured.  
 
 HCPs were concerned about how well patients actually understood their diagnosis. 
Patients seemed to understand the treatment of the diagnosis better than they understood the 
diagnosis. The lack of words in Zulu for osteosarcoma posed another challenge.   
 
And I think patients understand more the consequences of the diagnosis than the 
diagnosis itself. With this diagnosis I am going to cut off your hand, with this 
diagnosis I am going to have to give you so much of medication…  
 
 Healthcare professional factors. 
HCPs reported a lack of training and a perceived lack of competency with regard to 
communicating the diagnosis of cancer. Most indicated that they had learnt how to break bad 
news only by observing others. The orthopaedic surgeons and registrars were concerned that 
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they have a tendency to communicate too directly and be too task-oriented. Participants could 
not agree on whether there was one preferred method for discussing diagnosis; they were also 
unsure as to whether the diagnosis was thoroughly explained to patients. They expressed a 
need for practical instructions.  
 
...I don't know if I am doing it correctly… because I don't know if I am doing it 
right and the thing is the way I do it is kind of like I saw other people do it in 
what I think might be right... 
 
 HCPs reported the use of medical jargon thus detracting from the culture-centred 
communication previously advocated.  
 
…the manner in which the information is communicated to the patient is 
sometimes done in medical jargon. So you have a tumour that has metastasized, 
means nothing to people English or Zulu speaking who don’t have a medical 
background. 
 
 Organisational factors. 
HCPs reported challenges with MDT functioning arising from disjointed communication 
between team members. Documentation in the medical file did not report on whether patients 
had been informed of their diagnosis and what their level of understanding was making it 
difficult for allied health professionals to know what they could say to patients. Patients also 
had to wait for queries to be addressed as they would enquire about something from the 
wrong team member who then had to relay the message to the appropriate team member.  
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I have seen before where like the psychologist will go to see the patient and I will 
see the notes from the psychologist saying patient is asking about prosthesis, 
please educate patient on this or patient is asking about how much weight they 
will lose and what they can eat please ask the dietician… we kind of segmented… 
compartmentalized in what we do… So also the patient is getting sent from one 
person to the next with each person discussing their thing in a different time. He 
wants to know about a prosthesis now, that is his biggest concern and maybe a 
day or two later he can only get answers for that. 
 
 Organisational resource constraints posed another challenge. All members of the MDT 
could not attend the TSR ward rounds and the Osteosarcoma MDT meetings had not been 
scheduled due to resource constraints.  
 
We do have meetings; we have the osteosarcoma meetings, team meetings. And it 
was active for at least, well I think maybe four or maybe two or three months we 
haven’t… We haven’t had a meeting this year … 
 
 Lack of access to professional interpreters was another resource constraint. HCPs often 
did not have access to the interpreter before speaking to the patient. They were also 
concerned that they were placing the onus on the interpreter to inform patients of a cancer 
diagnosis. Inexperienced interpreters and patients were perceived to downplay the core 
message, and HCPs questioned the accuracy of their interpretations. They were concerned 
that student nurses lacked competence due to possible lack of knowledge about the condition 
and discomfort with breaking bad news. A reluctance to use metaphors, especially when the 
interpreter was inexperienced was reported. 
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...they send the student nurse who has just come out of gynae or something.  She 
has got no idea about cancer yet because she has just started.  And you know she 
has got to explain this now and it is difficult and even when I listen… I mean I am 
not Zulu I can hear sometimes there is things that is being said or being 
downplayed or you know things that are changed in translation. 
 
 Nurses reported on time constraints with regard to not having enough time to spend 
with patients after the diagnosis had been disclosed despite realising that they needed time to 
process the information. 
 
...you’re so pressed for time you’ve got all these other patients to attend to... 
 
Discussion 
Our results confirm the use of several strategies reported in the literature, including: the 
practice of preparing patients early for the possibility of a diagnosis of cancer (Girgis & 
Sanson-Fisher, 2010; Lind, DelVecchio Good, Seidel, Csordas, & Good, 1989); assessing 
patients’ knowledge and understanding of their condition (Girgis & Sanson-Fisher, 2010; 
Lind et al., 1989; Maguire, 1998; Narayanan, Bista, & Koshy, 2010; Travaline, Ruchinskas, 
& D’Alonzo, 2005); providing information in increments to reduce shock (Girgis & Sanson-
Fisher, 2010; Maynard, 1996; Numico, Anfossi, & Bertelli, 2009); informing patients of the 
reason for diagnostic tests as a means of preparing them for the diagnosis (Girgis & Sanson-
Fisher, 2010); and warning patients on several occasions regarding the possibility of a cancer 
diagnosis (Girgis & Sanson-Fisher, 2010; Lind et al., 1989; Maynard, 1996; Travaline et al., 
2005). This kind of patient-centred approach (Barclay, Blackhall, & Tulsky, 2007; Epstein & 
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Street, 2007; Moore et al., 2012; Schmid Mast, Kindlimann, Langewitz, 2005) also comprises 
relationship building (Epstein & Street, 2007; Platt & Keating, 2007); identifying patient 
needs and concerns (Maguire, 1998; Monden, Gentry, &, Cox, 2016); using open-ended 
questions to elicit patient concerns (Barclay et al., 2007); answering patients’ questions 
openly and honestly (Randall & Wearn, 2005); addressing patients’ emotional responses by 
offering support, and validating patients’ responses and reinforcing the diagnosis (Baile et al., 
2000; Brock, Gurekas, & Deom, 1993; Epstein & Street, 2007; Maguire, 1998). Delivering 
culturally and linguistically sensitive services (Dein, 2004) necessitated taking responsibility 
for improving communication by providing information in the patient’s language or 
developing a vocabulary of terms that is familiar to patients (Mullin, Cooper, & Eremenco, 
1998) and engaging in a dialogue with patients to explore cultural issues (Barclay et al., 
2007; Epner & Baile, 2012). Strategies for facilitating patient understanding entailed using 
images, pictures and information booklets (Doak et al., 1998; Randall & Wearn, 2005; 
Shahid, Durey, Bessarab, & Aoun, 2013); using metaphors (Arroliga, Newman, Longworth, 
& Stoller, 2002; Casarett et al., 2010); and listening for patients’ imagery and metaphors of 
their illness experience as a means of finding a common language for connecting with 
patients (Harrington, 2012; Reisfeld & Wilson, 2004). Repeating information, checking 
patient understanding (Baile et al., 2000; Epstein & Street, 2007), using simple language, 
avoiding medical jargon (Epstein & Street, 2007; Girgis & Sanson-Fisher, 2010; Shahid et 
al., 2013; Chatuverdi, Strohschein, Saraf, & Loiselle, 2014), and using experienced and 
professional interpreters (Barclay et al., 2007;  Epner & Baile, 2012; Kagawa-Singer et al., 
2010; Ngo-Metzger et al., 2006; Shahid et al., 2013) are also documented strategies. The 
therapeutic value of communicating hope at all stages of the disease (Barclay et al., 2007; 
Travaline et al., 2005) is denoted in the literature.  
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 Particular to this study, HCPs proposed several unique strategies for communicating in 
cross-cultural clinical settings. First, the strategy of culture-centred communication was 
extended beyond merely exploring cultural issues with patients to actively introducing 
cultural narratives in order to demonstrate knowledge of and openness to patients’ cultural 
practices and beliefs. Second, a new strategy for facilitating patient understanding involved 
explaining the stages of cancer to patients by informing them of their stage and of how cancer 
affects the body in every stage. This stage approach was also advocated as helpful for 
discussing metastases. Third, although commonly documented metaphors in the discourse of 
cancer include the war metaphor and the journey metaphor (Reisfeld & Wilson, 2004), HCPs 
in this study proposed the use of a ‘house metaphor’ and reported that patients responded 
well to this analogy. The use of metaphor in this cross-cultural clinical setting is reported to 
be useful hence HCPs in other cross-cultural settings should be encouraged to discover 
metaphors that may work in that specific context. Fifth, HCPs recommended checking what 
patients remembered and understood from previous explanations given. This strategy allowed 
HCPs to check for misperceptions and denial. Last, HCPS suggested instilling a relational 
hope that was not necessarily associated with cure but reassured patients of the MDT’s 
continued involvement throughout the disease process. HCPs used this strategy to ensure that 
patients did not feel abandoned thereby reinforcing the premise that hope is not exclusively 
dependent on cure (Back et al., 2008). 
 Our results also highlighted factors that complicate communicating a diagnosis of 
cancer to Zulu patients. Zulu patients’ fatalistic view of cancer and aperception of canceras a 
punishment have been reflected in studies of other cultural groups (Austin, Ahmad, McNally, 
& Stewart, 2002; Gullatte, Brawley, Kinney, Powe, & Mooney, 2010; Lasser, Ayanian, 
Fletcher, & DelVecchio Good, 2008; Lourens, 2013; Pérez-Stable, Sabogal, Otero-Sabogal, 
Hiatt, & McPhee, 1992), and such fatalistic views can seriously hamper help-seeking 
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behaviours (Austin et al., 2002; Lasser et al., 2008; Lourens, 2013). HCPs concern in this 
study about how much patients actually understand about their diagnosis is reflected in other 
research (Richardson, Thomas, & Richardson, 2006). Healthcare professional factors 
included lack of training (Barclay et al., 2007; Barnett, Fisher, Cooke, James, & Dale, 2007; 
Hebert, Butera, Castillo, & Mega, 2009; Monden et al., 2016; Payán et al., 2009), a perceived 
lack of competence (Girgis, Sanson-Fisher, & McCarthy, 1997) and learning the skills 
required by observing others (Colletti, Gruppen, Barclay, & Stern, 2001). The reported use of 
medical jargon was another challenge (Chapman, Abraham, Jenkins, & Fallowfield, 2003), as 
choice of vocabulary affects patient satisfaction and using the same vocabulary as the patient 
can improve patient outcomes (Williams & Ogden, 2004). Organisational factors impeding 
communication included lack of clear documentation as to previous patient communication 
which has been reported as a barrier to co-ordination of patient management and clinical 
governance (Barnett, Fisher, Wild, & Dale, 2002). Other organisational challenges pertaining 
to delays in patient queries being addressed, attendance and continuity of MDT meetings, 
lack of access to professional interpreters, and nursing time constraints may be attributed to 
financial and healthcare staffing constraints (Harrison, 2009) which have been documented as 
challenges with regard to continuity of cancer care (Lauria, 1991). The MDT literature 
advocates regular meetings for improved MDT communication (Fay, Borrill, Amir, Haward, 
& West, 2006; Fleissig, Jenkins, Catt, & Fallowfield, 2006) and cautions against MDT 
members working independently and liaising with one another informally (Miller, Freeman, 
& Ross, 2001). HCPs concerns regarding working with inexperienced interpreters 
(Richardson et al., 2006) and not having access to interpreters prior to communicating with 
patients (Barclay et al., 2007; Epner & Baile, 2012) is reflected in other cross-cultural 
research. Nursing time constraints pose another challenge as patients tend to value the 
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beneficial support of nursing staff and relied on them to supplement and clarify information 
(Warnock, Tod, Foster, & Soreny, 2010).  
 HCPs in this study highlighted distinctive factors that complicate communicating the 
diagnosis of cancer to Zulu patients. Zulu cultural health beliefs highlighted the divide 
between Western and traditional systems of health and illness. The Zulu people generally 
view the cancer diagnosis as an ancestral punishment or resulting from witchcraft and have 
been socialised to associate a cancer diagnosis with a poor prognosis. The isiZulu word for 
cancer reflects these cultural health beliefs and presents a significant barrier as the meanings 
associated with this word significantly complicates the diagnosis discussion especially when 
a good prognosis is possible. Language barriers present a significant challenge in this cross-
cultural setting. The lack of availability of medical terms in Zulu and the limitations with 
regard to the translatability of words into the patient’s language significantly impacts patient 
understanding. Language barriers further manifest in the lack of access to professional 
interpreters. Although the use of metaphor has been reported to be effective with Zulu 
patients and in oncology settings in general (Arroliga et al., 2002; Casarett et al., 2010; 
Reisfeld & Wilson, 2004), HCPs reported a reluctance to use metaphors, particularly when 
the interpreter was inexperienced, and thus hindering an opportunities for patients to have a 
greater understanding of their diagnosis.  
 
Limitations 
All those approached to participate were not available at the time of data collection, and this 
may have limited our ability to achieve data saturation. Although our use of discipline 
specific focus groups likely enhanced our ability to explore issues common to each 
professional group, it also may have restricted our opportunity to assess the inter-professional 
functioning of MDT members, which is likely an important factor given the high pressure 
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environment in which the study was conducted. Our results may have been enhanced had 
other qualitative data gathering techniques been used to complement the focus group 
interviews. 
Conclusion 
This study exposed distinctive strategies for communicating the diagnosis of cancer with 
Zulu patients in South Africa.  These strategies include actively introducing cultural 
narratives in order to demonstrate knowledge of and openness to patients’ cultural practices 
and beliefs, using the stages of cancer to explain the disease and its progression, effective use 
of metaphor to facilitate patient understanding, checking patients’ memory of previous 
discussions as a means of identifying misperceptions, and instilling hope through continued 
MDT involvement regardless of disease stage. We believe these strategies are likely valid in 
other cross-cultural clinical settings. 
 As well, several distinctive challenges emerged from this study. They pertained to 
patients’ cultural health beliefs and the issue of patient understanding and lack of vocabulary 
for various medical conditions in indigenous languages. Language barriers had far-reaching 
consequences for facilitating patient understanding as a lack of access to professional 
interpreters left HCPs unsure of what was being communicated and hesitant to use metaphors 
in their communication with patients.   
 This study produced unique strategies which will make a contribution to MDTs 
working with indigenous populations. It is therefore important to conduct research of this 
nature in other cross-cultural clinical settings. Our findings also emphasised the vital 
importance of training HCPs on communication of sensitive information in cross-cultural 
clinical settings. Most research and protocols for breaking bad news are generic; few refer to 
considerations that are specific for the particular cross-cultural clinical setting. While 
directions from these protocols are useful research resulting in recommendations for 
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managing the unique challenges encountered in any particular cross-cultural clinical settings 
is much needed. This study will contribute to the development of such recommendations for 
communicating the diagnosis of cancer across various cross-cultural boundaries.  
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Communicating about treatment of osteosarcoma in cross-cultural clinical settings: A 
qualitative review of content, process, challenges, and strategies 
 
Abstract 
An extensive literature exists on how to break bad news with regard to diagnosis and 
prognosis. However, research regarding the discussion of treatment options across cultural 
boundaries is sparse. This article reports on the manner in which treatment of osteosarcoma is 
discussed in a cross-cultural context with Zulu patients in South Africa. Methodologically, 
we conducted focus group interviews with professional nurses, allied health professionals, 
and orthopaedic physicians. Three focus groups with a total of twenty-three participants were 
conducted. We thematically analysed the interview transcripts using Guba’s Model of 
Trustworthiness to ensure rigour. We found that factors influencing treatment discussions in 
this cross-cultural clinical setting included the meaning and disclosure of cultural health 
beliefs. We identified strategies for responding to cultural factors associated with amputation, 
namely timing treatment discussions, and using support services, patient models and 
DVDs/videos. Strategies for responding to cultural and health beliefs that affect treatment 
included initiating the cultural discussion, demonstrating an understanding of patients’ 
cultural beliefs and, liaising with family and cultural decision-makers where possible. Our 
findings emphasised healthcare professionals’ reports of how patients can experience the 
discussion of culturally discordant treatment options as bad news. We recommend that the 
treatment discussion forms an integral part of guidelines for culturally competent 
communication with cancer patients. 
 
 




An extensive literature exists on communicating the diagnosis and prognosis of cancer to 
patients (Bennett and Alison, 1996; Figg et al., 2010; Girgis and Sanson-Fisher, 2010; 
Hagerty et al., 2005; Monden et al., 2016). However, the literature on discussing treatment 
options tends to be limited (Baile et al., 2000; Girgis and Sanson-Fisher, 2010). Research 
regarding the discussion of treatment options across cultural boundaries is especially sparse. 
Although informing patients of their treatment options and ensuring that they understand 
these options is considered good practice (Girgis and Sanson-Fisher, 2010), patients tend to 
be less satisfied with discussions regarding treatments as compared to those in which 
diagnosis is communicated (Galletari et al., 2002). In this study we explored healthcare 
professionals’ (HCPs) accounts of how treatment options are discussed in a cross-cultural 
clinical setting. It was conducted in the province of KwaZulu-Natal (KZN), South Africa, 
where healthcare encounters are largely culturally discordant, and focused on Zulu patients 
diagnosed with osteosarcoma.  
 Previous research at our study site reported that the majority of patients present with 
locally advanced or metastatic disease (Ferreira and Marais, 2012), which limits treatment 
options and results in very poor prognosis (Errani et al., 2011; Ferreira and Marais, 2012; 
Marais et al., 2015; Meazza and Scanagatta, 2016; Ritter and Bielack, 2010). With regard to 
surgical treatment options, a significant shift away from amputation to limb salvage (around 
80% of patients) has been reported (Bielack et al., 2009; Jaffe 2009). However, a substantial 
proportion of patients presenting at the study site are not candidates for limb salvage due to 
the advanced stage of the disease at presentation (Ferreira and Marais, 2012). HCPs 
consequently have to simultaneously inform patients of the diagnosis of osteosarcoma as well 
as the significant limitations with regard to treatment options. The purpose of this research 
study, therefore, was to understand how treatment is discussed in this context with the 




The study site offers uniqueness as it is the only facility in Western KZN that treats 
osteosarcoma and that offers patients a multidisciplinary (MDT) approach to management. 
The MDT comprises orthopaedic consultants and registrars; nurses from the orthopaedic and 
oncology outpatient clinics and wards; and allied health professionals including dieticians, 
occupational therapists, physiotherapists, social workers, and clinical psychologists. The 
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majority of the patients treated at this hospital belong to the indigenous Zulu ethnic group and 
isiZulu (one of South Africa’s 11 official languages) is their native tongue. HCPs receive 
medical training mostly in English or at some universities in Afrikaans and the majority of 
healthcare professionals are not of Zulu origin (Table 1). Zulu patients also typically engage 
in cultural health beliefs and practices that are in contrast to the Western medical model 
within which medical training is housed. They may conceptualise illness as resulting from 
displeasing the ancestors, witchcraft or troublesome social relationships (Vorobiof et al., 
2001; Mdondolo et al., 2003). 
 
Research Design and Methods 
We used a qualitative exploratory descriptive and contextual approach and conducted focus 
group interviews with three distinctive groups of professionals: professional nurses; allied 
health professionals; and orthopaedic physicians (including consultants and registrars). The 
focus group interview schedule was piloted with a social work colleague who has experience 
with working with cancer patients in the study setting. Interview questions focused on 
approaches that HCPs take when discussing the treatment of osteosarcoma with Zulu patients 
and the cultural considerations pertaining to this discussion.  
 
Participants and Sampling 
We recruited participants using census sampling. All 23 study participants were members of 
the multidisciplinary team involved with the care of Zulu patients with osteosarcoma. Five 
team members could not participate due to scheduling conflicts. Only four of the participants 
were isiZulu speaking highlighting the culturally discordant medical encounters at this health 
facility. For purposes of describing the sample and contextualising the findings, the 











Table1: Focus group demographic information (n=23) 
 
Orthopaedic consultants and registrars n=9 
Registered nurses from orthopaedic wards, orthopaedic clinic, oncology 
clinic and pain service 
n=5 
Allied health professionals (physiotherapists, occupational therapists, 
dieticians, social worker) 
n=9 
Gender 
     Males 




Ethnic Group (South Africa) 
     White 
     Indian 
     African (Zulu) 








Data Collection, Analysis and Trustworthiness 
The second author, an experienced qualitative interviewer, conducted the focus groups as she 
had no prior knowledge of the participants. The focus group interviews were conducted at the 
hospital as the participants work in a resource constrained environment and ranged in 
duration from 54 to 95 minutes. Interviews were audiotaped, transcribed verbatim and 
analysed for themes (Braun, 2006). The data was independently coded by the focus group 
interviewer and the primary investigator and further reviewed by two qualitative research 
experts before consensus was reached on the themes. Guba’s Model of Trustworthiness 
(Lincoln and Guba, 1985) was used to ensure rigour. 
 
Ethical Approval 
Ethical clearance to conduct the study was obtained from the Biomedical Research Ethics 
Committee at the University of KwaZulu-Natal. Anonymity was enhanced as the focus group 
interviewer had no prior contact with the participants. Voluntary participation and informed 




Three themes emerged from our focus group interviews. The first theme reports on the 
communication with Zulu patients about treatment options. The second theme highlights the 
cultural factors associated with the treatment discussion, and the last theme focuses on 
strategies used to respond to these factors. Importantly, the focus group process was 
transformative (De Laine, 2000) as it allowed for the Zulu HCPs to educate other participants 
about Zulu cultural beliefs and practices which enhanced awareness of cultural factors to be 
taken into account when communicating with Zulu patients.  
 
Communicating with Zulu patients about treatment  
This theme outlines the content, process and emotional aspects of the treatment discussion. 
 
Communicating about treatment options 
HCPs reported that the type of surgical procedure (limb salvage surgery or amputation) 
depended on whether (1) the tumour could be excised with wide margins and (2) a functional 
reconstruction of the limb could be achieved. If limb salvage surgery was a possibility, the 
orthopaedic physician explained to the patient that the cancer would be excised and replaced 
with a prosthesis. Participants also informed patients that chemotherapy was needed to shrink 
the tumour so that it was safer to excise it and salvage the limb. HCPs showed patients a joint 
replacement, explaining that limb salvage was like a knee replacement on a larger scale. 
 If patients required amputation, HCPs reported informing them that this was the only 
option. They informed patients without metastases that amputation would be potentially 
curative. They advised patients with lung metastases that metastasectomies could be 
performed. 
 Participants reported explaining to patients with borderline tumours (when HCPs are 
uncertain whether limb salvage or amputation will be performed) that they would first 
administer chemotherapy to shrink the tumour and would only subsequently make decisions 
about limb salvage or amputation. They perceived that patients tended to understand the 
explanation of chemotherapy shrinking the tumour. If amputation was the only option 
following chemotherapy, HCPs informed patients that if the tumour was removed and limb 
salvage was attempted, the limb would not be functional following tumour resection. They 




I say look there is no way for us to take the tumour out and the leg to remain you 
will have no blood flow to the leg or no feeling in the leg… we have to do an 
amputation. 
 
The process of discussing treatment with the Zulu patient 
HCPs proposed that patients should be told at the initial visit that treatment would be 
discussed in greater detail once the diagnosis was confirmed. They reported that this was 
difficult to achieve as patients requested treatment information immediately following 
diagnosis. Participants opted to discuss treatment options after informing patients of the 
prognostic consequences of not treating the tumour. Participants indicated that life-saving 
treatment discussions should be reserved for after the results of local and systemic staging 
investigations were available. They stressed that patients should be informed promptly, and 
emphasized noting that surgery is only one management possibility. Participants described 
how patients tended to only hear certain parts of the discussion at a time; they recommended 
repeating treatment options several times.  
 
The patient usually wants to know immediately. They say okay fine, I have got 
cancer but what are you going to do about it? 
 
 Participants suggested that the stages of cancer be used to communicate with patients 
about the unpredictability of disease progression. As the disease progressed, this change in 
stage could be used to explain adjustments in treatment goals. Patients should be informed of 
what is realistically possible in terms of treatment given the stage of the disease.  
 
So you give them the options and say listen, if we have got all the staging… this is 
what we need to do as a best shot to try and save your life. 
 
 Orthopaedic physicians indicated that they were careful about the language used in 
order to balance hope with honesty. They avoided using the word “save”, preferring instead 
the “best chance to save”. They told patients there were no guarantees, so as not to create 
false hope.  
 
Patient and provider emotions regarding the treatment discussion 
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Participants were concerned patients would react negatively if a patient-provider relationship 
had not been established prior to discussing drastic treatment options. Patients typically broke 
down when amputation was mentioned: they were very sad, tended to withdraw and 
sometimes refused hospital treatment. After discussing treatment options, especially 
amputation, patients usually wanted to return home to consult with elders, family members, 
and/or traditional healers. Often they did not return, delayed returning (which worsened 
prognostic outcomes), or, upon returning, refused further treatment.  
 
…they know they are going to have an amputation, they are very sad. I had a 
patient who, I just went to greet him and he sobbed. He pulled his blanket over 
his head and cried like a baby. 
 
...as soon as you say well the treatment that would help you the most is an 
amputation… that's then when everything becomes a problem.  That's when the 
whole communication breaks down, as soon as you say amputation, they shut 
down completely and they don't listen any further from there... 
 
 Participants found that patients typically responded well to the option of limb salvage. 
 
…people normally don't worry too much about that, if they hear… that they can 
keep their leg… they normally relax and they are not worried… 
 
 HCPs reiterated that they experienced a sense of urgency during the treatment 
discussion. They felt pressured to act before the disease spread, especially in non-metastatic 
cases. They were concerned about being direct with patients regarding the implications of not 
treating the condition, but insisted that truth-telling was the best approach. Orthopaedic 
physicians that were not Zulu felt disadvantaged as they perceived that traditional healers are 
able to claim cure while they are ethically and legally mandated to ensure that patients are 
well-informed.  
 




You can understand why we had such a massive disadvantage compared to a 
traditional healer.  They are not bound by medico-legal, I can sue you type of 
ethics. (They say) I will cure you and everybody has a big party… Because you 
are ethically bound and legally bound to tell the patient everything to take 
informed consent, you tell them it can kill you, it may very well kill you.  If we 
don't do anything it will kill you, if I operate on you, you can die on the table.  If 
we do everything and it goes perfectly it might come back later and kill you.  We 
just end up saying all these horrible things. 
 
Cultural factors influencing the treatment of osteosarcoma 
Participants reported that culture plays a significant role in the discussion of treatment. 
 
Zulu cultural and health beliefs 
HCPs indicated that some patients were concerned about community exclusion post 
amputation. They also reported that Zulu patients’ cultural beliefs dictate that they cannot 
become an ancestor if they have an amputation because their body would be incomplete. 
Participants suggested that these cultural beliefs were changing, as more patients were 
consenting to amputation. They attributed this change in belief to education initiatives on the 
radio.  
 
…that's part of the belief… once you have an amputation then you don't really 
belong to that community… they don't really accept you that well… 
 
...and he died from it in the end, from a giant cell tumour… he said if you 
amputate me I won't become an ancestor, so I am refusing… 
Is that changing? Because we are getting more consent for amputations… 
It is changing, there is a lot of discussions that are actually going on about that… 
Radio works well, they speak about these things (cultural beliefs). 
 
 Participants indicated that patients and/or their elders wanted to engage in traditional 
healing in an attempt to achieve cure and prevent amputation. Traditional healers can claim 
cure, which results in the community rejoicing. Patients preferred to go home as opposed to 
complying with HCPs’ proposal to invite family members to the hospital. Participants were 
98 
concerned that patients would neglect Western medicine when traditional options were seen 
by patients as mandatory. 
 
...they will tell you I want to go and see a traditional healer. 
 
So the intention with going to consult a traditional healer is because you as a 
patient believe that there is cure… 
 
…I do try and see if we can get any means to get to the family to come but most of 
the times they want to go back home rather than bringing someone. 
 
So how about going back home… they (the elders) will point out there is a good 
traditional healer that might help... but now they forget about the Western part of 
medicine. 
 
 Zulu HCPs discussed the cultural hierarchies in Zulu families and the significance of 
these hierarchies in decision-making. Participants reported that patients need to consult with 
their elders before agreeing to treatment even when they understood the nature of the 
condition.  
 
…we have hierarchies at home, from my father, to go down to my uncles and 
everybody… And then the issue will be discussed with all of them and then they 
will come up with their own inputs… 
 
 HCPs were concerned that the cultural decision-maker might not have insight into the 
patient’s condition and that patients would be deserted by the cultural hierarchy if they 
ignored their advice and made decisions independently.  
 
If you disregard or ignore her decisions, she (an identified elder) will decide to 
pull out and you feel that you are on your own… If let's say you have made a bad 
decision, she will say, but I told you and you went on and you got it wrong and 




Patient disclosure of traditional beliefs to providers 
HCPs perceived that patients’ willingness to share their cultural beliefs is an individual 
preference. Some patients withheld their desire to consult a traditional healer; others admitted 
to this need. There was no consensus regarding patients’ disclosure preferences. Some 
patients disclosed their traditional beliefs with greater ease to Zulu healthcare professionals 
whereas others more easily disclosed these beliefs to non-Zulu caretakers when prompted.  
 
You find that there’s a sister at our front desk, let’s say it’s a white sister or an 
Indian sister, she will prefer to come to me maybe because of the language 
barrier. (Zulu nurse participant) 
 
Most of the time if you actually speak to them (Zulu patients), (and ask them) are 
you going to go and see someone (traditional healer), they will tell you, well 
actually… you see… 
 
 Conversely, participants observed a link between patients’ reluctance, fear or 
embarrassment to disclose cultural beliefs and their perception that Western medicine is 
against cultural beliefs. Patients may therefore perceive that HCPs would try to hinder their 
compliance with cultural expectations.  
 
I think they are scared to tell us because they think we believe that it's you 
know… 
And that we are going to try and stop them. 
 
Especially that they know that at the hospital there’s that thing of medical, you 
know, against cultural… 
 
Responding to cultural factors associated with the treatment discussion 
Strategies for responding to the cultural factors associated with amputation and patients’ 
cultural and health beliefs emerged from the data. 
 
Strategies for responding to cultural factors associated with amputation 
Timing the treatment discussion was viewed as a means of preventing the patient from 
signing refusal of hospital treatment (RHT) before diagnostic testing was complete. HCPs 
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emphasized the importance of not answering questions regarding treatment options for 
osteosarcoma before the diagnosis was confirmed.  
 
I generally then stop and say well let's not talk about that now, let's focus on 
finding out what it is first and then once we know we will talk about what the 
possibilities are for treatment after that.   
 
 Another proposed strategy involved introducing patients to veteran patients. 
Participants suggested accessing patients who have been through the process successfully as 
models; including a patient model in the MDT to inspire newly diagnosed patients; and 
making a video of patients with successful outcomes. Exposure to veteran patients could 
result in ongoing support and demonstrate survival and the efficacy of Western medicine. 
However, patient models could demise and this should be considered when making these 
introductions. Using known characters/celebrities with access to better resources could create 
false expectations and should be avoided. 
 
Like somebody who has gone through it (Zulu patient with amputation) and they 
can say look I am out of it on the other side, this has actually helped me. 
 
 Participants tended to respond to refusal of amputation by: (1) offering patients other 
treatment options like chemotherapy; (2) facilitating follow up with oncology and other 
services like psychology, social work and dietetics, and (3) mobilising support by including 
the psychologist in diagnosis and treatment discussions where possible.  
 
…because if we get a diagnosis and he then refuses amputation but is willing to 
stay we can still do... chemo and (facilitate follow up from) dietitians and 
psychologists… oncology. 
 
Strategies for responding to cultural and health beliefs that affect treatment 
Participants reported needing to balance cultural sensitivity with the urgency for prompt 
treatment.  HCPs accepted their onus to initiate discussions about cultural requirements in 
order to fast track decision-making.  
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…ask this patient what is important to them and how do they see themselves 
managing this, do they feel they need to go to the Sangoma (traditional healer). I 
think time is also wasted because we expect the patient to tell us their needs 
like… I want to go home to discuss this…whereas if we initiated it and said what 
do you want to do now, what does your family think needs to happen we would 
maybe know on day one or day two… 
 
 HCPs’ emphasized the importance of acknowledging patients’ need to discuss 
treatment with their family and encouraging patients to engage in their cultural traditions. 
They suggested that patient guilt regarding choosing Western medicine could be mediated by 
encouraging cultural rituals. Participants also reported encouraging patients to follow 
Western and traditional approaches to managing health and illness.  
 
…I do understand that you, you want to discuss with the family… 
 
…you don’t want them to feel guilty about not following the culture but following 
the Western medicine culture. 
 
 Participants reported that they tried to liaise directly with family and cultural decision-
makers where possible. This practice improved communication. Negotiation was frequently 
used to persuade patients to not go home; rather suggesting they invite family members to the 
hospital. 
 
…if they say they want to speak to their family, what I usually do (is ask the 
patient) can't you get someone to come so that we can explain to them and then 
that person can go and explain to the family what is happening… 
 
 HCPs reported that when patients insisted on going home they gave the patient a 
deadline for returning from the family consultation and explained to the patient that the 
traditional healer would not be able to assist just as Western medicine could not cure every 
illness. They also reiterated with patients that the final decision was with them and not with 
the family. Participants ensured that patients were still well-informed.  
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…I do explain to them that okay it is your decision, whatever treatment 
options that we are going to give you.  It's your decision to make, it's not 
somebody else’s decision at home… 
 
 Participants proposed specific strategies for culturally competent communication. They 
reiterated not making assumptions based on culture and race, proposed taking responsibility 
for learning about the Zulu culture, and suggested including traditional healers in patient care.  
 
I think culture is very specific to an individual, we mustn’t think that all black 
patients are going to have that same culture… 
 
…the Department of Health as a government department needs to find a way to 
incorporate traditional healers into the medical setting. 
 
Discussion 
Communicating with Zulu patients about treatment  
Healthcare professionals in this study highlighted how they approached the task of discussing 
the treatment options for osteosarcoma with Zulu patients. The facts that the HCPs presented 
to patients were consistent with factual accounts in the literature (Errani et al., 2011; Luetke 
et al., 2014; Murphey et al., 1997; Ritter and Bielack, 2010). The process aspects of treatment 
discussions centred on delaying treatment information until staging investigations were 
completed; being clear about the consequences of not treating the tumour; balancing hope 
and honesty; and ensuring patient understanding by using analogies, repeating information, 
and by using the stages of cancer to explain disease progression and realistic treatment 
options.  
 Previous works have emphasised the importance of executing treatment discussions in a 
manner that engenders patient cooperation (Baile et al., 2000; Girgis and Sanson-Fisher, 
2010). HCPs in this study worked to engender such cooperation by acting promptly and 
encouraging patients to do the same in light of their late stage at presentation (Ferreira and 
Marais, 2012). Although it has been suggested that patients’ readiness to hear treatment 
information should be assessed only after sharing the diagnosis and prognosis (Baile et al., 
2000; Girgis and Sanson-Fisher, 2010), participants in our study reported skipping this step. 
HCPs were concerned about being overly direct with patients, but chose to be frank about 
poor prognostic outcomes in an attempt to communicate the seriousness of the condition. 
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This practice is in contrast to research that has indicated reluctance on the part of HCPs to 
reveal prognostic information (Fried et al., 2003; McGrath, 2002; Prigerson, 1992).  
 Emotional aspects of the treatment discussion pertained mostly to the treatment option 
of amputation. HCPs reported that amputation often evoked negative emotional and 
behavioural responses including an avoidance of treatment until the disease had progressed 
substantially. The latter demonstrates that cultural and health beliefs can negatively affect 
patients’ health-seeking behaviours (Hodge et al., 2014; Merriam and Muhamad, 2013). In 
light of these emotional and behavioural responses, HCPs in our study appreciated the 
importance of the patient-provider relationship (Epstein and Street, 2007; Platt and Keating, 
2007). They could also predict negative emotional responses to amputation which could 
facilitate appropriate management of patients’ emotions; an essential component of the 
breaking bad news process (Baile et al., 2000; Girgis and Sanson-Fisher, 2010; Narayanan et 
al., 2010).  
 
Cultural factors influencing the treatment of osteosarcoma and their management 
HCPs in this study demonstrated considerable knowledge of Zulu cultural beliefs and 
practices, a characteristic deemed essential for working in cross-cultural clinical settings 
(Mullin et al., 1998; Pierce, 1997; Tucker, 2013). They emphasised taking responsibility for 
learning about the Zulu culture (Matthews-Juarez and Juarez, 2011; Muñoz-Antonia, 2014; 
Pesquera et al., 2008). Cultural aspects reported on included the belief of having to remain 
intact in order to become an ancestor after death; the fear of being excluded from the 
community post-amputation; the belief in traditional healing as a means of cure; and the role 
of the cultural hierarchy in decision-making. HCPs also reflected on patients’ disclosure 
preferences and patients’ hesitation to disclose their cultural beliefs given their perception 
that Western healthcare professionals may hinder their desire to observe their traditions 
(Davis et al., 2012; Robinson and McGrail, 2004; Shelley et al., 2009). 
 HCPs reported on patients’ cultural beliefs regarding amputation. Proposed strategies 
for addressing Zulu patients’ responses to amputation included timing the treatment 
discussion, and using patient models or videos of patients who have successfully rehabilitated 
after amputation as a means of easing patient anxieties and facilitating decision-making 
(Baile and Beale, 2001; Krouse, 2001; Schofield et al., 2008). Participants ensured that 
patients received care whether or not they chose amputation. If patients refused amputation, 
HCPs offered other treatment options, facilitated follow up from oncology and allied health 
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professionals, and mobilised support by including the psychologist in diagnosis and treatment 
discussions where possible (Baile and Beale, 2001; Girgis and Sanson-Fisher, 2010). 
 Participants reported on patients’ belief in traditional healing. Strategies for responding 
to this cultural factor included encouraging patients to engage in their traditions, 
demonstrating respect for patients’ preference to consult traditional healers, and proposing 
that patients combine traditional and Western medicine (Broome and Broome, 2007). Patients 
with traditional belief systems associate consulting a traditional healer with hoping for a cure 
and receiving spiritual and physical gain from the consultation (Muhamad et al., 2012). 
Participants were concerned about the paradigm divide of the hope of a miracle cure from 
traditional healers versus the Western medical message of no cure (Summerton, 2006). 
Research has shown that patients from indigenous populations, especially when diagnosed 
with a life-threatening illness such as cancer, may integrate Western medicine and traditional 
healing (Broome and Broome, 2007; Muhamad et al., 2012; Struthers and Eschiti, 2004). 
However, our study highlighted a concern that patients would neglect Western medicine 
when they returned home to engage in their traditions. HCPs also experienced that patients 
tended to delay returning to the hospital or avoided medical treatment completely.  
 Proposed strategies for fast-tracking treatment decision-making included initiating 
cultural discussions, liaising directly with the cultural decision-makers regarding treatment 
(Barclay et al., 2007; Broome and Broome, 2007), and suggesting that family members come 
to the hospital as opposed to patients going home. Most patients using alternatives to Western 
medicine may have an expectation of the clinician to initiate the discussion regarding these 
practices (Shelley et al., 2009). Furthermore, given the fact that the Zulu culture is located in 
a collectivistic paradigm where patients tend to defer to the collective for decision-making 
(Iwelunmor et al., 2014), liaising directly with cultural decision-makers may fast-track 
treatment. Despite HCPs’ proposing that patients invite family members to come to the 
hospital, patients mostly insisted on returning home. Participants then tended to give patients 
a deadline for returning, warned them that traditional healing may not be effective, reminded 
patients that the ultimate decision was theirs, and ensured that patients were well-informed 
about their condition. These strategies denote a paternalistic, individualistic approach and 
demonstrate limitations with regard to veritable understanding of patients’ cultural 
paradigms. Patients who have cultural health beliefs embedded in traditional healing believe 
in the curative capacity of traditional medicine (Muhamad et al., 2012). Similarly, reinforcing 
individualism with regard to decision-making negates the collectivistic paradigm within 
which Zulu patients operate (Washington, 2010). Although HCPs might be well-intentioned 
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and focused on life-saving, strategies used for patients that insist on going home are not 
indigenously collaborative and favour Western approaches to medical decision-making. 
HCPs in this study demonstrated a willingness to engage collaboratively cross-culturally. An 
awareness of the use of paternalistic strategies in response to patients that insist on going 
home will therefore assist HCPs to change this approach. 
 
Limitations of this Study 
Although themes were repeated within the focus groups, all members of the MDT were not 
available for data collection, and this may have limited our ability to achieve data saturation. 
Furthermore, our use of discipline specific focus groups may have restricted our opportunity 
to assess the inter-professional functioning of MDT members. We also note that the use of 
other qualitative data-gathering techniques may have complemented the focus groups and 
enhanced our data.  
 
Conclusion 
This study, the first of its kind in the South African context, explored how treatment of 
osteosarcoma is discussed across specific cross-cultural boundaries, characterized cultural 
factors associated with discussing treatment options, and identified strategies for responding 
to these factors. Cultural factors highlighted included patients’ beliefs about amputation, their 
need to access traditional healing and their requirements regarding collective treatment 
decision-making. Participants highlighted the importance of balancing respect for patients’ 
cultural preferences with the need to expedite treatment decision-making in order to improve 
prognostic outcomes. Their proposed strategies for responding to patients’ aversive responses 
to amputation entailed timing the treatment discussion, using patient models and visual media 
to ease patient anxieties, referring patients appropriately, and mobilizing support. Strategies 
for attending to cultural and health beliefs impacting on treatment decision-making included 
initiating the cultural discussion, seeking and demonstrating an understanding of patients’ 
cultural beliefs, liaising directly with family and cultural decision-makers, learning about the 
patient’s culture, and working collaboratively with traditional healers. While participants 
reported significant efforts to provide culturally competent care, medical paternalism 
emerged in response to patients that insisted on going home to engage in their traditions.  
 The strategies that we present will be useful in other cross-clinical settings where 
patients belong to collectivistic cultures and observe traditions and other practices that are 
significantly different to Western medical approaches. We recommend that guidelines for 
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culturally competent communication with cancer patients explicitly discuss the issues of 
managing culturally discordant treatment options. This study will contribute to the 
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Communicating about prognosis with regard to osteosarcoma in a South African cross-cultural 
clinical setting: Strategies and challenges  
 
ABSTRACT 
Objectives: Effective prognostic communication with patients is a prerequisite for treatment decision-
making, yet it is a difficult task to manage with confidence. This paper explored the strategiesused 
and challenges faced when communicating about prognosis in a cross-cultural clinical setting.  
Methods: We used a qualitative exploratory descriptive contextual design and gathered data using 
focus group interviews with healthcare professionals. Twenty-three healthcare professionals 
participated in three focus groups. We analysed the data thematically. Guba’s Model of 
Trustworthiness was used to ensure rigour.  
Results: Our findings revealed strategies for communicating about prognosis. Assessing patient 
emotions and knowledge and providing patients with clear prognostic information emerged as 
prominent strategies. Healthcare professionals proposed communicating frankly about the 
consequences of not treating osteosarcoma, treatment limitations, metastases and poor prognoses. 
They also suggested presenting prognostic information in a staged approach, normalising death, and 
not specifying life expectancy. In addition, informing patients that a palliative amputation would help 
with pain management emerged as a strategy for instilling hope. Various patient, provider and disease 
factors were identified as challenges when discussing prognosis.  
Significance of the Results: Deviations from Western research findings emphasized the need for 
studies exploring prognostic communication in cross-cultural encounters. Our study highlighted the 
need for creative and thoughtful approaches to communicating sensitive information in cross-cultural 
clinical settings.  
 






Effective prognostic communication with patients is a prerequisite for treatment decision-making and 
future planning that is commensurate with patient preferences (Robinson et al., 2008). However, 
communicating about prognosis is widely documented as a challenging task (Back et al., 2008; 
Hagerty et al., 2004; Lamont & Christakis, 2003; Russell & Ward, 2011). Patients typically have 
varied preferences regarding prognosis information (Innes & Payne, 2009) that are sometimes 
complicated by cultural and family expectations and demands (Russell & Ward, 2011). In addition, 
the medical literature provides conflicting directives. Some studies indicate that patients want and 
need detailed information, and other studies report that patients want to limit their discussions about 
poor prognoses (Back et al., 2008).  
 This study was conducted with healthcare professionals working in a cross-cultural clinical 
setting in KwaZulu-Natal, South Africa. The study is part of a larger project aimed at developing an 
evidence-based practice guideline for communicating with Zulu patients diagnosed with 
osteosarcoma. The Zulu people are indigenous and place great value on traditional belief systems and 
oftentimes prefer a family-centred model of medical decision-making (Russell & Ward, 2011) 
especially when the proposed surgical treatment option is amputation (Chapter 4). A 2012 study 
revealed that 66.67% of the patients presenting at the study site with osteosarcoma between 2009 and 
2011 already had metastatic disease (Ferreira & Marais, 2012). Healthcare professionals (HCPs) 
therefore find communicating prognosis to be especially challenging in this cross-cultural context as 
patients present late for treatment and tend to practice systems of healing and decision-making that are 
different to the Western medical system.  
 Prognostic communication literature often advocates the patient-centred approach proposing 
individualised assessments of what patients want to know (Back & Arnold, 2006; Ngo-Metzger et al., 
2008). A staged approach to providing prognostic information (Del Vecchio Good et al., 1990) and 
respecting the fact that patients sometimes prefer to maintain some ambiguity about the future (Innes 
& Payne, 2009), has also been recommended. Prognostic information needs to be varied not only 
between individuals but also for a given individual over time (Russell & Ward, 2011). Patients have 
also indicated that even when they wanted detailed information, they preferred to negotiate the extent, 
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format, and timing of the information they received (Hagerty et al., 2004). The healthcare 
professionals in this study may experience difficulties in implementing these proposed strategies. 
Given the late presentation of patients at the study site, HCPs have to communicate diagnostic and 
treatment information urgently. The treatment options are closely related to patients’ understanding of 
their prognosis and the outcomes resulting from various approaches to treatment. This paper explores 





This study was conducted at a tertiary hospital in the province of KwaZulu-Natal (KZN), South 
Africa. The hospital forms part of the national public health system that serves more than 80% of the 
South African population. The majority of the patients receiving services at this hospital are of Zulu 
origin. Zulu patients speak isiZulu, one of South Africa’s 11 official languages, while healthcare 
professionals mostly speak English or Afrikaans. The hospital’s Tumour, Sepsis and Reconstruction 
Unit (TSR), dedicated to the treatment of musculoskeletal tumours, is the only one of its kind in 
Western KZN and services a population of more than 3.5 million people.  
 
Research Design and Methods 
We used a qualitative exploratory descriptive contextual design. We gathered data from three separate 
focus group interviews with orthopaedic consultants and registrars; allied health professionals 
including dieticians, occupational therapists, physiotherapists, and a social worker; and nurses from 
the orthopaedic and oncology outpatient clinics and wards. The focus group interview schedule was 
piloted with a social work colleague who has experience with working with cancer patients in the 
study setting. Questions explored how HCPs discuss prognosis with patients and also investigated 
how HCPs responded to questions from patients regarding prognosis if they chose not to discuss 
prognosis with patients.  
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Participants and Sampling  
The TSR Unit uses a multidisciplinary team (MDT) approach to managing patients diagnosed with 
osteosarcoma. The MDT comprises the orthopaedic consultants and registrars, the allied health 
professionals (physiotherapists, dieticians, occupational therapists, social workers, clinical 
psychologists) and orthopaedic and oncology nursing staff. We used census sampling and invited all 
these members of the MDT to participate in the focus groups. Twenty-three HCPs participated and 
five were not available due to scheduling constraints. Demographic information regarding participants 
is presented in Table 1 in order to contextualise the findings. Four Zulu healthcare professionals 
participated in the study thus emphasising the fact that medical encounters are largely culturally 
discordant at this tertiary hospital.  
 
 
Table1: Focus group demographic information (n=23) 
 
Orthopaedic consultants and registrars n=9 
Registered nurses from orthopaedic wards, orthopaedic clinic, oncology 
clinic and pain service 
n=5 
Allied health professionals (physiotherapists, occupational therapists, 
dieticians, social worker) 
n=9 
Gender 
     Males 




Ethnic Group (South Africa) 
     White 
     Indian 
     African (Zulu) 








Data Collection, Analysis and Trustworthiness 
The second author, an independent researcher with qualitative expertise and with no prior knowledge 
of the participants conducted the focus group interviews. The interviews ranged in duration from 54 to 
95 minutes and were audiotaped and transcribed verbatim. We used thematic analysis (Braun & 
Clarke, 2006) to analyse the data. The primary researcher and the focus group interviewer 
independently coded the data, and themes were then discussed and agreed upon. Themes were further 
independently reviewed by two qualitative research experts. Following multiple discussions with all 
three qualitative experts, themes were then finalised. The data analysis process was an iterative one. 
Guba’s Model of Trustworthiness was used to ensure the rigour of the data collection and analysis 
processes (Lincoln & Guba, 1985; Shenton, 2004).  
 
Ethical Approval and Considerations 
We obtained ethical approval for the study from the Biomedical Research Ethics Committee at the 
University of KwaZulu-Natal. Participation was voluntary, and written informed consent was 
obtained from all participants. 
 
RESULTS  
The findings highlighted the specific strategies that HCPs reported using when discussing prognosis 
with Zulu patients diagnosed with osteosarcoma. The challenges that the study population 
encountered with regard to this prognostic discussion are also outlined. Participants reflected on the 
transformative nature of the focus groups (De Laine, 2000) as it created an opportunity for reflection 
on practice, and co-construction of culturally relevant strategies for communicating prognosis. 
 
Strategies for managing the prognostic discussion 
This theme highlighted the strategies that the participants reported using in managing the prognostic 
discussion.  
Strategy 1: Assess patient emotions and knowledge 
HCPs indicated that they first enquired about patients’ thoughts, fears, and impressions of the future. 
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So I try to first find out what are their thoughts, what are they scared about, what are 
they feeling is going to happen and patients do know, especially prognosis, they do know 
when the end is near… 
 
Strategy 2: Provide patients with realistic prognostic information 
Participants indicated that they informed patients about the prognostic consequences of not treating 
the osteosarcoma and also preferred to communicate honestly about treatment limitations, metastases 
and poor prognoses. The late presentation of patients and additional time required for cultural 
practices meant that HCPs had to share prognostic information urgently in order to fast-track 
treatment decision-making.  
 
Strategy 2.1: Inform patients about the prognostic consequences of not treating osteosarcoma 
HCPs informed patients that if left untreated, the cancer would spread and the patient would not 
survive. Patients requiring amputation typically requested to go home to consult traditionally and 
perform rituals if indicated, thus causing treatment delays. HCPs were therefore especially direct with 
these patients. Participants sometimes phrased this discussion by informing patients that if nothing 
was done this would be bad and if the amputation was done there was a chance of survival.  
 
I tell them that if left untreated it can spread and it will kill you.   
 
I am saying if we do nothing it's bad, if you do something there is a chance of a good 
result. 
 
Strategy 2.2: Inform patients about treatment limitations 
Participants informed patients about treatment limitations. They explained the nature of osteosarcoma 
to patients and informed patients that this type of cancer was not curable. Participants cautioned 
against telling patients that amputation could cure due to the possibility of recurrence. 
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And then I typically explain that this cancer is not curable… osteosarcoma… if you leave 
it untreated it will kill you… 
 
Participants reported that they informed patients that even with surgery the cancer could recur. HCPs 
reiterated that patients had to return within six months and then annually to check for cancer 
recurrence.  
 
…it might spread later, you know even if we take it out now and we do an amputation 
now it does not mean that the cancer can't come back. 
 
Strategy 2.3: Inform patients that they have metastases 
When patients had metastases, HCPs informed them that the condition was not curable but that 
amputation could help with pain. Patients were informed that limited intervention was possible due to 
the metastases. 
 
…if we know that it's a metastatic disease and it is not curable to tell them that it has 
spread already, we can do something about the pain that they have in the leg and the 
amputation will help for that pain for example but it has already spread and we can't do 
much about that. 
 
Strategy 2.4: Inform patients about a poor prognosis 
HCPs highlighted being honest with patients about the terminal nature of the disease if the 
osteosarcoma was reasonably expected to result in the death of the patient within a short period of 
time. The period of time was not specified. 
 




Strategy 3: Use a staged approach  
Some of the allied health participants indicated that they dealt with prognosis in stages because the 
condition entailed long-term treatment. They focused on immediate goals and if the disease 
progressed, goals were adjusted to maintenance or palliative care.  
 
I would deal with it in phases because as we said it is a long term treatment and we are 
going to wait and see. For now your issue is this so our goals will be this. If it became 
worse, then we are going to change our goals to either maintenance or palliative care. 
 
Strategy 4: Normalise death  
Participants approached talking to patients about dying by trying to normalise death. HCPs told 
patients that everyone is going to die and extended this explanation by indicating that they too could 
die at any time. Participants indicated that they could not specify when the patient would die. They 
informed patients that it could be a long time and that they could die from something else as well.  
 
…I can drive out of the hospital and you know get into an accident and die and you may 
still survive for quite a long time after that, so everyone is going to die… 
 
Strategy 5: Do not specify a time frame 
Participants reported informing patients about poor prognoses but emphasised that patients should 
never be informed of their life expectancy. Some participants indicated that they would not know how 
to respond to a question about life expectancy.  
 





Challenges related to communicating about prognosis 
Although the participants were able to propose a number of strategies for communicating about 
prognosis, the prognostic discussion presented a number of challenges that HCPs did not know how to 




HCPs reported that patients’ emotional responses varied from being in denial to being overly 
optimistic. Participants were also concerned that patients would view treatment as futile when they 
were informed of poor prognoses. They had experienced that informing a Zulu patient about a poor 
prognosis in relation to cancer often resulted in these patients not returning to the hospital. HCPs 
hypothesized that this was possibly due to patients believing that they were going to die regardless. 
Participants also experienced that patients stopped listening when they were informed of poor 
prognoses. 
 
…of course some patients are in denial, some patients are overly optimistic… 
 
…once we start saying no you are going to die because of cancer then they are not going 
to come back to you. 
 
 Participants observed that patients did not ask about prognosis and indicated that some patients 
may not want prognostic information. Participants also noted that they would want to know the odds 
of surviving but that Zulu patients had never asked them about the odds of survival.  
 
…you know if someone tells me okay you have got cancer, it hasn’t spread, if we do an 
amputation that is potentially curative, my thing will be okay what's the chances of that 
being curative?  You know that would be my first question.  So what are my odds? No 
one has ever asked me that. 
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Healthcare Provider Factors 
Competency concerns and lack of training regarding communicating about prognosis were reported. 
Allied health professionals experienced that there was unclear communication of prognostic 
information.  
 
From a physio side it can be a bit difficult when patients ask you am I going to die from 
this you know… whereas not being fully medically trained in that aspect we can’t always 
answer those questions for patients. 
 
…the problem is nobody tells you, say this and then say that… 
 
 Certain role expectations emerged amongst the HCPs with regard to who should communicate 
with patients regarding prognosis. Nurses were of the opinion that it was ethical procedure for doctors 
to communicate the prognosis to patients. They indicated that they often interpreted prognostic 
information for doctors. 
 
…call the doctors and they would explain… 
 
…you always let the doctor tell the patient the prognosis but we’re always standing 
there… 
 
 HCPs had varied perspectives regarding discussing prognosis with patients. Some were of the 
opinion that patients should determine how much they wanted to know. Other participants were 
unsure of whether to discuss poor prognoses with patients. They were concerned that informing 
patients accordingly could be adding to the bad news of the diagnosis and result in loss of hope. Some 
HCPs expressed discomfort about talking about prognosis whereas others felt that they would be 
withholding the truth if they did not inform patients about a poor prognosis. Discussing prognosis was 
especially challenging when HCPs had to inform patients requiring a palliative amputation that 
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despite the amputation they would still have limited life expectancy. They were guarded as they did 
not want to create false hope. 
 
I know there are some people that would say you mustn’t tell people if they are 
terminally ill, that they are going to die. 
 
I don't feel comfortable talking about prognosis… 
 
I find prognosis being the most difficult one to deal with when they say for a palliative 
amputation… 
 
 HCPs reported struggling with the timing of the prognostic communication. Zulu patients often 
insisted on going home to consult with the elders and perform rituals after being informed about 
treatment options especially when this entailed amputation (Chapter 4). This left HCPs in a difficult 
position regarding the timing of informing patients regarding prognosis especially when a delay in 
treatment would result in a poor prognosis. Participants were concerned that when patients went home 
they would be preoccupied with being told about a poor prognosis instead of focusing on consulting 
the decision-makers regarding proposed treatment options. 
 
You know as soon as they get home they say, the Doctor said I am going to die.  And then 
eventually even if the decision-maker at home or the family sits down and asks about the 
options, the (patient) keeps saying no, I am going to die… the Doctor told me. (The 
patient) is now against whatever they (the family) are saying. 
 
Disease Factors 
Allied health professionals reported on the unpredictable and aggressive nature of osteosarcoma and 
its progression. They indicated that discussing prognosis was difficult because the condition changed 
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so quickly. Treatment could start with rehabilitation and dealing with functional issues which then 
progress to palliative care very quickly. 
 
In my view of prognosis… I don’t know that it can be discussed with the patient because 
it is an osteosarcoma, it can change from the one stage to the other very quickly… 
 
DISCUSSION 
The data revealed several strategies for managing the prognostic discussion with Zulu patients and 
highlighted a number of challenges that HCPs were not able to resolve. Due to the late presentation of 
patients at the study site, HCPs felt compelled to communicate the urgency of treatment with patients 
and this typically included communicating prognostic information. Despite the uniqueness of the 
setting and participants’ competency and training concerns, all the proposed strategies have been 
supported in the literature.  
 HCPs recommended assessing patient emotions and knowledge by asking them open-ended 
questions (Back et al., 2008). They then advocated that patients should receive realistic information 
about the prognostic consequences of not treating the osteosarcoma, treatment limitations, metastases, 
and poor prognoses. This strategy, referred to as realism, can facilitate sound medical decision-
making for both patients and HCPs (Back & Arnold, 2006). However, taking the realistic approach 
without structuring the conversation and demonstrating empathy can be perceived as being uncaring 
(Back & Arnold, 2006). Participants reported that they attempted to phrase information positively.  
 Participants also proposed the strategy of normalising death by talking openly about it and even 
mentioning the self in relation to death. A willingness to talk about death and doing so in a skilful 
manner without fear has been emphasised (Sinclair, 2006; Wenrich et al., 2001). Participants 
preferred not to communicate estimations of life expectancy which is in line with general practice 
(Daugherty & Hlubocky, 2008) and clinical practice guidelines on communicating prognosis which 
recommended that HCPs should avoid being exact about time frames (Clayton et al., 2007). 
 The allied health professionals proposed a staged approach to communicating prognosis (Del 
Vecchio Good et al., 1990; Back et al., 2005; Back & Arnold, 2006; Clayton et al., 2007). This 
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strategy may be challenging at the study site as patients typically present late for treatment (Ferreira & 
Marais, 2012) leaving HCPs with the challenging task of communicating diagnosis, treatment and 
prognosis in close succession or simultaneously. A staged approach may be more useful for patients 
that present with localised or metastatic disease that is amenable to surgical management. 
 The strategy of instilling hope did not overtly emerge from the data. However, participants’ 
tendency to inform patients that a palliative amputation would help with pain management has been 
described as a means of instilling hope (Clayton et al., 2005). Patients have reported that when HCPs 
emphasised what could be done, e.g. pain and symptom control, this fostered hope (Baile et al., 2000; 
Clayton et al., 2005). Hope therefore is not exclusively dependent on cure (Back et al., 2008) and 
should be offered at all stages of the disease (Barclay et al., 2007; Kirk et al., 2004). 
 Participants also reported on challenges to the prognostic communication process that they 
could not resolve. They highlighted Zulu patients’ emotional responses, their beliefs that treatment 
would be futile and their tendency to withdraw when poor prognoses were communicated. These 
reported responses may be associated with Zulu patients’ cultural and health beliefs regarding cancer 
(Chapter 3). The isiZulu word for cancer, umdlavuza, means something that destroys everything or 
something that cannot be stopped (Chapter 3). Participants further indicated that Zulu patients never 
asked about prognosis or the odds of surviving. This is in contrast to Western research which showed 
that most cancer patients wanted some degree of prognostic awareness (Innes & Payne, 2009), with 
metastatic cancer patients wanting detailed prognostic information (Hagerty et al., 2004). Patients’ 
reported tendency to never ask about survival rates is also significantly different from Western trends 
(Hagerty et al., 2004). However, most surveys regarding patient preferences for detailed prognostic 
information have been conducted on English-speaking patients. Little is known about the prognostic 
communication preferences of ethnically diverse populations (Mitchison et al., 2012).  
 The HCPs identified a number of challenges that pertained specifically to them. They 
highlighted competency and training deficits (Butow et al., 2002; Hancock et al., 2007; Russell & 
Ward, 2011) and role expectations regarding who communicated prognosis (Reinke et al., 2010). 
Furthermore, HCPs could not agree on whether patients should be given prognostic information 
(Innes & Payne, 2009). Reasons for preferring nondisclosure centred on HCPs’ discomfort regarding 
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disclosing prognosis (Baile et al., 2000; Hancock et al., 2007; Kirk et al., 2004; Mack & Smith, 2012) 
and concerns that prognostic disclosure would result in negative emotional outcomes for patients 
(Hancock et al., Mack & Smith, 2012) and would destroy hope (Back et al., 2008; Finlay & Cassarett, 
2009; Russell & Ward, 2011). Disclosing a palliative amputation was highlighted as a particular 
challenge. HCPs preferring prognostic disclosure were concerned about withholding the truth from 
patients and argued that patients should be truthfully informed of their prognosis (Hancock et al., 
2007; Wenrich et al., 2001). Being clear about the palliative or curative goals of treatment and 
specifying the outcomes that can be improved by the treatment have been recommended (Clayton et 
al., 2007). Mack et al. (2007) found no evidence that prognostic disclosure resulted in negative 
emotional outcomes or made patients less hopeful. In fact, research showed that honesty about 
prognostic information maintained and sometimes increased hope even in patients with advanced 
disease (Mack & Smith, 2012).  
 HCPs were also unsure of when to give Zulu patients prognostic information. They often went 
home to discuss treatment options with family decision-makers, and HCPs were concerned that they 
would fixate on the poor prognosis if they were given prognostic information before going home. 
Prognostic information should however be provided when there are requests or expectations that are 
inconsistent with clinical judgement (Clayton et al., 2007), as in this case when patients go home to 
consult with decision-makers and often delay returning to the hospital (Chapter 4). Furthermore, 
discussing prognosis facilitates treatment decision-making (Cartwright et al., 2014; Clayton et al., 
2007). Patient knowledge of prognosis has been shown to play a significant role in making 
appropriate treatment choices (Weeks et al., 1998).  
 With regard to disease factors, allied health professionals reported that the unpredictable nature 
of osteosarcoma complicated the prognostic discussion. As the majority of patients presenting at the 
study site have metastatic disease (Ferreira & Marais, 2012), the progression-free survival rate for 
these patients is poor and the condition is usually incurable requiring palliation (Errani et al., 2011). 
Furthermore, in patients with localised disease the 5-year survival rate is 60 to 70% (Errani et al., 
2011) with a 30 to 35% chance of local or systemic recurrence (Bacci et al., 2005). There are 
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therefore survival and disease progression rates available which the allied health professional staff 
may not be aware of as they have not been medically trained. 
Limitations of the Study 
Firstly, all those that were eligible to participate were approached but some MDT members were not 
available at the time of data collection. Secondly, discipline specific focus groups were conducted 
which may have limited interprofessional synergy and data outcomes. Lastly, the use of other 
qualitative data-gathering may have enriched the data. 
 
RECOMMENDATIONS FOR FUTURE RESEARCH  
The study findings provided information on what is said and why it is said however, further 
investigation is required to explore how it is said. Deviations from Western research findings 
emphasized the need for studies exploring prognostic communication in cross-cultural encounters. 
Contextual research on patients’ preferences and suggestions on how to communicate about prognosis 
emerged as a prominent area for future research. Research exploring patients’ experience of the 
proposed strategies would also assist in refining these strategies. 
 
CONCLUSION 
This paper explored strategies used and challenges faced when communicating about prognosis in this 
cross-cultural clinical setting. Patients at this study site present late for treatment, and therefore have 
to receive diagnostic, treatment and prognostic information within close succession or simultaneously. 
In addition, this cross–cultural clinical setting requires that healthcare professionals integrate cultural 
beliefs and practices into their management of patients. Healthcare professionals proposed strategies 
for responding to these unique conditions. They expressed concerns regarding cultural competency 
and highlighted a lack of training regarding prognosis communication. However, they came up with 
strategies that are well documented in the literature. They chose to be innovative and relied on 
experiential knowledge. 
 Importantly, various patient, disease and healthcare provider factors that posed challenges to 
the prognostic communication process were also outlined. HCPs did not necessarily have solutions to 
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these challenges, however some of the factors highlighted demonstrated participants’ sensitivity to 
cultural aspects of patient care. Furthermore, Zulu patients were reported to respond differently to 
prognostic information as compared to Western findings. The strategies reported on in this paper will 
contribute to the evidence-based practice guideline for communicating with Zulu patients diagnosed 
with osteosarcoma. Our study highlighted the uniqueness of this cross-cultural setting and the need for 
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Part 3: Conducting In-depth Interviews with the Zulu Patients 
 
The third part of this study addresses the third requirement for evidence-based practice, namely 
accessing patient preferences. The aim was therefore to obtain patient-based data by conducting in-
depth interviews with Zulu patients regarding how the diagnosis, treatment and prognostic aspects of 
osteosarcoma is communicated to patients, their understanding of the diagnosis and treatment of 
osteosarcoma as well as their experience of the communication of these components. Furthermore, we 
accessed participants’ descriptions of the role of culture in the management of this life-threatening 
illness. Part 2 highlighted the healthcare providers’ voices and Part 3 illumines the voices of our Zulu 
patients diagnosed with osteosarcoma. Chapter six is prepared in the submission format required for 
the journal Ethnicity and Health.  
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Chapter 6: Communication across the osteosarcoma disease trajectory: 
Patients’ factual, emotional and cultural accounts 
 
Brown O., Aldous C., Van Rooyen D., Marais LC. 
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Communication across the Osteosarcoma Disease Trajectory: Patients’ Factual, 
Emotional and Cultural Accounts 
 
Abstract 
Patients’ accounts of the process of receiving information regarding the diagnosis, treatment 
and prognosis of cancer in cross-cultural clinical settings are underreported. This study 
explored how the diagnosis, treatment and prognosis were communicated to patients and 
what patients understood about their diagnosis and treatment. Furthermore, we examined the 
patients’ experiences of this communication and the role of culture in managing the 
condition. We used a qualitative case study approach with in-depth interviews that were 
analysed thematically. Data were verified using Guba’s model of trustworthiness. Our results 
revealed that patients were relatively well-informed regarding diagnosis and treatment 
information. Perceptions of and emotional responses to the diagnosis and treatment of 
osteosarcoma as well as rich descriptions of the cultural and health beliefs, cultural decision-
making processes and rituals practiced emerged. Findings also highlighted the importance of 
providing adequate information regarding diagnosis and treatment side-effects. The 
variability within a culture strongly emerged in this study reinforcing the importance of not 
stereotyping based on pre-existing knowledge of a cultural group. Participants also 
recommended integrating traditional and Western practices and accommodating patients’ 
traditional preferences. The findings of this study will make a meaningful contribution to the 
development of an evidence-based practice guideline for culturally competent patient-
provider communication with Zulu patients diagnosed with osteosarcoma.  
 
Keywords: patient-provider communication; patient emotions; patient perceptions; patient 
knowledge; cultural considerations; cross-cultural clinical settings 
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Introduction 
Patients’ accounts of the process of receiving information regarding the diagnosis, treatment 
and prognosis of cancer in cross-cultural clinical settings are underreported. The South 
African literature is especially scant in this regard (Herselman 1996; Lourens 2013; Mullin, 
Stewart, and Eremenco 1998). This study tries to address that problem. It focuses specifically 
on Zulu patients diagnosed with osteosarcoma. The Zulu people are indigenous to Southern 
Africa. They tend to follow traditional approaches to health and illness. In the eastern South 
African province of KwaZulu-Natal, where the majority of the province population is Zulu, 
70% of patients consult traditional healers prior to visiting physicians or other practitioners 
trained in a Western model (Puckree et al. 2002). Indigenous South Africans commonly 
understand illness as being caused by supernatural forces, triggered by punishment from the 
ancestors, witchcraft or disequilibrium in social relationships, among other reasons (Lourens 
2013; Mdondolo, De Villiers, and Ehlers 2003; Vorobiof, Sitas, and Vorobiof 2001). Zulu 
patients often prefer a family-centred model of medical decision-making (Vorobiof, Sitas, 
and Vorobiof 2001).  
 Clinical observations and research conducted (Chapters 3, 4, 5) at the study site 
highlighted various cultural dimensions that play a significant role in the management of 
Zulu patients diagnosed with osteosarcoma. In addition, the majority of patients presenting at 
the study site already have locally advanced or metastatic osteosarcoma which negatively 
affects treatment options and outcomes for survival (Ferreira and Marais 2012). 
Osteosarcoma is the most frequent primary solid malignancy of bone and is derived from 
primitive mesenchymal cells. Untreated osteosarcomas can result in local and/or metastatic 
disease progression (Ritter and Bielack 2010). Despite advances in treatment of 
osteosarcoma, survival is dependent on diagnosis prior to progression beyond localised 
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disease (Federman et al. 2009). Other challenges identified at the study site included the high 
risk of relapse despite adequate multi-modal treatment as well as poor prognostic outcomes.  
 This study is part of a larger research project aimed at developing an evidence-based 
practice guideline for culturally competent patient-provider communication with patients 
diagnosed with osteosarcoma (Brown et al. 2016). Clinical opinion was explored via focus 
group interviews which were conducted with healthcare professionals at the study site. This 
paper presents the voices of the Zulu patients receiving treatment for osteosarcoma. The aim 
of our study was therefore to explore and describe 1) how the diagnosis, treatment and 
prognostic aspects of osteosarcoma are communicated to patients, 2) their understanding of 
the diagnosis and treatment of osteosarcoma, 3) their experience of the communication of 





This study was conducted at a tertiary hospital in the province of KwaZulu-Natal (KZN), 
South Africa. The study site forms part of the national public health system that serves more 
than 80% of the South African population. The healthcare system in KZN uses a referral 
system and specific referral patterns are followed. Patients may present at their local clinic or 
district hospital and may then be referred to a regional or tertiary hospital depending on the 
nature of the presenting problem. The KZN Department of Health has a transport system 
which brings patients from the local hospital to the tertiary facility. However, patients still 
have to transport themselves from home to their local hospital in order to access the hospital 
transport. Patients may travel as far as 450 kilometres to receive tertiary services. The 
Tumour, Sepsis and Reconstruction Unit that specialises in the treatment of musculoskeletal 
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tumours and the Oncology Department at the study site serve a population of approximately 
3.5 million people.  
 KwaZulu-Natal has a population of 10.9 million people of a total South African 
population of 54 956 900 million (Statistics South Africa 2015). More than half of the 
province is rural (Rural Health Factsheet 2015), unemployment rates are high (Rural Health 
Factsheet 2015, Statistics South Africa 2016) and 56.6% of the KZN population live below 
the upper-bound poverty line (R620 per capita per month in 2011 prices (Rural Health 
Factsheet 2015). Exact statistics are not available but it is estimated that more than 80% of 
the KwaZulu-Natal population is Zulu. The Zulu people speak isiZulu, one of South Africa’s 
11 official languages. Medical encounters are largely culturally discordant at this tertiary 
hospital. HCPs receive medical training mostly in English or at some universities in 
Afrikaans and the majority of healthcare professionals are not of Zulu origin.  
 
Research Design and Method 
We used a qualitative descriptive case study design and conducted in-depth individual 
interviews with Zulu patients. The interview schedule was piloted to ensure that the 
appropriate data would be elicited for the purpose of the study. Questions explored how 
diagnosis, treatment and prognosis were communicated to the patient; what patients 
understood about their diagnosis and treatment; their experience of the communication; and 
the role of culture in managing the condition.  
 
Participants and Sampling  
Convenience sampling was used to gather participants for the study. Adult Zulu patients 
diagnosed with osteosarcoma were approached to participate. Patients were accessed from a 
record held at the Tumour, Sepsis and Reconstruction Unit that treats patients with 
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musculoskeletal tumours. Four participants agreed to participate in the research. One of the 
participants lived locally; another lived 78km from the hospital and the remaining two lived 
159km away. Patient information is presented in Table 1. 
 
Table 1: Patient Information 







Participant 1 Male 27 Unemployed Yes Christian Amputation 
Participant 2 Male 24 Unemployed Yes Christian  Amputation 
Participant 3 Female 33 University 
student  
Yes  Christian Limb 
salvage 
Participant 4 Male 22 Unemployed Yes Christian Amputation 
 
Participants 1 and 3 were diagnosed in 2011 and now attend the Oncology Department at the 
study site for regular follow up. Participant 2 was diagnosed in 2014 and Participant 4 was 
diagnosed in 2014 but only had an amputation in 2016.  
 
Data Collection, Data Analysis and Trustworthiness  
Patients were contacted by isiZulu speaking fieldworkers and invited to participate in the 
study. Skilled interviewers conducted in-depth interviews in isiZulu using a semi-structured 
interview schedule. Interviews were audio-taped, transcribed verbatim and translated into 
English and back translated to check for accuracy of translations. 
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The data were analysed using thematic analysis (Braun and Clark 2006). An experienced 
qualitative researcher independently coded and analysed the data. Guba’s model of 
trustworthiness with its four criteria was utilized to ensure rigour (Lincoln and Guba 1985; 
Shenton 2004). 
 
Ethical Approval and Considerations 
Ethical approval was obtained from the Biomedical Research Ethics Committee at the 
University of KwaZulu-Natal. The interviewer explained the research to participants and 
ensured that participation was voluntary, that written informed consent was obtained and that 
the principles of confidentiality and anonymity were upheld. The cover letter which included 
the consent form was available in isiZulu. 
 
Results 
Eight themes emerged from the transcript analysis. Each theme is described and accompanied 
by illustrative verbatim quotations.  
 
Theme 1: The Zulu patient’s account of how the diagnosis was communicated  
All patients were informed that diagnostic testing was required. Patients were either informed 
of their diagnosis after diagnostic testing or warned of the possibility of a cancer diagnosis 
before commencing diagnostic testing, and then informed that the tests confirmed the 
diagnosis.  
 
Oh, they told me that they discovered that I had cancer from the tests that they 
had conducted on me. [P1] 
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Before I did any tests, they said they suspect that I might have osteosarcoma, but 
they said they won’t say that it is so without running some tests.  The tests came 
back positive.  [P2] 
 
 Patients reported on the factual knowledge received regarding the cause of 
osteosarcoma, the common age at diagnosis, and the fact that that they had cancer of the 
bone.  
 
I was told was a random cancer that could happen to anyone, but it was mostly 
found in people whose ages ranged from birth to twenty five, which was when I 
had found out at age twenty five. [P1] 
 
They told me that this cancer that I’m suffering from is cancer of the bone… [P4] 
 
They told me that there are different types of cancers.  For instance, in my case it 
was osteosarcoma, which is cancer of the bone. [P2]  
 
 Patients were provided with knowledge regarding metastases and the possible 
recurrence of osteosarcoma. Patients were informed when they had metastases. The education 
regarding recurrence provided at the time of diagnosis prepared patients who were later 
diagnosed with lung metastases.  
 
Before they amputated my arm, they said it has spread quite rapidly. [P4] 
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They told me that it’s possible for the cancer to spread… That happened to me… 
The cancer spread to the lung.  [P2] 
 
 Patients reported that HCPs warned them of possible bad news, checked their readiness 
to receive the diagnosis, attempted to offer privacy when communicating the diagnosis, and 
offered patients reassurance. 
 
…so they took me out of the ward and took me to a room that looked almost like 
this one.  It was just the doctors and me as the patient when they told me. [P1] 
 
They told me that they have something to tell me about the disease that I have.  
They asked if I was okay with being told at that time.  I said its fine they can tell 
me.  They then drew the curtains because I was in the ward.  [P4] 
 
Theme 2: The Zulu patient’s account of how treatment options were communicated  
Patients indicated that communication about treatment was prioritised hence they understood 
the urgency of intervening.  
 
The way they took it is that they made it a priority that also made me understand 
that if you don’t take it as an immediate priority it will jeopardize your life 
quickly. [P1] 
 
 Patients reported that HCPs educated them about surgical treatment options and 
chemotherapy. Patients indicated that when they required amputation they were informed that 
this was the only surgical option. When both limb salvage and amputation were possibilities, 
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the risks and benefits of each option and the requirement of chemotherapy before surgery 
were explained to patients. A patient indicated that he was informed that the best ‘life-saving’ 
option for him was amputation.  
 
…the only way is to operate and remove the cancer from the infected area so that 
it does not spread [P1] 
 
They then said it’s better if they remove the arm because the tumour was 
enlarged... Amputate the whole arm. [P4] 
 
There were two options when it came to the operation.  It was either they would 
amputate my leg or do a limb salvage… They presented them well… They told me 
the pros and cons of amputation.  Same thing with limb salvage. [P2] 
 
…the specialist there told me that the safest way to save my life was to amputate 
the affected limb… [P1] 
 
They told me that it’s possible that the cancer returns, but if I do chemotherapy, it 
will be able to control the cancer. [P4] 
 
I was told that I was going to undergo chemotherapy for three months. And then 
after that, go for an operation. [P2] 
 
 Patients reported that oral and intravenous chemotherapy as well as the side-effects of 
chemotherapy were explained to them.  
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…there’s chemotherapy… chemotherapy drip and chemotherapy tablets. [P3]   
 
So to cure it or to prevent it from spreading and to control it, you have to go 
through chemotherapy.  Chemotherapy does this to a person’s body and these are 
the side effects…  Hair loss, weight loss, vomiting a lot.  [P3] 
 
 Patients indicated that they were informed that they would develop metastases without 
surgical intervention and chemotherapy.  
 
…if they did not amputate and if I had not gone for chemo, it would easily have 
spread.  [P1] 
 
…they said there is a way to treat it so that it doesn’t spread to another part of 
the body, because if you leave it for too long without it being treated, it spreads to 
other parts of the body. [P2] 
 
 Patients conveyed that they were advised that if metastases were detected, they may 
require further surgical intervention. One of the patients with lung metastases was informed 
that he could either have surgery or he could have chemotherapy. 
 
Because when it had spread in the lungs, they gave me options to choose from... 
Because I had gone to chemotherapy two or three times, they gave me an option 
to either have an operation or go back to chemotherapy on my fourth visit.  [P3] 
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The cancer spread to the lung.  I went for an operation again. [P2] 
 
 Although the treatment options of radiation and oral chemotherapy were mentioned to 
some of the patients, these seemed to not have been elaborated on.  
 
Then with radiation and the other form of chemotherapy tablets, they (healthcare 
professionals) didn’t dwell on it a lot because they were focusing on the drip 
(intravenous chemotherapy). [P3] 
 
Theme 3: The Zulu patient’s account of how prognosis was communicated 
Patients indicated that prognosis was explained in terms of the threat of recurrence and 
metastases. They were advised that the cancer would metastasize to the lungs, chest, and 
other organs if left untreated. Patients were also informed that the cancer could recur despite 
having been treated hence regular follow ups and diagnostic testing was essential. 
 
Every three months I go for a CT scan, bone scan, X-rays, everything. [P3] 
 
They told me that it’s possible for the cancer to spread to another part of your 
body despite the fact that the affected area has been treated. [P2] 
 
After undergoing chemo and having the operation, you carry on doing tests and 
going to X-rays and CT scans.  I had gone to do a CT scan and it showed that the 




Theme 4: The Zulu patient’s understanding of the information provided 
Patients were able to relay factual information regarding the diagnosis of osteosarcoma, the 
role of diagnostic tests, the concept of metastases and the implications thereof. With regard to 
treatment information, patients had knowledge of the surgical options and the reason why 
amputations were performed above the affected area. They also knew about oral and 
intravenous chemotherapy, the role of chemotherapy in managing metastases, and the side-
effects of chemotherapy. Patients’ knowledge of radiotherapy as a treatment option was 
limited. 
 
The cancer that I have is bone cancer. [P3] 
 
According to my knowledge, it attacks the bones.  [P2] 
 
What happened was they took me to theatre and cut out that bone and took it for 
testing.  After about twenty days they came back and told me that it was cancer… 
[P1] 
 
And with amputation, as they had seen where the cancer was, they would need to 
amputate above that affected area so that they can be certain that the cancer 
affected area was fully removed. [P1] 
 
It had grown a lot in one place.  So they decided to amputate.  Then I went 
through chemotherapy.  I did three cycles of chemotherapy.  Six cycles once, six 
cycles twice, six cycles thrice. [P3] 
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With chemo, they are trying to kill the diseases that are still in your body, so if 
those diseases are still active they need to clear them with chemotherapy in order 
that they do not spread further.  [P1] 
 
Theme 5: The Zulu patient’s perception of the diagnosis and treatment options 
Perceptions of the diagnosis varied from associating the diagnosis with death and dying at the 
time of receiving the diagnosis, to viewing cancer as a serious illness that is not necessarily 
associated with death as more information was provided. Perceptions varied regarding 
whether cancer is curable.  
 
You associate cancer with death up until you get mental help and until 
then, you will always associate it with death.  [P1] 
 
In my opinion, when it is detected early, I can say that it is curable. [P2] 
 
 Perceptions of treatment varied from an association with death and dying to being 
viewed as a means of cure. Amputation specifically was perceived to have far-reaching 
consequences with regard to self-esteem, intimate relationships, future planning and the 
ability to earn a living, and was associated with a feeling of incompleteness. A positive view 
of chemotherapy was reported as it was understood as a means of curing cancer. 
 
…they will amputate my leg, I was the type of person who used my mobility to 
make a living… how was I going to make a living once they amputate my leg.  I 
have dreams of furthering my studies but how was I going to continue with that? 
…the moment you lose a body part, there are some dreams you had that needed 
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your entire body that you will never accomplish.  So even your self-esteem gets 
affected especially for us younger men who are still chasing ladies.  [P1] 
 
Theme 6: Zulu patients’ emotions regarding the diagnosis and treatment options 
Emotional responses to the diagnosis included sadness and the fear of being judged, pitied or 
excluded. The amount of information impacted significantly on emotional responses. Patients 
who did not understand anything about cancer tended to have a neutral reaction. Receiving 
information was reported to increase hope and improve adjustment to the diagnosis. Efforts to 
move towards an acceptance of the diagnosis in order to prevent a negative attitude also 
emerged from the data. 
 
So when you think of explaining this to the next person, you feel as though this 
person will either judge you or pity you hence at times you feel unaccepted and 
decide not to talk about it.  [P1] 
 
When I found out I have cancer I cried day and night because at the end of the 
day we as the youth, you still have your dreams and want to have a family and all 
that.  [P1] 
 
…when I was told that I have this disease, I was not scared.  I didn’t have any 
problem because I didn’t understand anything about cancer.  [P2] 
 
At that time, I didn’t understand much about cancer…  I took it lightly... But as 
time went on, it dawned on me that I have this disease, cancer, so I have to accept 
it and get a solution so that I don’t have a negative attitude. [P3] 
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 Emotional responses to treatment information included a loss of hope and feeling 
traumatised especially in response to amputation and the side-effects of chemotherapy. 
Another patient responded positively to treatment information in that he readily agreed to 
surgery as it was associated with the cancer being excised.  
 
…once you do chemotherapy you may discover that you may not be able to 
conceive and have children, that is very traumatizing.  [P1] 
 
Theme 7: Zulu patients’ experience of the communication process 
Zulu patients were satisfied with the content and process of information provided regarding 
diagnosis and treatment. Patients reported receiving sufficient information that was relayed in 
a manner that facilitated patient understanding. A need for more information regarding the 
side-effects of chemotherapy was expressed. 
 
They were clear and explained everything perfectly. [P2] 
 
I don’t have any suggestions because I don’t see anything more that could be 
done to improve.  Things are okay as they are… I think everything is fine as it is. 
[P2] 
 




 Positive emotional outcomes of hope and adjustment to diagnosis resulting from the 
communication approach taken were reported. 
 
I’m still okay, it’s going to be controlled.  They gave me hope and motivated me. 
[P3] 
 
...the doctors’ approach and the way they explained everything to me are what 
helped. [P1] 
 
 Patients also commented on the quality of communication related to care in general and 
relayed that HCPs took an interest in them and communicated patiently, openly and 
respectfully. 
 
When the doctor came to check on me, he didn’t just sign and leave.  He would 
ask me how I slept, how is the pain, what I need in terms of painkillers… 
 Things like that.  They were very patient with me.  [P3] 
 
The doctor will also ask if I am in pain.  If I am in pain, I tell him and then he 
helps to relieve the pain.  [P4] 
 
I was always happy because when I got to the ward the nurses explained 
everything in detail regarding everything that I had to do and the things that they 
will do. [P4] 
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Respect is there in everyone, because I see old doctors and old nurses who 
respect me. They don’t say because you are young, we won’t give you any 
attention or respect you.  They respect me and that makes me happy. [P3] 
 
Theme 8: Cultural aspects for consideration when treating Zulu patients 
This theme focuses on Zulu patients’ cultural and health beliefs, cultural decision-making 
processes, rituals and patients’ proposal for combining Western and traditional approaches to 
managing illness. 
Cultural and health beliefs 
Individual differences with regard to cultural and health beliefs emerged. Patients indicated 
that Zulu people use traditional medicines and consult with the ancestors when they are ill. 
The importance of not abandoning tradition was emphasised as medical tests cannot always 
identify the cause of illness resulting in patients needing to go home to practice their cultural 
traditions. The belief that something has possibly been cast on the patient in the form of 
witchcraft to cause the illness was also highlighted. Even though all participants indicated on 
the demographic questionnaire that they followed traditional belief systems, some preferred 
Western medicine over traditional medicine. Patients who preferred Western medicine 
indicated that their families favoured traditional belief systems.  
 
We, as African people believe in that when we get illnesses and diseases we 




At home yes, we do follow tradition, but I don’t believe in them.  I don’t believe 
that they will help me because at home they also gave me options that I should go 
to a traditional healer who will help me, and do one, two and three. [P3] 
 
 Diagnosis did not seem to require cultural intervention. Traditional beliefs came to the 
fore when treatment, specifically amputation, was discussed. This was explained in terms of 
the Zulu culture dictating that a person cannot be buried with missing body parts hence Zulu 
people prefer not to donate their organs. In addition, if the person had left home intact, they 
cannot return home missing a limb. Those that adhered to the traditions had to return home to 
consult with the elders and observe traditions as going to theatre without doing so could 
result in negative consequences like not regaining consciousness or becoming paralysed. For 
one of the patients, the experience of negative life events which were associated with bad 
luck necessitated following traditional practices to prevent further bad luck.  
 
I don’t think traditions have much to do with that because when I discovered that 
I had cancer there was nothing I had to do tradition wise, but when I found out 
that I was going to be amputated, was when traditions came into play. [P1] 
 
 Another patient believed in prayer and did not believe in traditional medicine and hence 
did not consult with a traditional healer.   
 
So you see if I believed in traditional healers and medicine, I would have gone to 




 One of the patients expressed that he preferred Western medicine and perceived that 
Western medicine would be more likely to save his life than traditional medicine. 
 
…as long as my life is saved because if I had believed in a traditional healer, 
maybe I wouldn’t be here today. 
 
 
Consultation and decision-making 
Patients reported on the role of consultation in decision-making with regard to surgical 
procedures. Consultation entailed approaching the elders in the family who then usually 
consulted with the ancestors. Consulting well with the ancestors was associated with surgical 
success. Consultation with traditional healers was also advocated to obtain clarity. One of the 
patients that strictly adhered to Zulu traditions reported on how he was first taken to the 
traditional healer to ascertain the accuracy of the Western diagnosis. Emphasis was placed on 
consulting with an honest traditional healer. His elders found an honest traditional healer that 
confirmed that the patient’s leg could not be saved. The traditional healer found that the 
patient’s cancer had nothing to do with traditions and encouraged the patient to have surgery.  
 
Normally what they do first is they take you to the traditional healers to ascertain 
that what the Western doctors had diagnosed was accurate, and luckily they 
found an honest traditional healer who told them it was true that the leg could not 
be saved.  [P1] 
 
 Three of the participants involved their families in the diagnosis and treatment but 
made their own decisions regarding surgery. These patients’ families respected their decision 
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to use Western medicine and supported them. None of these patients consulted a traditional 
healer even though one was explicitly advised to do so.  
 
Yes, I did speak to my family.  But they didn’t have a problem with my decision.  
They preferred the hospital... It was my decision.  It’s just that I had to tell them 
about what was going on.  The decision was mine. [P2] 
 
Yes, I did tell my aunty that I stay with that I’m considering amputating my arm...  
My aunt said she’s scared, but if I have made that decision, it’s fine as long as I 
will get the help that I need. [P4] 
 
…at home they also gave me options that I should go to a traditional healer who 
will help meI said okay, fine, but he will not help me.  My decision is that I must 
go to the hospital, where I will get help the right way. [P3] 
 
Rituals 
The patients referred to rituals that were performed to ensure the success of their surgeries. 
Families performed rituals regardless of patient preferences. Only one of the patients 
indicated that no rituals were performed before the operation. Patients referred to a ritual 
involving the burning of incense to inform the ancestors about the surgery and to ask for a 
successful outcome. It was reported that traditional healers usually asked patients to wait a 
month before doing surgery so that they could perform Zulu rituals in order to cure the 
patient before the surgery. 
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But I believe they did burn incense when I was at hospital.My family 
believes in ancestors… Maybe they were just asking that the ancestors 
work with the doctors while I was on the operating table. [P2] 
 
My aunt burned the incense so that when I go to the operating room, 
everything will go well. [P4] 
 
 One of the patients reported that when he arrived home after the operation, he was not 
allowed to enter the home. A ritual was first performed outside the yard so that he could enter 
the yard cleansed. The purpose of the cleansing ritual was to remove things like bad luck (e. 
g. cancer diagnosis) and evil spirits from the patient and his family and to prevent this bad 
luck from entering the home. The cleansing rituals were performed with Zulu medicine and 
chickens. An animal is used, either a chicken or a goat to present the ill person to the 
ancestors. The ancestors are asked to welcome the affected person and watch over them so 
that the person can continue with life and deal with their condition. The ancestors have to be 
informed that the patient now has one instead of two limbs. When the patient entered the yard 
an announcement was made that the ritual had been done and he was then welcomed. 
 
Combining Western and traditional belief systems 
Patients indicated that it is important to acknowledge the existence of the traditional but to 
also understand that some diseases need Western medical treatment. Participants stated that 
Zulu patients should not abandon their traditions but that they should know that there are 
diseases like cancer, TB, and HIV that require Western treatment. At the same time it was 
proposed that culture and traditions should not be abandoned as there are times that a disease 
is related to something that needs traditional intervention.  
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We can’t turn our backs on the existence of such things (witchcraft, traditional 
medicine, ancestors), yes, they do exist, they can also make you sick and kill you 
but we must also understand that there are those diseases that need the treatment 
of Western medicines and doctors… So what I’m saying is one should not 
abandon their traditions but they must know that there are diseases such as 
cancer, TB, HIV and the like. [P1] 
 
 Patients acknowledged traditional rituals like burning incense and consulting traditional 
healers but also advised that people should not hesitate to seek Western medical assistance if 
the need arose. Conversely, it was proposed that the Western medical professionals should 
allow patients to observe their traditions. 
 
If a person feels that they are not feeling well, even if they perform traditional 
rituals and burn incense and consult traditional healers… if the illness forces 
them to go to hospital, they mustn’t be scared to go to hospital because they will 
get help. [P4] 
 
Discussion  
Our study accessed patients’ accounts of the process of receiving information regarding the 
diagnosis, treatment and prognosis of osteosarcoma and retrieved cultural information 
pertaining to the management of the condition. This study revealed unique findings that not 
only contribute substantially to improved management of Zulu patients diagnosed with 
osteosarcoma but also provide HCPs with feedback regarding the aspects of communication 
that are going well.  
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 Some of our unique findings pertain to Zulu patients’ extensive understanding of the 
diagnosis of osteosarcoma, diagnostic procedures, the treatment options applicable to treating 
osteosarcoma and the side-effects of chemotherapy. This finding is in contrast to local 
(Lourens 2013) and international (Makaryus and Friedman 2005) research findings where 
patients lacked information about their diagnosis and treatment. Furthermore, Zulu patients’ 
reports of receiving sufficient information are also in contrast to local research findings at 
another South African tertiary hospital (Vangu 2010).  
 Our study also highlighted patients’ varied perceptions and emotional responses to 
diagnosis and treatment and exposed the difference in perception between HCP and patient 
perceptions of amputation. Exploring and acknowledging patients’ perceptions of treatment 
options may help to resolve this discrepancy. Importantly, receiving information had a 
positive influence on patients’ perceptions of and emotional responses to the diagnosis. 
Receiving sufficient information regarding chemotherapy and its side-effects may also assist 
with patient adjustment especially as patients highlighted a lack of information pertaining to 
the side-effects of chemotherapy and demonstrated negative responses to this treatment. 
Patients expressed a need for improved communication of the side-effects of 
chemotherapy.Cancer patients typically want more detailed information about treatment side-
effects (Mcloughlin and Oosthuizen 1996). 
 A significant contribution of this paper is embedded in Zulu patients’ descriptions of 
their cultural and health beliefs, the decision-making practices in their families, and the 
rituals practiced. Despite reports that indigenous African people are obligated to comply with 
cultural rules (Yen and Wilbraham 2003; Chapter 4), some of the patients in this study made 
their own decisions regardless of family recommendations regarding rituals and consultation 
with traditional healers. Individual differences within cultural groups (Epner and Baile 2012; 
Kagawa-Singer, Valdez Dadia, and Surbone 2010; Mullin, Stewart, and Eremenco 1998; 
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Norman 1996) can be expected. Although knowledge of cultural practices and preferences is 
a prerequisite for culturally competent communication, patients should not be stereotyped 
based on this knowledge.  
 Furthermore, Zulu patients encouraged integrating Western and traditional approaches 
to managing illness and proposed that HCPs should accommodate patients’ cultural 
preferences. It is not uncommon for patients from indigenous populations, especially when 
diagnosed with a life-threatening illness like cancer, to integrate Western medicine and 
traditional healing (Broome and Broome 2007; Lourens 2013; Muhamad, Merriam, and 
Suhami 2012; Struthers and Eschiti 2004; Yen and Wilbraham 2003). The intra-cultural 
variability (Engebretson, Mahoney, and Carlson 2008) noted in this study and the 
recommendation for the accommodation of patients’ cultural preferences (Bensing 2000) 
necessitates a patient-centred approach to medicine. 
 
Limitations of the Study 
Patients were asked to provide retrospective accounts of their experiences and the interviews 
were conducted at one point in time and not as the disease process unfolded. Furthermore, 
there were considerable challenges with regard to locating participants and this limited the 
size of the sample. Although a Zulu interviewer ensured that patients could express 
themselves in their own language, the interviewer already knew what patients meant with 
regard to some of the cultural aspects that were discussed and hence these were not further 
explored. Zulu patients’ accounts of how prognosis was communicated are limited and 






This study pioneers an understanding of Zulu patients’ knowledge and experience of patient-
provider communication regarding the diagnosis, treatment and prognosis of osteosarcoma. 
The findings highlighted the complexity of working in cross-cultural clinical settings. HCPs 
have to be conversant with cultural beliefs and practices but still be able to accommodate the 
individual voices of patients. They have to develop an understanding of their patients’ 
experience of their illness and its treatment including their perceptions of and emotional 
responses to the diagnosis, treatment and prognosis. HCPs also have to be sensitive to the fact 
that their perceptions about illness management may differ considerably from patients’ 
perceptions. It is therefore important to invite the individual patient to discuss their 
experience. Working in cross-cultural clinical settings also requires a flexibility which allows 
for the integration of Western and traditional approaches to healing if this is the patient’s 
preference. In addition, HCPs have to ensure that they provide adequate information 
regarding diagnosis and treatment, especially side-effects of treatment. The findings of this 
study will make a meaningful contribution to the development of an evidence-based practice 
guideline for culturally competent patient-provider communication with Zulu patients 
diagnosed with osteosarcoma. Our findings stressed the need for a patient-centred approach 
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Part 4: Developing the Evidence-Based Practice Guideline 
 
This section comprises the evidence-based practice guideline which is the culmination of this research 
project. Evidence from the integrative literature review, focus groups with healthcare professionals 
and in-depth interviews with the Zulu patients were used to develop the evidence-based practice 
guideline. Chapter seven presents the manuscript that will be submitted for publication. However, the 
complete evidence-based practice guideline with the reviewer comments and scores and a more 
detailed description of the methods is presented in Appendix H. The items from the AGREE II 
(Appraisal of Guidelines, Research and Evaluation) appraisal instrument that were used to score the 





1. Brouwers MC, Kho ME, Browman GP, Burtgers JS, Cluzeau F, Feder G, Fervers B, Graham ID, 
Grimshaw J, Hanna SE, Littlejohns P, Makarski J, Zitzelsberger L. AGREE II: advancing 
guideline development, reporting and evaluation in health care. Can Med Assoc J. 
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Guideline aim: The aim of this guideline is to present healthcare providers treating Zulu 
patients diagnosed with osteosarcoma with evidence-based recommendations that can 
facilitate culturally competent communication regarding the diagnosis, treatment and 
prognosis of osteosarcoma.   
Methods and materials: The AGREE II (Appraisal of Guidelines, Research and Evaluation) 
appraisal instrument was used as a guide for developing the evidence-based practice 
guideline. An integrative literature review, focus groups with healthcare providers and in-
depth interviews with Zulu patients were conducted to gather the evidence for the evidence-
based practice guideline. The guideline was reviewed by an expert panel using the AGREE II 
tool.  
Setting: This guideline was developed for healthcare providers communicating with adult 
Zulu patients diagnosed with osteosarcoma.  
Results: The guideline specifies generic aspects such as the awareness, knowledge, skills and 
provider attitudes required for culturally competent communication as well as the type of 
healthcare system that can support and cultivate such communication. The guideline then 
details specific recommendations for communicating the diagnosis, treatment and prognosis 
of osteosarcoma to Zulu patients.  
Conclusion: Healthcare providers will require cultural competence and communication 
training to facilitate the implementation of the guideline. Limitations with regard to the body 
of evidence are recognised. Despite these limitations, this guideline is the first of its nature in 
the South African context and provides valuable insights regarding the ingredients required in 
order to work effectively in cross-cultural clinical settings. Evidence-based practice can 
contribute to improving culturally competent communication with cancer patients receiving 
treatment at culturally discordant healthcare facilities.  
 
Key words: evidence-based practice guideline; cancer; osteosarcoma; cultural competence; 





Communicating the diagnosis and prognosis of cancer is widely documented as challenging 
tasks.
1-10
 Furthermore, ensuring that patients understand their treatment options is considered 
good practice.
11
 Performing these tasks in cross-cultural clinical settings complicates patient-
provider communication.
12
 Culture plays a significant role in how patients’ health-related 
values, beliefs and behaviours are shaped, and affects how patients and communities 
approach the diagnosis and treatment of cancer as well as their trust in healthcare providers 
and institutions.
13,14
 Culture also affects professionals’ and institutions’ approach to minority 
patients and contributes substantially to disparities in access to healthcare for minority and 
underprivileged patients.
14,15
 An evidence-based practice guideline would contribute 
significantly to improving culturally competent communication with cancer patients 
receiving treatment at culturally discordant healthcare facilities.  
 This guideline was developed for healthcare providers communicating with adult Zulu 
patients diagnosed with osteosarcoma. The Zulu people are indigenous and reside in the 
predominantly rural South African province of KwaZulu-Natal. They speak isiZulu, one of 
South Africa’s 11 official languages. This province has an overall population of 10.9 million 
(of a total South African population of 54 956 900 million), the majority of which is 
classified as Zulu.
16 
The focus on osteosarcoma resulted from observations in clinical practice 
of the significant role that cultural factors play including extensive familial, ancestral and/or 
traditional healing consultations and rituals before agreeing to certain treatment optionin the 
management of osteosarcoma. In addition, research findings indicated that the majority of 
patients presenting at the study site already have locally advanced or metastatic disease.
17 
Other observations in clinical practice related to delayed presentation included denial and/or 
underestimation of the seriousness of the condition. Our research with healthcare providers 
and Zulu patients at the study site confirmed that cultural considerations were paramount 
when treating Zulu patients diagnosed with osteosarcoma (Chapters 3-6). 
 Despite advances in treatment of osteosarcoma, survival is dependent on diagnosis 
prior to progression beyond localised disease.
18
 The late presentation of patients therefore 
limits treatment options and results in very poor prognosis.
17,19-22 
Healthcare providers in this 
setting are therefore expected to simultaneously inform patients of the diagnosis of 
osteosarcoma, the significant limitations with regard to treatment options, and prognostic 
considerations in a culturally sensitive manner that engenders cooperation in the patient while 
allowing them the opportunity to fulfil their cultural obligations. This evidence-based 
166 
guideline was developed to address the shortcomings that were identified at the study site, 
where healthcare encounters were largely culturally discordant.  
 
METHODS AND MATERIALS 
The AGREE II (Appraisal of Guidelines, Research and Evaluation) appraisal instrument was 




2.2. Scope and Purpose 
The aim of this guideline is to present healthcare providers treating adult Zulu patients 
diagnosed with osteosarcoma with evidence-based recommendations that can facilitate 
culturally competent communication regarding the diagnosis, treatment and prognosis of 
osteosarcoma. The review question read: How is culturally competent patient-provider 
communication best delivered by healthcare providers to adult Zulu patients diagnosed with 
osteosarcoma? The targeted patient population are adult Zulu patients diagnosed with 
osteosarcoma.  
 
2.2 Stakeholder Involvement  
The guideline was developed by one of the members of the multidisciplinary team working 
with Zulu patients diagnosed with osteosarcoma. The developer is a content expert with 
methodological experience in both quantitative and qualitative research.  
 Furthermore, the healthcare providers working in a multidisciplinary team context with 
Zulu patients diagnosed with osteosarcoma participated in focus groups and Zulu patients’ 
views and preferences were investigated using in-depth interviews.  
 The evidence-based practice guideline was developed for use amongst healthcare 
providers (doctors, nurses and allied health professionals) working with Zulu patients 
diagnosed with osteosarcoma. The doctors working in the Orthopaedics Department are the 
first port of call for these patients. Nurses working in orthopaedic and oncology outpatient 
clinics and wards have the most contact with Zulu patients diagnosed with osteosarcoma. 
Allied health professionals working with this patient group include physiotherapists, clinical 
psychologists, social workers, occupational therapists and dieticians.  
 
2.2 Rigour of Development  
An integrative literature review was conducted to review the existing evidence. Details of the 
integrative literature review process are available in Brown et al.
24
 In addition, focus groups 
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with healthcare providers (Chapters 3-5) and in-depth individual interviews with Zulu 
patients (Chapter 6) were conducted in order to contextualise the guideline. The approach 
taken therefore reflects the general consensus in the literature that evidence-based practice 
typically includes three key components namely, research-based evidence available from the 
literature, clinical expertise and patient preferences.
25,26
 The recommendations were 
developed using content analysis. A comprehensive and frequently used hierarchy system 
(Table 1) was applied to rate the evidence.
27 
The guideline development process was 
supervised by content and methodological experts. In addition, the guideline was also 
reviewed by an expert panel which consisted of five content and methodological experts. 
 
Table 1: Rating System for the Hierarchy of Evidence for Intervention/Treatment Questions
27
 
Level I (strongest evidence) Evidence from a systematic review or meta- analysis of all 
relevant randomized controlled trials (RCTs) 
Evidence from evidence-based clinical practice guidelines 
based on systematic reviews of RCT’s 
Level II Evidence obtained from at least one well-designed RCT 
Level III Evidence obtained from well-designed controlled trials 
without randomization (quasi-experimental study) 
Level IV Evidence from well-designed non-experimental studies 
(case-control, correlational, cohort studies) 
Level V Evidence from Systematic reviews of descriptive or 
qualitative studies 
Level VI Evidence from a single descriptive or qualitative study 
Level VII Evidence from the opinion of authorities and/or reports of 
expert committees 
 
2. GUIDELINE RECOMMENDATIONS 
The recommendations are based on levels IV, VI and VII evidence from the integrative 
literature review, focus groups with healthcare providers and patient interviews. Cultural 
competence has varied definitions but seems to require the acquisition, integration and 
application of awareness, knowledge, skills and attitudes regarding cultural differences in 
order to effectively deliver expert care that meets the unique cultural needs of patients; to 
manage and reduce cross-cultural misunderstanding in discordant medical encounters; and to 
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successfully negotiate mutual treatment goals with patients and families from different 
cultural backgrounds.
15,30-37
 The guideline first specifies generic aspects such as the 
awareness, knowledge, skills, and provider attitudes required for culturally competent 
communication as well as the type of healthcare systems that can support and cultivate such 
communication. The guideline then details specific recommendations for communicating the 
diagnosis, treatment and prognosis of osteosarcoma to Zulu patients.  Table two provides a 
summary of the guideline recommendations and the associated levels of evidence. 
 
Table 2: Guideline Recommendations and associated Levels of Evidence
 
Guideline Recommendations Levels of Evidence 
Healthcare provider 
awareness 
Develop contextual awareness Level IV, VI, VII 
Develop self-awareness Level VI, VII 
Develop interpersonal awareness Level VI, VII  
Develop awareness of cultural expectations in the 
healthcare setting 
Level VI, VII 
Healthcare provider 
knowledge 
Acquire knowledge of broader contextual factors Level VI, VII 
Acquire context specific knowledge Level VI, VII 
Acquire self-knowledge Level VII 
Acquire knowledge of the patient’s culture Level VII 
Healthcare provider 
skills 
Acquire and apply cross-cultural communication 
skills 
Level VII 
Ensure patient understanding Level IV, VI, VII 
Manage differences in the patient-provider 
encounter 
Level IV, VI, VII 
Build the patient-provider relationship Level IV, VI, VII 
Conduct a comprehensive patient assessment Level VI, VII 
Accommodate the patients’ family Level VI, VII 





Take responsibility for cultural aspects of health 
and illness  
Level VI 
Take responsibility for combating discrimination 
in healthcare settings  
Level VI 
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Guideline Recommendations Levels of Evidence 
Take responsibility for learning about the Zulu 
culture  
Level VI 
Be willing to learn from patients  Level VII 
Be open to change and growth  Level VI 
Be culturally sensitive  Level VI, VII 
Be willing to listen  Level VI 
Develop and demonstrate respect for cultural 
diversity, for the patient’s culture and their 
cultural values  
Level IV, VI, VII 
Demonstrate respect for patients’ spiritual and 
religious beliefs  
Level VII 
Develop an appreciation of different health belief 
systems  
Level VII 
Be willing to explore culture with individual 
patients  
Level VII 
Validate different cultures  Level VII 
Engage in continual self-examination and self-
reflection to examine one’s own values and 
assumptions  
Level VI, VII 
Be willing to adjust behaviours and attitudes  Level VII 
Reflect on own interaction with cultural groups in 




Cultivate the characteristics of culturally 
competent healthcare systems 
Level VI, VII 
Strategies employed by culturally competent 
healthcare systems 





osteosarcoma to Zulu 
patients 
Provide patients with factual information Level VI 
Set the stage for truth-telling Level VI 
Engage in patient-centred communication Level IV, VI, VII 
Engage in culture-centred communication Level IV, VI, VII 
Facilitate understanding of the diagnosis Level VI 
Recommended Provide patients with factual information Level VI 
170 




osteosarcoma to Zulu 
patients 
Follow a specific process when discussing 
treatment 
Level IV, VI, VII 
Strategies for responding to cultural factors 
associated with amputation 
Level VI 
Strategies for responding to cultural and health 











Assess patient emotions and knowledge Level VI 
Inform patients of the prognostic consequences of 
not treating the osteosarcoma 
Level VI 
Inform patients of treatment limitations Level VI 
Inform patients regarding metastases and 
treatment limitations result from the metastases 
Level VI 
Inform patients of poor prognoses Level VI 
Use a staged approach when patients have non-
metastatic or minimally metastasised disease 
Level VI 
 
2.1 Generic requirements for culturally competent communication 
Evidence-based rationale 
Generic requirements for engaging in culturally competent communication include the 
development of awareness, the acquisition of knowledge, the acquisition and implementation 
of skills and strategies and fostering certain attitudes.
15,30
 The development and practice of 
culturally competent communication by individual practitioners and multidisciplinary teams 
is best fostered in the context of culturally competent healthcare systems. Culturally 
competent healthcare systems provide linguistically and culturally appropriate services and 




3.1.1 Healthcare provider awareness 
Different types of healthcare provider awareness are required for working in cross-cultural 




3.1.1.1 It is recommended that healthcare providers develop contextual awareness of: 
 the country’s socio-political history37 
 the sociocultural factors that affect the patient-provider relationship38 
 patient demographics in the service area39,40 
 the role of gender in culture40,41 
 the role of religion in culture40,41 
 patients’ level of education42,43 
 patients’ experiences of discrimination in clinical settings44 
 dominant cultural narratives regarding health and illness45 
 culturally constructed myths about cancer46 
 cancer patients possibly combining allopathic and traditional medicine45 
 
3.1.1.2 It is recommended that healthcare providers develop self-awareness of own: 
 culture47 
 cultural beliefs48 
 belief systems49 
 spirituality50 
 cultural assumptions, biases and stereotypes14,38,47,49,51 
 
3.1.1.3 It is recommended that healthcare providers develop interpersonal awareness of: 
 inherent power differentials between patient and provider37 
 interaction between patient and provider’s culture47,52 
 communication differences between cultures41,53 
 
3.1.1.4 It is recommended that healthcare providers develop awareness of cultural 
expectations in the healthcare setting related to the: 
 level of family involvement required49,54 
 role of family in cross-cultural clinical settings15,40,54,55 
 
3.1.2 Healthcare provider knowledge 
Culturally competent communication requires the acquisition, integration and application of 
knowledge regarding the context, the self, and the patient’s culture. 
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3.1.2.1 It is recommended that healthcare providers acquire knowledge of broader 
contextual factors pertaining to: 
 racism, sexism, ageism48,56 
 socio-political barriers to accessing healthcare14,51,57 
 the impact of past and present racism51 
 the role of gender in the communication process14 
 the role of age in the communication process14 
 patients’ role expectations in the communications process14 
 socio-historical cultural context14 
 socio-cultural differences between self and patient51 
 
3.1.2.2 It is recommended that healthcare providers acquire context specific knowledge of: 
 the cultural groups attending services in the provider’s clinical setting39,51,53,55,57,58 
 serviced population’s disease profiles, health disparities and treatment outcomes34,53 
 cultural health-related needs and health-seeking behaviours51 
 cultural approaches to illness and treatment38 
 cultural meanings of cancer14 
 patients’ perception of their illness53 
 influence of culture on how patient interacts with healthcare system49 
 
3.1.2.3 It is recommended that healthcare providers acquire self-knowledge of own: 
 culture45,51,53,57 
 belief system51 
 biases and stereotypes14,49,51,57 
 
3.1.2.4 It is recommended that healthcare providers acquire knowledge of the patient’s 
culture, specifically: 
 the patient’s health belief systems44,54,57 
 the patient’s traditional health system54 
 the role of gender in decision-making 39,54 
 the role of family in decision-making39,54 
 preferences regarding language used to discuss cancer15 
 nonverbal communication standards15 
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3.1.3 Healthcare provider skills 
The healthcare provider is expected to acquire, integrate and apply a variety of skills in order 
to successfully deliver culturally competent patient-provider communication.  
 
3.1.3.1 It is recommended that healthcare providers deliver culturally and linguistically 
sensitive services by acquiring and applying the following cross-cultural communication 
skills: 
 Engage in culturally sensitive communication recognising the values beliefs and practices 
of the patient and presenting the communication accordingly
14,15,46,59
 
 Engage in culturally congruent communication which recognises that cultural variations 




 Observe culturally appropriate nonverbal communication etiquette14 
 Use congruent verbal and nonverbal communication14,57 
  
3.1.3.1.1 It is recommended that healthcare providers ensure patient understanding by 
acquiring and applying the following communication skills and strategies:  
 Provide clear,54, 57 accurate,54,57open,43,44,50,60 flexible,43 and transparent50 communication 
 Provide information in the patient’s language54 
 Learn the language54 
 Develop a vocabulary of terms familiar to the patient54 
o Include some basic isiZulu phrases in conversations [focus groups] 
 Use language that patients can understand [focus groups] 
 Use simple language37,42-44 [focus groups] 
 Encourage the patient to ask questions41 [focus groups] 
 Repeat information several times37 [focus groups] 
 Check patient understanding of information37,44,52,53,54,59 [focus groups] 
 Check what patients remember from previous explanations [focus groups] 




3.1.3.2 It is recommended that healthcare providers manage differences in the patient-
provider encounter:  
 Avoid stereotyping and generalisations14,34,38,51,53,54,57 [focus groups] 
 Do not make assumptions about patient race, nationality and language15 [focus groups 
and patient interviews]  
 Treat patients equally42,43 
 Encourage patients to raise concerns about discrimination44 
 Create a culturally safe and caring environment37,60 
 Individualise patient care38,60 
 
3.1.3.3 It is recommended that healthcare providers build the patient-provider relationship: 
 Invest time in the beginning39,53,61 
 Engage the patient57 
 Build rapport37,41 
 Gain patient trust28,41,43,46,57 
 Respond to patients’ emotions [focus groups & patient interviews] 
 Actively engage patients in decision-making41,53,59 [focus groups] 
 Encourage and empower patients to raise trust issues44 
 Address patients according to cultural preference57 
 Recognise inherent power differentials57 
 Be open about own cultural frame of reference45 
 Acknowledge own cultural background to patients15 
 Respond skilfully to cultural discordance57 
 
3.1.3.4 It is recommended that healthcare providers conduct a comprehensive patient 
assessment: 
 Assess patients’ specific communication needs61 
 Conduct a cultural assessment by actively exploring patients’ culture:50,52,61 
o Invite patients to describe their cultural backgrounds58 
o Explore views on family and community in the healthcare context58 
o Explore cultural57 and health beliefs49 
o Explore family expectations, feelings and concerns50 
o Explore level of family involvement required49 
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o Determine who the main decision-makers are (patient or family?)38,39 [patient 
interviews] 
o Explore preferences for truth disclosure15,49,53 
o Explore patients’ spiritual and religious beliefs15,50 
o Ask patients about their disease process [focus groups] 
 Use Kleinman’s eight questions28,58 
 
3.1.3.5 It is recommended that healthcare providers acquire and apply the skill of 
accommodating the patients’ family: 
 Invest in and gain family trust42,57 
 Communicate with extended family as per patient’s directive57 [focus groups] 
 Afford the family maximum control possible if this is a patient need50 
 
3.1.3.6 It is recommended that healthcare providers instil and maintain hope regardless of 
the disease stage by [focus groups]: 
 Emphasising what can be done 
o Inform patients that a palliative amputation could help with pain management 
 Reassuring patients of continued involvement of the multidisciplinary team 
 Differentiating the different problems that would be addressed  
 Explaining how the different problems would be addressed 
 Avoiding the provision of false hope 
o Do not inform patients that amputation could cure due to the possibility of disease 
recurrence 
 
3.1.4 Healthcare provider attitudes 
It is recommended that healthcare providers cultivate and integrate the following attitudes 
in order to facilitate culturally competent communication: 
 Take responsibility for cultural aspects of health and illness38 
 Take responsibility for combating discrimination in healthcare settings38 
 Take responsibility for learning about the Zulu culture [focus groups] 
 Be willing to learn from patients57 
 Be open to change and growth60 
 Be culturally sensitive15,38,60 
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 Be willing to listen60 




 Demonstrate respect for patients’ spiritual and religious beliefs42 
 Develop an appreciation of different health belief systems56 
 Be willing to explore culture with individual patients53 
 Validate different cultures58 




 Be willing to adjust behaviours and attitudes53 
 Reflect on own interaction with cultural groups in the clinical setting53 
 
 
3.1.5 Culturally competent healthcare systems 
Culturally competent healthcare systems are a requirement for the delivery of culturally 
competent communication. 
3.1.5.1 It is recommended that healthcare systems cultivate the following characteristics: 
 Are responsive to individual needs and to how cultures are perceived46,51 
 Promote and facilitate effective patient-centred communication51 
 Respect cultural differences, and support effective care for diverse populations51 
 Provide ethnic-specific services14 
 Convert an awareness of disease prevalence into practices and policies34 
 Develop and implement policies to support effective cross-cultural communication51,60 
 Link with culturally competent agencies and community organisations that provide 




 Have adequate support services60 
 Include traditional healers in patient care [focus groups] 
 
3.1.5.2 It is recommended that healthcare systems employ the following cultural competence 
strategies: 
 Use patient navigators32,39,41,57,62,63 
 Use experienced and professional interpreters14,15,28,38,41,44,45,49,54,58 
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 Use images to assist providers when discussing cancer with patients37 [focus groups] 
 Monitor patient characteristics44 
 Translate written communications38 
 Provide language-concordant encounters44 
 Provide patient-centred care62 
 Consult communities on cultural needs37 
 Integrate community resources into cancer care14 
 Display images of people from cultural groups attending the service37 
 Have ethnically similar staff visible37 
 
2.2 Recommended strategies for communicating the diagnosis, treatment and prognosis 
of osteosarcoma 
The focus groups and patient interviews revealed specific strategies for communicating the 
diagnosis of osteosarcoma to Zulu patients. General recommendations for discussing 
treatment as well as proposed strategies for managing cultural factors that affect treatment are 
outlined. Prognosis discussion recommendations are less extensive but still provide some 
guidance on how to approach this challenging task.  
 
3.2.1 Recommended strategies for communicating the diagnosis of osteosarcoma to Zulu 
patients 
Evidence-based rationale 
Communicating the diagnosis of cancer in cross-cultural clinical settings is documented as a 
challenging task.
64
 Results from the focus group interviews with healthcare providers 
highlighted distinctive factors that complicate communicating the diagnosis of osteosarcoma 
to Zulu patients. The Zulu people generally view the cancer diagnosis as an ancestral 
punishment or resulting from witchcraft and have been socialised to associate a cancer 
diagnosis with a poor prognosis. The isiZulu word for cancer reflects these cultural health 
beliefs and presents a significant barrier as the meanings associated with this word 
significantly complicates the diagnosis discussion especially when a good prognosis is 
possible. The isiZulu word for cancer is umdlavuza and refers to something that ravages, 
destroys, or cannot be stopped. Furthermore, language barriers present a significant challenge 
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in this cross-cultural setting. The lack of availability of medical terms in isiZulu and the 
limitations with regard to the translatability of words into the patient’s language significantly 
impacts patient understanding. Language barriers further manifest in the lack of access to 
professional interpreters. Communicating the diagnosis of osteosarcoma to the Zulu patients 
therefore requires an understanding of cultural and health beliefs and incorporating this 
knowledge into diagnostic conversations.  
 
3.2.1.1 It is recommended that healthcare providers provide patients with factual 
information about their condition including [patient interviews]:  




3.2.1.2 It is recommended that healthcare providers set the stage for truth-telling by: 
 Starting the diagnosis discussion right from the beginning [focus groups] 
 Assessing how much the patient knows 
 Warning patients a few times about possible cancer diagnosis [focus groups and patient 
interviews] 
 Giving patient incremental information as the diagnostic process unfolds [focus groups] 
 Informing patients of the reasons for diagnostic tests [focus groups and patient 
interviews] 
 Warning patients before delivering bad news when the diagnosis is confirmed [focus 
groups and patient interviews] 
 Warning patients by reminding them of earlier conversations of possible diagnosis [focus 
groups] 
 Checking patients’ readiness to receive the diagnosis [patient interviews] 
 Offering privacy when communicating the diagnosis [patient interviews] 
 Confirming diagnosis only once patient has been warned [focus groups and patient 
interviews] 
 
3.2.1.3 It is recommended that healthcare providers engage in patient-centred 
communication by: 
 Building a relationship with the Zulu patient (see 3.1.3.3) [focus groups] 
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 Spending time with the patient [focus groups] 
 Offering the patient support [focus groups] 
 Demonstrating a personal interest in the patient [focus groups] 
 Assessing and addressing patient needs, emotions and coping [focus groups and patient 
interviews] 
 Responding to patient questions about the diagnosis [focus groups] 
 Assessing patients’ reactions to the diagnosis [focus groups] 
 Responding appropriately to patients’ reactions to the diagnosis [focus groups] 
 Managing the response of denial by [focus groups] 
 acknowledging that the diagnosis is difficult to accept  
 reinforcing the diagnosis  
 helping patients to accept the diagnosis 
 Mobilising support by having a psychologist present when patients are informed of the 
diagnosis [focus groups] 
 
3.2.1.4 It is recommended that healthcare providers engage in culture-centred 
communication by: 
 Taking responsibility for improving communication (see also 3.1.3.1.1) [focus groups] 
 Demonstrating an understanding of Zulu cultural health beliefs [focus groups] 
 Reassuring patients that their diagnosis is [focus groups]: 
o not due to anything that they have done  
o not a punishment 
o not due to bewitchment 
 Demonstrating a genuine interest in the Zulu culture by [focus groups]:   
o Asking patients questions about  (see also 3.1.3.4) 
 their cultural practices 
 their religious practices 
 their understanding of the aetiology of the condition 
 how they want to manage the condition  
 their cultural health beliefs 
 Offering patients the best care possible regardless of language discordance [focus groups] 
 
180 
3.2.1.5 It is recommended that healthcare providers facilitate understanding of the 
diagnosis by [focus groups]: 
 Using visual aids  
o Use images, pictures and information brochures 
 Explaining the stages of cancer   
o Educate patients regarding their stage of the disease  
o Educate patients about the effects of cancer in every stage 
 Using metaphors  
o Use metaphors to explain concepts like cells, organs, tumours and metastases 
o Use patient-initiated metaphors 
 
3.2.2 Recommended strategies for communicating the treatment of osteosarcoma to Zulu 
patients 
Evidence-based rationale 
Owing to the late presentation of patients for treatment at the study site, treatment options are 
limited and prognoses are often poor.
17
 Healthcare professionals (HCPs) consequently have 
to simultaneously inform patients of the diagnosis of osteosarcoma as well as the significant 
limitations with regard to treatment options. A number of cultural factors have been identified 
with regard to discussing the treatment option of amputation with Zulu patients. Healthcare 
providers reported in the focus group interviews that Zulu patients’ cultural beliefs dictate 
that they cannot become an ancestor if they have an amputation because their body is 
incomplete. The issue of post-amputation community exclusion was also raised. The patient 
interviews also revealed that cultural considerations become important when treatment, 
specifically amputation, is discussed. Focus groups and patient interviews further indicated 
other Zulu cultural and health beliefs that affect treatment such as the belief in traditional 
healing and the need to consult with cultural decision-makers before agreeing to treatment. 
The recommendations on how to communicate with Zulu patients regarding the treatment of 
osteosarcoma therefore take these cultural beliefs and practices into account.  
 
3.2.2.1 It is recommended that healthcare providers provide patients with factual 
information pertaining to [focus groups and patient interviews]: 
 Surgical treatment options 
 Limb salvage is explained if this is an option 
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 Amputation is discussed if it is the only option or in the case of borderline tumours 
 Chemotherapy  
 Its purpose 
 When and how it will be used 
 Side-effects of chemotherapy (emphasised in patient interviews) 
 Treatment of metastases (metastasectomies and/or chemotherapy)  
 
3.2.2.2 It is recommended that healthcare providers follow this process when discussing 
treatment with patients: 
 Delay providing treatment information until staging investigations are completed 
 Inform patients about the prognostic consequences of not treating the tumour, e.g. 
metastases, shortened life-span [focus groups and patient interviews] 
 Balance hope and honesty [focus groups] by 
 Communicating the urgency of intervening [patient interviews] 
 Offering patients reassurance [patient interviews] 
 Ensure patient understanding by (see also 3.1.3.1.1) [focus groups]: 
 Using analogies 
 Using the stages of cancer to explain disease progression and realistic treatment 
options. 
 Explore and manage patients’ emotions associated with amputation and chemotherapy 
[patient interviews] 
 
3.2.2.3 It is recommended that healthcare providers use these strategies for responding to 
cultural factors associated with amputation [focus groups]: 
 Time the treatment discussion to prevent the patient from signing refusal of hospital 
treatment (RHT) before diagnostic testing is complete.  
 When patients refuse amputation, offer patients other treatment options like 
chemotherapy and refer patients to other services like oncology, psychology, social work 
and dietetics. 
 Mobilise support by having a psychologist present when patients are informed of that an 
amputation is required 
 Expose patients to veteran osteosarcoma patients who have successfully adjusted to 
amputation 
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 Show newly diagnosed patients a video of patients with successful outcomes  
 
3.2.2.4 It is recommended that healthcare providers use these strategies for responding to 
cultural and health beliefs that affect treatment: 
 Initiate cultural discussions in order to fast track decision-making [focus groups] 
 Demonstrate an understanding of patients’ cultural beliefs by:  
o Acknowledging patients’ need to discuss treatment with their family [focus groups] 
o Encouraging patients to engage in their cultural traditions and rituals [focus groups 
and patient interviews] 
o Encouraging patients to combine Western and traditional approaches [focus groups 
and patient interviews] 
o Respecting patients’ cultural health beliefs and their desire to consult traditional 
healer [focus groups and patient interviews] 
 Liaise directly with family and cultural decision-makers where possible [focus groups] 
 Negotiate with patients to not go home and to rather invite a family member(s) to the 
hospital [focus groups] 
 
3.2.3 Recommended strategies for communicating prognostic information pertaining to 
osteosarcoma with Zulu patients 
Evidence-based rationale 
Given the late presentation of patients at the study site, HCPs have to communicate 
diagnostic and treatment information urgently. The treatment options are closely related to 
patients’ understanding of their prognosis and the outcomes resulting from various 
approaches to treatment. 
 
3.2.3.1 It is recommended that healthcare providers assess patient emotions and knowledge 
by: 
o Enquiring about patients’ thoughts, fears, and impressions of the future [focus 
groups] 
 
3.2.3.2 It is recommended that healthcare providers inform patients of theprognostic 
consequences of not treating the osteosarcoma [focus groups and patient interviews]: 
 Inform patients of the likelihood of metastases if the osteosarcoma was not treated. 
183 
 Inform patients of the effect on survival if the osteosarcoma was not treated.  
 
3.2.3.3 It is recommended that healthcare providers inform patients of treatment 
limitations:  
 Explain the nature of osteosarcoma to patients and inform patients that this type of cancer 
is not curable [focus groups] 
 Inform patients that even with surgery the cancer could recur [focus groups and patient 
interviews] 
 Inform patients that they have to return within six months and then annually to check for 
cancer recurrence [focus groups and patient interviews] 
 
3.2.3.4 When patients have metastases, it is recommended that healthcare providers inform 
patients that: 
 That they have metastases [focus groups and patient interviews] 
 The condition is not curable but that amputation could help with pain [focus groups] 
 Treatment options are limited due to the metastases [focus groups] 
 
3.2.3.5 It is recommended that healthcare providers inform patients of poor prognoses: 
 Inform patients about the terminal nature of the disease if the osteosarcoma is reasonably 
expected to result in the death of the patient within a short period of time [focus groups] 
 Normalise death [focus groups] 
 Do not inform patients of the life expectancy [focus groups] 
 
3.2.3.6 It is recommended that healthcare providers use a staged approach to 
communicating about prognosis [focus groups]. Given the late presentation of patients at this 
tertiary hospital, a staged approach may be more useful for patients that present with 
localised or metastatic disease that is amenable to surgical management. 
 Communicate about immediate treatment goals and if the disease progresses, 
communicate about adjustments in treatment goals to for example palliative care.  
 If treatment is working and cancer is remitting, communicate with patients about 





There are limitations with regard to the body of evidence used to develop this guideline. 
These included the mostly low level evidence (Level VII) in the integrative literature review; 
the lack of availability of some of the healthcare providers at the time of data collection; 
patients’ retrospective accounts of their experiences as the interviews were conducted at one 
point in time; and challenges experienced with regard to locating participants limited the size 
of the sample.  
 
4. CONCLUSIONS 
Communicating with patients about cancer in cross-cultural clinical settings is widely 
recognized as a challenging task. This guideline offers guidance with regard to approaching 
this daunting task. It was developed based on evidence derived from an integrative literature 
review, focus groups with healthcare providers that work with Zulu patients diagnosed with 
osteosarcoma, and interviews with patients diagnosed with osteosarcoma. The research with 
healthcare providers and patients provided higher levels of evidence for some of the 
recommendations. Further development of this guideline needs to address the remaining 
limitations. Healthcare providers will require cultural competence and communication 
training in order to facilitate the implementation of the guideline. Despite the limitations of 
the body of evidence, this guideline is the first of its nature in the South African context and 
provides valuable insights regarding the ingredients required in order to work effectively in 
cross-cultural clinical settings. Evidence-based practice can contribute significantly to 
improving culturally competent communication with cancer patients receiving treatment at 
culturally discordant healthcare facilities.  
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Chapter 8: Synthesis and Discussion 
 
8.1 Chapter Overview 
This chapter revisits the rationale for the study and the aim and objectives of the research. A synopsis 
of the main findings of the study and the original contributions of the work is provided. The 
limitations of the study and recommendations for future research, training and policy development are 
also outlined. Practice implications are briefly revisited.   
 
8.2 Rationale for the Study 
Observations in clinical practice indicated that the management of osteosarcoma in Zulu patients 
requires a number of cultural considerations. In addition, patients typically present at the study site 
with locally advanced or metastatic disease.
1 
Osteosarcoma is the most common primary cancer of 
bone, and the complexity of its treatment necessitates a multi-disciplinary approach.
2 
The late 
presentation of patients and further delays stemming from patients’ preferences to fulfil cultural 
practices results in treatment limitations and very poor prognosis.
1-5 
Healthcare providers in this 
setting are therefore expected to simultaneously inform patients of the diagnosis of osteosarcoma, the 
significant limitations with regard to treatment options, and prognostic considerations in a culturally 
sensitive manner that engenders cooperation in the patient while allowing them the opportunity to 
fulfil their cultural obligations. Healthcare encounters at the study site are largely culturally 
discordant. This study therefore aimed to gather evidence which could inform the development of an 
evidence-based practice guideline. The aim of the guideline is to provide recommendations for 
engaging in culturally competent communication with adult Zulu patients regarding the diagnosis, 
treatment and prognosis of osteosarcoma. 
 
8.3 Research Aim and Objectives 
The overall aim of the study was to develop an evidence-based practice guideline for culturally 
competent patient-provider communication with Zulu patients with regard to osteosarcoma diagnosis, 
treatment and prognosis. The study had four objectives that cohered in order to meet the overall aim 
of the study: 
 
Objective 1: Conduct an integrative literature review to gather evidence from previous research. The 




Objective 2: Gather evidence from healthcare providers. An exploratory descriptive contextual study 
design was used to investigate the approach taken by healthcare providers when discussing 
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osteosarcoma, its treatment and prognosis with Zulu patients as well as the cultural aspects considered 
during these discussions. A semi-structured focus group interview guide was used to elicit relevant 
information. 
 
Objective 3: Gather evidence from Zulu patients. An exploratory descriptive contextual study of 
patients previously treated for osteosarcoma to explore patient understanding of the osteosarcoma 
diagnosis, its treatment and prognosis, and patient experience of patient-provider communication 
throughout the illness experience was conducted. Patients’ cultural descriptions related to the 
management of osteosarcoma were also elicited. Qualitative in-depth semi-structured interviews were 
conducted to gather this information.  
 
Objective 4: Develop an evidence-based practice guideline for culturally competent patient-provider 
communication with osteosarcoma patients based on the evidence collected in Objectives 1, 2 and 3. 
The evidence-based practice guideline was developed by using the AGREE II (Appraisal of 
Guidelines, Research and Evaluation) appraisal instrument as a guide.
7 
 
8.4 Schematic Representation of the Work 
Figure 1 provides a summary of the chapter outline of the study as well as the process followed in 
































Chapter 1: Introduction 
Chapter 2: Integrative Literature Review 
Evidence from the Literature 
Chapter 8: Synthesis and Discussion 
Chapter 3: Communicating Diagnosis 





Chapter 4: Communicating about Treatment 
Evidence from the Healthcare Providers 
Chapter 5: Communicating Prognosis 
Evidence from the Healthcare Providers 
 
Chapter 6: Patient accounts of the Diagnosis, 
Treatment and Prognosis Communication  
Evidence from the Patients 
Eviden 
Chapter 7: Evidence-based 
Practice Guideline 
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8.5 Summary of the Main Findings 
The integrative literature review provided directives on how to deliver culturally competent 
communication to adult cancer patients. It unpacked the awareness, knowledge, skills and healthcare 
provider attitudes and personal characteristics required for culturally competent communication. 
Characteristics and strategies of culturally competent healthcare systems required to support 
individual efforts and models of effective cross-cultural communication also emerged from the 
documents included in the review (Chapter 2). The grave need for scientifically rigorous research 
yielding higher levels of evidence in the field of cancer and culturally competent patient-provider 
communication was emphasised by the lack of quality evidence for all the themes that were presented 




Table 1: Delivering Culturally Competent Communication to Cancer Patients 
Themes Sub-themes 
Healthcare provider skills   Communication skills 
 Managing difference in the patient-provider encounter  
 Skills required for building the patient-provider relationship  
 Ability to conduct a patient assessment beyond the biomedical  
 Accommodating the patient’s family  




 Contextual awareness  
 Self-awareness 
 Interpersonal awareness  





 Context specific knowledge  
 Self-knowledge  
 Knowledge of patient’s culture  
 Knowledge of broader contextual factors  
Culturally competent 
healthcare systems  
 Characteristics of culturally competent healthcare systems  
 Strategies employed by culturally competent healthcare systems 
Providers’ personal 
characteristics and attitudes 
 Healthcare providers’ personal characteristics 
 Healthcare providers’ attitudes 
Models of effective cross-
cultural communication  
 
 Kleinman’s questions 
 The LEARN Model  
 The BELIEF Model 
 The Four Habits Model of Highly Effective Clinicians 
 
 
Following the integrative literature review, we conducted research with healthcare providers and Zulu 
patients. Most research and protocols for discussing sensitive information with patients are generic; 
few refer to considerations that are specific for the particular cross-cultural clinical setting. Although 
directions from these protocols are useful, evidence from our research could be used to develop 
recommendations for managing the unique challenges encountered in cross-cultural clinical settings. 
Evidence from the healthcare provider and patient studies can be classified as Level VI evidence. 
These studies broke contextual ground as it offered an African perspective of culturally competent 
patient-provider communication with cancer patients with specific reference to osteosarcoma. Care 
was taken to ensure methodological rigour as is discussed in Chapter one.  
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Our research with the healthcare providers produced a number of strategies for communicating with 
Zulu patients about the diagnosis, treatment and prognosis of osteosarcoma. These strategies also 
addressed cultural considerations and provided detailed information on the cultural factors that have 
to be taken into account when managing Zulu patients diagnosed with osteosarcoma (Chapters 2, 3, 
4). Cultural factors included Zulu patients’ beliefs about cancer and amputation, their need to access 
traditional healing and their requirements regarding collective treatment decision-making. Healthcare 
providers highlighted the importance of balancing respect for patients’ cultural preferences with the 
need to expedite treatment decision-making in order to improve prognostic outcomes. Challenges 
encountered with regard to discussing diagnosis, treatment and prognosis were also outlined in these 
three chapters. In addition to confirming previously identified strategies and challenges, this study 
also unearthed unique strategies and challenges peculiar to this cross-cultural clinical setting. Despite 
the uniqueness of some of these strategies, they could be useful in other cross-cultural clinical settings 
where patients belong to collectivistic cultures, and observe traditions and other practices that are 
significantly different to Western medical approaches. Our findings also emphasised the vital 
importance of training healthcare providers on communication of sensitive information in cross-
cultural clinical settings. Details of the strategies and complicating factors that emerged in terms of 
communicating diagnosis, treatment and prognosis are briefly outlined in Tables 2 and 3. 
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Table 2: Strategies for Communicating Diagnosis, Treatment and Prognosis 
Diagnosis 
Set the stage for truth-telling  Start discussion right from the beginning 
 Assess how much the patient knows 
 Ask patients about their disease process 
 Warn patients a few times about possible cancer diagnosis 
 Give patients incremental information as the diagnostic 
process unfolds 
 Inform patients of the reasons for diagnostic tests 
 When diagnosis is confirmed, warn patient before 
communicating the diagnosis 
 Warn patient by reminding patient of earlier conversations of 
possible diagnosis 
 Confirm diagnosis only once patient has been warned 
 Maintain hope 
Engage in patient-centred 
communication 
 Build a relationship with the Zulu patient 
 Spend time with the patient  
 Offer the patient support 
 Demonstrate a personal interest in the patient 
 Assess and address patient needs, fears and concerns, and 
coping 
 Respond to patient questions about the diagnosis 
 Manage denial 
Engage in culture-centred 
communication 
 Take responsibility for improving communication 
 Include some basic isiZulu phrases in conversations 
 Demonstrate an understanding of Zulu cultural health beliefs 
 Reassure patients that their diagnosis is not due to punishment 
or bewitchment 
 Demonstrate a genuine interest in patients’ culture  
 Ask patients questions about culture, religion, their 
understanding of their condition 
 Offer patients the best care possible regardless of language 
discordance 
Facilitate understanding of the 
diagnosis using visual aids 
 Use images, pictures and information brochures 
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Diagnosis  
Facilitate understanding by 
using the stages of cancer 
 Educate patients regarding their stage of the disease  
 Educate patients about the effects of cancer in every stage 
Facilitate understanding of the 
diagnosis using metaphors 
 
 Use metaphors to explain concepts like cells, organs, tumours 
and metastases 
 Use patient-initiated metaphors 
Check patient understanding 
 
 Repeat information several times 
 Check what patients remember from previous explanations 
Address language barriers: 
 
 Use language that patients can understand  
 Avoid using medical jargon 
 Use professional or experienced translators 
Instil hope through MDT 
involvement 
 
 Reassure patients of continued involvement of the 
multidisciplinary team 
 Differentiate the different problems that would be addressed  
 Explain how the different problems would be addressed 
 Maintain hope regardless of disease stage 
Treatment 
Communicating about treatment 
options 
 Inform patients about surgical options 
 Inform patients about chemotherapy 
Process suggestions when 
communicating treatment 
options 
 Delay providing treatment information until staging 
investigations are completed 
 Inform patients about the prognostic consequences of not 
treating the tumour, e.g. metastases, shortened life-span 
 Balance hope and honesty  
 Ensure patient understanding  
 Explore and manage patients’ emotions associated with 
amputation and chemotherapy  
Strategies for responding to 
cultural factors associated with 
amputation 
 Timing the treatment discussion 
 Introduce patients to veteran patients that have had amputation 
 Manage refusal of amputation by ensuring continuity of care 
and mobilising support 
Strategies for responding to 
cultural and health beliefs that 
affect treatment 
 Initiate discussions about cultural requirements in order to fast 
track decision-making 
 Encourage patients to engage in their cultural traditions 
 Encourage patients to follow Western and traditional 
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approaches 
 Liaise with family and cultural decision-makers where possible 
 Do not make assumptions based on culture and race 
 Take responsibility for learning about the Zulu culture 
 Include traditional healers in patient care 
Prognosis 
Assess patient emotions and knowledge 
Provide patients with realistic 
prognostic information 
 
 Inform patients about the prognostic consequences of not 
treating the osteosarcoma  
 Inform patients about treatment limitations  
 Inform patients that they have metastases  
 Inform patients about a poor prognosis 
Use a staged approach 
Normalise death 























Table 3: Complicating factors in communicating with Zulu patients  




 Cultural health beliefs about cancer as punishment; caused by 
bewitchment; resulting in a poor prognosis 
 Cultural health beliefs about amputation 
 isiZulu word for cancer is associated with poor prognosis 
 Lack of clarity regarding how much patients understand about the 
diagnosis 
 Patients understand consequences of the diagnosis and not the 
actual diagnosis 
 Lack of clarity regarding words in Zulu for the diagnosis of 
osteosarcoma  
 Patient and family preference for traditional healing 
 The need for consultation with elders and family members before 
treatment decision-making 
 Patient nondisclosure of traditional beliefs to healthcare 
providers 
 Patients’ tendency to withdraw when poor prognosis is 
communicated 
 Patients not asking about prognosis  
Healthcare provider factors  Lack of training 
 Perceived lack of competence  
 Tendency to use medical jargon 
 Role expectations regarding who communicates about prognosis 
 Varied perspectives regarding whether patients should be informed 
about poor prognoses 
 Timing the prognosis discussion in light of patients’ preferences to 
go home to discuss treatment options 
Organisational factors  Disjointed MDT functioning 
 Resource constraints  
        attendance and scheduling of MDT forums 
        lack of access to professional translators 
        nursing time constraints 
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Our research with Zulu patients diagnosed with osteosarcoma revealed that these patients had 
extensive understanding of the diagnosis of osteosarcoma, diagnostic procedures, the treatment 
options applicable to treating osteosarcoma and the side-effects of chemotherapy. Their perceptions 
and emotional responses with regard to diagnosis and treatment of osteosarcoma varied. Importantly, 
healthcare providers should note that receiving information had a positive influence on patients’ 
perceptions of and emotional responses to the diagnosis. Patients also reported negative views of 
chemotherapy and negative emotional responses to its side-effects. As with diagnosis information, 
receiving sufficient information regarding chemotherapy and its side-effects may also assist with 
patient adjustment especially as patients highlighted a lack of information pertaining to the side-
effects of chemotherapy. A significant contribution of Chapter six is embedded in Zulu patients’ 
descriptions of their cultural and health beliefs and practices. Specific rituals that are performed to 
ensure successful outcome of medical procedures, to cleanse patients from bad luck and to address the 
issue of witchcraft were outlined. Consultation with a reputable traditional healer was flagged as an 
important cultural practice. However, patients varied in their adherence to traditional belief systems, 
participation in rituals and the extent to which they deferred decision-making to the familythus 
emphasising the need for a patient-centred approach to medicine which takes the patient’s needs and 
preferences into account, and allows for differences among patients with the same diagnosis and/or 
from the same ethnic group.
8,9 
The interviews with Zulu patients produced eight themes. These are 




















Table 4: Themes from the Patient Interviews 
Themes Sub-themes 
The Zulu patient’s account of 
how the diagnosis was 
communicated 
 Informed about diagnostic testing 
 Given factual information about osteosarcoma 
 Informed about metastases and recurrence 
 Emotional well-being and privacy prioritised 
The Zulu patient’s account of 
how treatment options were 
communicated 
 Treatment communication prioritised thus communicating 
urgency 
 Given factual information about surgical treatment options and 
chemotherapy 
 Informed that disease would metastasise without surgical 
intervention and chemotherapy 
 Advised that further treatment would be required if metastases 
were detected 
The Zulu patient’s account of 
how prognosis was 
communicated 
 Explained in terms of the threat of recurrence and metastases 
 Informed that disease would metastasise if left untreated 
 Informed about recurrence despite treatment 
 Need for follow ups and diagnostic testing reiterated 
The Zulu patient’s 
understanding of the 
information provided 
 Could relay detailed information aboutthe diagnosis of 
osteosarcoma, the role of diagnostic tests, the concept of 
metastases and the implications thereof 
 Had knowledge of the surgical options and the reason why 
amputations were performed above the affected area 
 Knew about oral and intravenous chemotherapy and side-
effects 
The Zulu patient’s perception of 
the diagnosis and treatment 
options 
 Perceptions about diagnosis varied from catastrophic to 
realistic 
 Perceptions about treatment varied from catastrophic to being 
seen as a means of cure 
Zulu patients’ emotions 
regarding the diagnosis and 
treatment options 
 Diagnosis - Sadness and the fear of being judged, pitied or 
excluded 
 Patients with no understanding of the diagnosis reacted 
neutrally 
 Receiving information improved emotions pertaining to 
diagnosis for those that responded negatively 
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Themes Sub-themes 
 Treatment - loss of hope and feeling traumatised 
 When treatment was seen as a means of excising the cancer – 
responses were positive 
Zulu patients’ experience of the 
communication process 
 Satisfied with content and process of information provision 
 Wanted more information on side-effects of chemotherapy 
 Positive emotional outcomes of hope and adjustment to 
diagnosis resulting from the communication  
 Reported that healthcare providers had taken a genuine interest 
in them 
Cultural aspects for 
consideration when treating 
Zulu patients 
 Described their cultural and health beliefs and practices 
 Described the role of consultation with elders, ancestors and 
traditional healers in decision-making 
 Varied in adherence to traditional belief systems, participation 
in rituals and the extent to which decision-making was 
deferred to the family 
 Proposed combining Western and traditional belief systems 
 
  
The evidence-based practice guideline (Chapter 7) which was the overall aim of this research project 
was developed based on the findings from the integrative literature review and the studies conducted 
with the healthcare providers and the Zulu patients. These three sources of evidence facilitated the 
development of a guideline that presents generic requirements and recommendations for culturally 
competent communication, and denotes specific strategies for communicating diagnosis, treatment, 
and prognosis to Zulu patients diagnosed with osteosarcoma. The evidence-based practice guideline 
also explicates areas that require further research and refinement. Table 5 provides a brief overview of 
the recommendations proposed in the evidence-based practice guideline. 
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Table 5: Brief Overview of the Guideline Recommendations 
Generic requirements for culturally competent communication 
Healthcare provider 
awareness 
 Develop contextual awareness 
 Develop self-awareness 
 Develop interpersonal awareness 
 Develop awareness of cultural expectations in the healthcare setting 
Healthcare provider 
knowledge 
 Acquire knowledge of broader contextual factors 
 Acquire context specific knowledge 
 Acquire self-knowledge 
 Acquire knowledge of the patient’s culture 
Healthcare provider skills  Acquire and apply cross-cultural communication skills 
 Ensure patient understanding 
 Manage differences in the patient-provider encounter 
 Build the patient-provider relationship 
 Conduct a comprehensive patient assessment 
 Accommodate the patients’ family 
 Instil and maintain hope regardless of the disease stage 
Healthcare provider 
attitudes 
 Take responsibility for cultural aspects of health and illness  
 Take responsibility for combating discrimination in healthcare 
settings 
 Take responsibility for learning about the Zulu culture  
 Be willing to learn from patients  
 Be open to change and growth  
 Be culturally sensitive  
 Be willing to listen  
 Develop and demonstrate respect for cultural diversity, for the 
patient’s culture and their cultural values  
 Demonstrate respect for patients’ spiritual and religious beliefs  
 Develop an appreciation of different health belief systems  
 Be willing to explore culture with individual patients  
 Validate different cultures  
 Engage in continual self-examination and self-reflection to examine 
one’s own values and assumptions  
 Be willing to adjust behaviours and attitudes  





 Cultivate the characteristics of culturally competent healthcare 
systems 
 Strategies employed by culturally competent healthcare systems 
Recommended strategies for communicating the diagnosis, treatment and prognosis of 
osteosarcoma 
Recommended strategies 
for communicating the 
diagnosis of osteosarcoma 
to Zulu patients 
 Provide patients with factual information 
 Set the stage for truth-telling 
 Engage in patient-centred communication 
 Engage in culture-centred communication 
 Facilitate understanding of the diagnosis 
Recommended strategies 
for communicating the 
treatment of osteosarcoma 
to Zulu patients 
 Provide patients with factual information 
 Follow a specific process when discussing treatment 
 Strategies for responding to cultural factors associated with 
amputation 





pertaining to osteosarcoma 
with Zulu patients 
 
 Assess patient emotions and knowledge 
 Inform patients of the prognostic consequences of not treating the 
osteosarcoma 
 Inform patients of treatment limitations 
 Inform patients regarding metastases and treatment limitations 
result from the metastases 
 Inform patients of poor prognoses 
 Use a staged approach when patients have non-metastatic or 
minimally metastasised disease 
 
 
8.6 Original Contributions  
There is very limited research available on culturally competent patient-provider communication in 
our South African context where multiculturalism and discordant medical encounters abound. This 
study breaks ground and alerts to the magnitude of research that is required in cross-cultural clinical 
settings, especially in the South African context. Most research and protocols for communicating 
about cancer are generic and have not been developed in the African context. Although these 
protocols are useful, research resulting in recommendations for managing the unique challenges 
encountered in cross-cultural clinical cancer settings has not been conducted. Our evidence-based 
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practice guideline (Chapter 7) therefore makes an original contribution to the body of knowledge as it 
is the first of its kind for the South African context. It not only provides recommendations on generic 
requirements for culturally competent patient-provider communication, but also explicates specific 
strategies and recommendations for communicating about the diagnosis, treatment, and prognosis of 
osteosarcoma to the Zulu patient. Furthermore, each of the objectives that lead to the development of 
this guideline yielded unique findings. The integrative literature review (Chapter 2), which was 
conducted to gather existing evidence, was the first of its kind and synthesised how to deliver 
culturally competent patient-provider communication to cancer patients. The focus groups with 
healthcare providers allowed access to rich narratives about communication of diagnosis, treatment 
and prognosis with Zulu patients diagnosed with osteosarcoma. Although an extensive literature exists 
on communicating the diagnosis of cancer to patients, this research uncovered unique strategies for 
communicating diagnosis which were not previously noted in the literature (Chapter 3).
10-13 
These 
strategies included actively introducing cultural narratives when communicating with patients in order 
to demonstrate knowledge of and openness to patients’ cultural practices and beliefs;  facilitating 
patient understanding of diagnosis and metastases by explaining the stages of cancer to patients; 
introducing a unique metaphor not previously described in literature thereby encouraging the 
discovery of metaphors that may work in a specific context; checking what patients remembered and 
understood from previous explanations given in order to identify patient misperceptions and denial; 
and instilling a relational hope that was not necessarily associated with cure but reassured patients of 
the MDT’s continued involvement throughout the disease process (Chapter 3). Interestingly, although 
healthcare providers reported competency concerns and lack of training with regard to communication 
of sensitive information to patients, they still reported on methods of communicating diagnosis and 
prognosis that are confirmed in the literature (Chapters 3 and 5). Healthcare providers in this study 
therefore demonstrated innovationand relied on experiential knowledge to guide their communication 
with Zulu patients. Furthermore given that the literature on discussing treatment options in the cancer 
context is limited, our research revealed content and process suggestions regarding the treatment 
discussion pertaining to osteosarcoma (Chapter 4).
12,.14 
Importantly, our research also provided insight 
into Zulu cultural and health beliefs regarding cancer (Chapter 3) and cultural practices related to the 
treatment option of amputation (Chapters 4 and 6). The patient interviews revealed rich data on the 
rituals and decision-making processes inherent in Zulu cultural hierarchical structures but also 
demonstrated how these processes have evolved (Chapter 6). Our research also provided access to 
Zulu patients’ emotional responses to and perceptions of diagnosis and treatment of osteosarcoma. 
This study further provided an opportunity to correlate Zulu patients’ descriptions of how the 
diagnosis, treatment and prognosis were communicated (Chapter 6), with healthcare providers’ 
accounts (Chapters 3, 4 and 5). Although there are strong correlations between Zulu patients’ and 
healthcare providers’ accounts of the communication of these various aspects, healthcare providers 
provided a richer account of the prognosis discussion (Chapter 5). Furthermore, delivers another first 
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in that provides insights into contrasting perceptions between providers and patients regarding the 
treatment option of amputation (Chapter 6). 
 
8.7 Strengths of the Study 
The strengths of this study are reflected in the actions taken to ensure scientific rigour and ethical 
research practice across all four objectives. With regard to the integrative literature review, an 
established approach was used to conduct the review.
6
 In addition, an independent reviewer 
experienced in the integrative literature review methodology verified the inclusion and exclusion of 
records, independently appraised the documents, and verified the data extraction and content analysis 
of the data extracted from the included documents. Guba’s Model of Trustworthiness was used as a 
guide to ensure the scientific rigour of the studies conducted with the healthcare providers and the 
Zulu patients.
15 
The focus group interviews were conducted by an experienced qualitative researcher 
in order to minimise bias as the primary investigator is part of the MDT that treats Zulu patients 
diagnosed with osteosarcoma. The focus group interviewer and the primary investigator 
independently coded the data which was further reviewed by two qualitative research experts. The 
data analysis process was extensive and iterative. The interviews with Zulu patients were conducted 
by Zulu fieldworkers and the consent form was also available in isiZulu. Patients were encouraged to 
express themselves freely and also advised that they could withdraw from the study at any time 
without any recourse. The data from these interviews were translated into English and back translated 
to ensure accuracy of translation. Data was independently coded by a qualitative research expert and 
themes were then agreed upon. The research designs and methodologies for all the studies were 
described in detail and allows for replicability of the work. The evidence-based practice guideline was 
developed using the AGREE II Instrument which provides a framework for assessing the quality of 
guidelines; provides a methodological strategy for the development of guidelines; and informs what 
information should be reported in guidelines and in what manner.
16 
The guideline development 
process was supervised by experienced researchers and clinicians and reviewed by five expert panel 
reviewers.  
 
From an experiential perspective, focus group participants reflected that they experienced the focus 
group participation as transformative. They were able to reflect on their current practice, share 
challenges with and learn from fellow participants. In addition, experiential knowledge was revealed 
as healthcare providers demonstrated innovation by using a number of strategies which were 
confirmed in the literature; this despite their concerns about competency and lack of training. In 
addition, the researchers developed an awareness of cultural competency deficits during the writing 
process. An example - phrases like ‘strategies for managing challenges associated with amputation’ 
were changed to ‘strategies for managing factors associated with amputation’. There was a 
realisation that cultural practices and beliefs cannot be perceived as ‘challenges’ if there is to be an 
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appropriate culturally competent response to patients. Following this realisation, the researchers 
further appreciated that patients’ cultural beliefs and practices are not to be ‘managed’ as something 
separate to who they are. The sub-theme eventually read as follows: Strategies for responding to 
cultural factors associated with amputation. 
 
8.8 Limitations of the Study 
The evidence derived from the integrative literature review was mostly low level evidence (Level VII) 
and hence the results had to be interpreted with caution.
17 
Furthermore, most of the studies that met 
the inclusion criteria for inclusion in the integrative literature review were international. With regard 
to the focus groups with healthcare providers, all those that were eligible to participate were 
approached but some MDT members were not available at the time of data collection. Our use of 
discipline specific focus groups likely enhanced our ability to explore issues common to each 
professional group, however it may have restricted our opportunity to assess the inter-professional 
functioning of MDT members, which is likely an important factor given the high pressure 
environment in which the study was conducted. Our results may have been enhanced had other 
qualitative data gathering techniques been used to complement the focus group interviews. With 
regard to the patient interviews, patients were asked to provide retrospective accounts of their 
experiences and the interviews were conducted at one point in time and not as the disease process 
unfolded. Furthermore, the challenges experienced with regard to locating participants limited the size 
of the sample. Although a Zulu interviewer ensured that patients could express themselves in their 
own language, the interviewer already knew what patients meant with regard to some of the cultural 
aspects that were discussed and hence these were not further explored. Zulu patients’ accounts of how 
prognosis was communicated were limited in comparison to the healthcare providers’ descriptions of 
the prognosis communication. 
 
8.9 Practice Implications 
The obvious contribution to clinical practice resulting from this work is represented in the evidence-
based practice guideline (Chapter 7). However, each of the manuscripts, if read in isolation, make a 
significant contribution to practice. The integrative literature review (Chapter 2) provided a detailed 
table of the requirements for culturally competent patient-provider communication. Chapter three 
presented strategies for communicating about diagnosis in cross-cultural settings. Chapter four had 
content and process suggestions for discussing treatment in situations where intervention is urgent. 
This chapter also discussed some strategies for responding to cultural beliefs and practices in a 
culturally competent manner. Specific strategies for communicating about prognosis to patients were 
outlined in Chapter five. In chapter six, patients alluded to ways in which practice in cross-cultural 
settings can be improved. They emphasised providing adequate information to patients and 
recommended that cultural beliefs and practices be respected and integrated into the management of 
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cancer. Variability in patients’ experience of their illness and in the extent to which they engage in 
cultural practices is an important consideration in cross-cultural clinical settings. Healthcare providers 
should be careful not to stereotype based on pre-existing knowledge of a cultural group or of how 
individuals are expected to respond to a life-threatening illness.  
 
8.10 Future Directions 
8.10.1 Research 
Although all areas can be expanded on, one of the main areas that require further research is that of 
prognosis. The study findings from the focus group interviews with healthcare providers offered 
information on what is being said to patients and why it is said however; further investigation is 
required to explore how it is said. Contextual research on patients’ preferences for prognostic 
communication emerged as a prominent area for future research. This need was further emphasised 
when prognosis descriptions in the patient study were limited. Furthermore, although patients reported 
that they were satisfied with how the diagnosis, treatment and prognosis was communicated to them, 
research exploring patients’ experience of the proposed communication strategies that emerged from 
the focus group interviews could assist in refining these strategies. Deviations from Western research 
findings and the discovery of unique strategies and challenges emphasized the need for studies further 
exploring patient-provider communication in cross-cultural encounters. Methodologically, the use of a 
range of qualitative data gathering techniques may enhance research findings. The guideline has not 
been piloted with the target group as this task was beyond the scope of the current research study. 
However, implementing the guideline and conducting research to investigate its effectiveness will 
facilitate further development of the guideline.  
 
8.10.2 Training 
The healthcare providers consistently mentioned a lack of training and resultant competency concerns 
with regard to sharing sensitive information with patients. Including detailed modules on 
communication and cultural competency should be considered an essential part of training healthcare 
providers. Communication has far-reaching consequences with regard to patient satisfaction, 
negotiation of treatment goals, adherence and health outcomes in general. However, training can also 
be implemented at health facility level as is proposed with regard to implementing the evidence-based 
practice guideline that was developed as part of this study.  
 
8.10.3 Policy 
This research study focused on clinical cultural competence but alluded to the importance of 
culturally competent healthcare systems in providing competent communication to patients across 
cultural boundaries. Culturally competent healthcare systems develop and implement policies to 
support effective cross-cultural communication.
18,19
 Lack of access to resources like professional 
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interpreters and patient navigators require policy intervention at a systems level. Healthcare systems 
where culturally discordant patient-provider encounters abound can contribute significantly to 
culturally competent practice through policy development and implementation that support culturally 
competent practices. This evidence-based practice guideline includes a section on culturally 
competent healthcare systems and can be used as a guide when developing policies.  
 
8.11 Chapter Conclusion 
This chapter synthesised the main findings of this research project and explicated the original 
contributions of the work. The strengths and weaknesses of the study were also explained. The 
chapter concludes with a discussion of the practice implications derived from our findings and future 
directions for culturally competent communication in culturally discordant clinical settings in terms of 
research, training and policy. 
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Statement of purpose 
 
The purpose of this study is to develop evidence-based practice guidlines for culturally competent 
patient-provider communication with Zulu patients regarding the diagnosis, treatment and prognosis 
of osteosarcoma. The study will be conducted with osteosarcoma patients and health professionals 
treating osteosarcoma at a tertiary hospital in KwaZulu-Natal. An integrative literature review 
detailing the existing evidence for culturally competent patient-provider communication will also be 
conducted. At this stage in the research culturally competent patient-provider communication will 
generally be defined as the demonstration of an understanding of the importance of social and cultural 
influences on patients’ health beliefs and behaviours and a consideration of how these factors interact 






This study aims to make a contribution to the improved management of Zulu patients diagnosed with 
osteosarcoma. Clinical observations have highlighted various cultural dimensions that play a 
significant role in the management of these patients. Zulu patients diagnosed with osteosarcoma often 
present for treatment when the disease has already started metastasising. Furthermore patients often 
demonstrate a misunderstanding of the nature of the disease both before and after medical 
counselling. Treatment options may include limb ablation or limb salvage which presents patients 
with various cultural considerations. Culturally appropriate management of the Zulu patient with 
osteosarcoma could significantly reduce time between diagnosis and treatment. The aggressive nature 
of osteosarcoma combined with late presentation for treatment increases the risk of metastases which 
may then result in palliative as opposed to curative management of patients. 
The researcher aims to explore Zulu patients’ understanding of the diagnosis, treatment and prognosis 
of osteosarcoma. Patients previously treated for osteosarcoma at the Tumour, Sepsis and 
Reconstruction Unit at a tertiary institution in Kwa-Zulu Natal will be approached to explore their 
understanding of the disease and to gain insight into their experience at the hospital during diagnosis 
and treatment. An exploratory descriptive study of the current approach that health professionals take 
when discussing cancer, its treatment as well as prognosis with patients will be conducted. Patients 
will be interviewed by Zulu-speaking fieldworkers with the aid of semi-structured interview guides 
and focus group interviews will be conducted with providers. A literature review will guide the 
construction of these interview schedules. Knowledge gained from analysing data gathered from 
patients and health professionals in conjunction with an integrative literature review will be used to 
develop an evidence based practice guideline for culturally competent patient-provider 
communication with regard to osteosarcoma. It is envisaged that the guideline could be adapted for 
use with other cancers.  
The project outputs will include three to five peer-reviewed publications and presentations at medical 
and psychology conferences. Furthermore, a concise report of the findings and the manner in which 
culturally competent patient-provider communication can be implemented in South African healthcare 
settings will be submitted to the Department of Health HOD and KZN Health Research and 
Knowledge Management. The findings will also be distributed to medical training institutions. 
The main purpose of the project is to improve patient care by providing patients with culturally 
competent patient-provider communication in order for patients to assimilate their diagnosis and make 
decisions regarding treatment. In addition, the findings of this project can be used to influence training 
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1. DEFINING THE RESEARCH PROBLEM 
According to Steyn and Muller
1
 cancer, which is classified as a non-communicable disease, is on the 
increase in South Africa despite advances in treatment, and prevention and education efforts. Non-
communicable diseases (NCDs) are the leading cause of mortality globally, causing more deaths than 
all other causes combined. According to the World Health Organisation (WHO),
2
 36 million people 
died from NCDs in 2008 globally with 21 percent of these deaths being attributed to cancers. 
Globally, deaths due to NCDs are projected to increase by 17% over the next ten years, but the 
greatest increase (24%) is expected in the African region. By 2030 it is estimated that NCDs will 
contribute to 75% of global deaths.
3
 According to the WHO, NCDs accounted for 29% of deaths in 
South Africa in 2008, with seven percent of these deaths being attributed to cancers. Statistics South 
Africa attributed 40% of deaths to NCDs in 2008, with seven percent being attributed to cancer.
4
 
Osteosarcoma is the most frequent primary solid malignancy of bone and is derived from primitive 
mesenchymal cells. Untreated osteosarcomas can result in local and/or metastatic disease 
progression.
5
 Despite advances in treatment of osteosarcoma,
6
 survival is dependent on diagnosis 
prior to progression beyond localised disease. The majority of patients presenting at the study site 
already have locally advanced or metastatic disease thus negatively affecting treatment options and 
outcomes for survival.
7
 Treatment options include chemotherapy and surgery which can include either 
limb salvage or limb ablation.
8
 Limb salvage is not an option in patients with advanced local disease, 
meaning that limb ablation, often more as a palliative and quality of life measure is the only surgical 
option at the study site.  
A further complication in addition to the late presentation of these patients for treatment is that Zulu 
patients often require extensive familial and ancestral consultations and rituals before agreeing to limb 
ablation. This further delay in treatment, given the aggressive nature of osteosarcoma can further 
complicate quality of life and survival outcomes. It then becomes important for providers to 
communicate an understanding of these cultural beliefs while at the same time communicating the 
urgency of the matter and the negative effect on survival. This requires the skill of breaking bad news 
in a culturally sensitive manner that engenders cooperation in the patient while allowing them the 
opportunity to fulfil their cultural obligations. The purpose of this research is therefore the 
development of an evidence-based practice guideline for culturally competent patient-provider 
communication in order to maximise treatment outcomes for Zulu patients diagnosed with 
osteosarcoma. 
2. LITERATURE OVERVIEW AND MOTIVATION 
The primary motivation for undertaking this research stems from observations in clinical practice and 
research findings
7
 indicating that Zulu patients diagnosed with osteosarcoma often present for 
treatment when the disease has already started metastasising. Furthermore, the principal investigator 
and members of the multidisciplinary team have noted that these patients tend to demonstrate a 
misunderstanding of the nature of the disease both before and after medical counselling. 
Osteosarcoma is the most frequent primary solid malignancy of bone and is derived from primitive 
mesenchymal cells. Untreated osteosarcomas can result in local and/or metastatic disease 
progression.
5
 It has been noted in the literature that patients present late for treatment partly due to 
misdiagnosis at community health centres (CHCs) or district hospitals,
7
 while practice indicated that 
late presentation may be partially due Zulu patients’ preference to exhaust all traditional healing 
options before seeking Western medical assistance. A delay in diagnosis and treatment significantly 
affects prognosis. This study therefore intends to gain insight into Zulu patients’ conceptualisations of 
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the illness, understand current provider practices with regard to interacting with Zulu patients about 
osteosarcoma and gather existing evidence from the literature by conducting an integrative literature 
review in order to develop evidence-based practice guidelines for culturally competent patient-
provider communication. The ultimate aim is the reduction of health disparities and the maximisation 
of health outcomes for Zulu patients diagnosed with osteosarcoma. The background for this study is 
now explicated.
 
Communicating with cancer patients 
A detailed literature search delivered no literature specifically pertaining to osteosarcoma and patient-
provider communication hence this section will focus on cancer in general. Communicating with 
cancer patients presents with unique challenges due to the life-threatening nature of the illness. 
Despite advances in treatment, cancer is still commonly associated with negative emotions such as 
fear and anxiety.
9 
Discussing the diagnosis, treatment and prognosis of cancer with patients is 
commonly viewed as breaking bad news.
10
 Bad news is typically defined as information that 
negatively and seriously affects an individual’s view of their future.
11
 Healthcare providers generally 
regard breaking bad news and coping with the emotional responses of patients resulting from such 
news as stressful.
12
 Providers’ communication skills have a significant effect on both the patient and 
the provider. The link between effective patient-provider communication and patient satisfaction, 
compliance with treatment, quality of life and health outcomes is well-documented.
12,14,15
 Effective 
patient-provider communication can also positively influence provider burnout, professional 
satisfaction and decrease litigation.
16
 For the cancer patient, effective provider communication can 
affect the psychological well-being of patients receiving a cancer diagnosis and increase their sense of 
control and involvement in their care.
17
 However this benefit is reciprocal as providers are equally 






 defined good patient-provider communication as patients understanding the health 
information and treatment recommendations that are explained to them, and feeling comfortable 
enough to ask for clarification when they do not understand something. According to Raynor
20
, 
increasing individuals’ ability to understand and participate in their healthcare is an international 
health priority. The ability to understand health information is known as health literacy. Individuals’ 
health literacy can greatly affect health outcomes and mortality.
21
 Patients with inadequate health 
literacy may not understand medical jargon regarding diagnosis, treatment and prognosis.
22
 
Furthermore, the literature suggests that there is great variability in the degree of patient 
understanding of their cancer, that patients tend to incorrectly state the extent of the disease and the 
goal of treatment, and tend to overestimate prognosis.
23,24,25
 It is essential that cancer patients 
understand their diagnosis and various treatment options available to them in order to facilitate 
informed decision-making. However, studies have indicated that patients have preferences with regard 
to the manner in which bad news is delivered to them. 
      Patient information needs 
A review of patients’ preferences with regard to receiving bad news revealed that four components, 
namely setting, manner of communicating bad news, what and how much information is provided and 
emotional support are considered important factors.
10
 For example, Parker et al
26
 found in their study 
that provider expertise and receiving diagnostic and treatment information was most important to 
patients followed by the need for support from providers when receiving information. On the other 
hand, Hack
25 
reported that communication outcomes are enhanced when providers primarily attend to 
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the emotional needs of patients when breaking bad news. Patients’ information needs may also be 
influenced by their attitudes to cancer and their strategies for coping. Patients may want information 
at diagnosis but this may vary across the disease trajectory depending on factors such as their faith in 
their doctor’s expertise, their need to maintain hope by avoiding detailed knowledge, and an 
awareness of limited resources which results in an acceptance that limited information is a given.
27
 
Patient preferences have also been associated with demographic variables such as age, gender, and 
educational level with younger patients, female patients and more highly educated patients 
consistently expressing a need to receive detailed information as well as emotional support.
10
 
The cancer literature on providing information to patients tends to encourage truth-telling in breaking 
bad news to patients. The literature alerts to the fact that while diagnoses are often readily disclosed as 
providers are ethically and legally expected to do so, disclosure of prognostic information occurs less 
often.
28
 A systematic review of the literature by Hagerty et al
29
 revealed that there is little available 
evidence regarding the best method for communicating prognosis or of the impact of prognostic 
information on patient outcomes. A number of difficulties arise when communicating prognosis to 
patients such as level of truth-telling regarding survival estimates especially in the case of patients 
with poor prognoses.
30
 A study by Hagerty et al
31
 of metastatic cancer patients found that most of 
these patients wanted detailed prognostic information but preferred to negotiate the extent, format, 
and timing of the information they received while another study found that patients with advanced 
disease desired less information about their illness.
32
 A South African study revealed that 78.5 percent 
of that study sample wanted to be informed of prognosis with regard to their specific cancer.
33
 Culture 
has also been shown to complicate information provision when discussing prognosis with patients.
34
 
This aspect is discussed in more detail in the following section. The variability in research findings 
are a clear indication that providers need to assess patient information needs and be weary of adopting 
a generic approach to addressing these needs.
25,30,32
 
     Culture and patient-provider communication  
Culture can be defined as “a system of beliefs, values, rules and customs that is shared by a group and 
is used to interpret experiences and direct patterns of behavior”.
35
 Culture is an important 
consideration in clinical care as it plays a significant role in how patients’ health-related values, 
beliefs and behaviours are shaped.
35
 Cultural diversity in South Africa essentially means that patients 
are more often than not treated by a provider from a different culture to their own. Managing cancer in 
a multicultural context further complicates the patient-provider relationship.
36
 An example where this 
is evident is related to patient information needs across the disease trajectory. Some cultures such as 
Italian, Chinese and Japanese cultures may value nondisclosure of diagnosis and of a terminal 
prognosis
37,38
 whereas cultures derived from a Western philosophy tend to value fully informing 
patients.
39
 It is important for providers to become aware of cultural preferences regarding cancer 
disclosure. This would include understanding of patient preferences for involving the family in 
decision-making, the use of nonverbal communication and the psychosocial impact of terminologies 
used.
37,40
 Understanding all these facets does by no means intimate that providers can adopt a ‘one 
size fits all’ approach when addressing individuals from certain cultural backgrounds, as various 




Culture affects patients’ and communities’ interaction with cancer, patients’ approaches to its 
treatment and trust in providers and institutions.  Similarly culture has been shown to affect individual 
professionals’ and institutions’ approach to minority patients.
41 
While it is well-known that cultural 
factors are crucial to diagnosis, treatment and efficient management of illness, overemphasis on 
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culturally categorising patients may result in stereotyping.
42
 The other side of this pertains to 
providers’ awareness of their own cultural backgrounds and contexts
43
 and of how this interacts with 
that of the patient as well as the culture of medicine.
42,43
 Disparities in healthcare particularly those 
related to race and ethnicity, are well-documented and significantly influence access to and optimal 
use of healthcare services.
14,44,45,46,47
 However, the concept of culture, as earlier defined, is not solely 
associated with race and ethnicity.
48
 It is noteworthy that South Africa presents with disparities in 
health and wealth that are amongst the highest in the world.
47
 Despite post-apartheid South Africa 
awarding high priority to health equity
49
, a 2008 study by Kon and Lackan
46
 showed that Black and 
Coloured South Africans were still underserved and disadvantaged especially with regard to health 
care. Health disparities have multiple complex causes including genetics, poverty, access to health 
care, behaviour, and environmental factors.
45
 The complex interactions of political and racially 
motivated policies such as the South African apartheid policies
47
 as well as globally documented 
causes of health disparities such as low socioeconomic status, unemployment, lower levels of 
education, and occupations and living environments that expose individuals to hazards
50
 require 
intervention at many levels in order to address the problem of health disparities. While large scale 
interventions on the policy and institutional level may be required, literature increasingly points to the 
role that cultural competence can play in reducing health disparites.
14,41,44,51
 
“Cultural competence in health care entails: understanding the importance of social and cultural 
influences on patients’ health beliefs and behaviors; considering how these factors interact at multiple 
levels of the health care delivery system; and, finally, devising interventions that take these issues into 





cultural competence in medicine as complex and multi-layered. Cultural competence can be achieved 
via organisational, structural and clinical cultural competence interventions.
51
 On the organisational 
level this refers to ensuring that the leadership and staff compliment of a health care delivery system 
is diverse and representative of its patient population. Structural cultural competence interventions 
address structural processes that limit access to quality health care while clinical cultural competence 
interventions address provider knowledge of the interaction between sociocultural factors and health 
beliefs and behaviours as well as equipping providers with the skills to manage these culturally 
complex interactions. The overall aim of this research is the development of an evidence-based 
practice guideline for culturally competent patient-provider communication with regard to 
osteosarcoma diagnosis, treatment and prognosis. This study will address the issue of culturally 
competent patient-provider communication and therefore falls in the domain of clinical cultural 
competence interventions. Culturally competent patient-provider communication can be defined as the 
ability to communicate with awareness and knowledge of how sociocultural factors contribute to 
healthcare disparities, how cultural factors influence health beliefs and behaviours and in addition 
possessing the skills to manage these factors effectively in cross-cultural patient-provider contexts.
53 
Inherent in the concept of cultural competence as described above is the patient-centered approach to 
medicine. This approach, in line with the concept of cultural competence, expects that the provider 
takes the patient’s needs and preferences into account
54
 and allows for differences among patients 




 argues that patient-centered 
medicine and evidence-based medicine are on opposite ends of the continuum as the former purports 
humanism and a biopsychosocial approach and the latter denotes positivism and a biomedical 
approach. Both paradigms are deemed relevant and essential, and on close inspection are possible at 
the same time despite them housing completely opposite paradigms. Bensing
54
 described 
communication as absolutely key to patient-centered medicine and intimated that strengthening the 
evidence base of patient-centered medicine lies in conducting communication research. This author 
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firstly calls for research that links communication to health outcomes and also appeals for greater 
efforts in synthesising the evidence in order to develop evidence-based practice guidelines and 
protocols. This study is in line with the latter plea with specific emphasis being placed on culturally 
competent patient-provider communication with Zulu patients diagnosed with osteosarcoma. While 
much has been written on the concept of cultural competence, there is a lack of agreement with regard 
to how to best implement this at the individual patient care level.
48
 The aim is that a review of the 
evidence from existing literature as well as the generation of new evidence by means of semi-
structured interviews with patients and providers will result in an evidence-based practice guideline 
for this specific population group. The approach taken in this research therefore reflects the general 
consensus in the literature that evidence-based practice typically includes three key components 




The interviews with providers will take an interprofessional approach and diverge from the cited 
literature where providers are mostly medical professionals. Interprofessionalism promotes 
collaborative practice that is organised around the needs of the population being servedand includes 
multiple health workers from different professional backgrounds working together with patients, 
families, carers and communities in order to deliver the highest quality of care.
57
 The team consists of 
consultants and registrars from the Department of Orthopaedics at the institution where the study will 
be conducted, registered nurses, a social worker, a clinical psychologist, dieticians, a physiotherapist 
and an occupational therapist. Community organisations and individuals are co-opted as the need 
arises depending on patient needs. All members of the team will be approached for participation in the 
research. 
The benefits and purpose of evidence-based practice guidelines are to summarise and synthesise 
knowledge and innovations in medicine; to reduce variation in practice; and to improve quality of 
patient care.
58,59
 Evidence-based practice guidelines are developed in a transparent and structured 
manner and reviews, rates and synthesises a large body of evidence resulting in a series of 
recommendations that can improve provider practice and patient outcomes simultaneously. This study 
will conclude with the developed guidelines being reviewed by an expert panel consisting of people 
with expertise in clinical content; experts in literature reviews or guideline development, or both; and 




3. AIM AND OBJECTIVES 
The overall aim of the study is to develop an evidence-based practice guideline for culturally 
competent patient-provider communication with Zulu patients with regard to osteosarcoma diagnosis, 
treatment and prognosis. This aim will be achieved by meeting the following 4 objectives:  
Objective 1: A study of patients previously treated for osteosarcoma to explore patient understanding 
of the osteosarcoma diagnosis, its treatment and prognosis, and patient experience of the patient-
provider relationship throughout the illness experience. Qualitative semi-structured interviews will be 
conducted to gather this information. Trained fieldworkers will conduct the interviews in Zulu. 
Objective 2: An exploratory descriptive study of the approach taken by health professionals when 
discussing osteosarcoma, its treatment and prognosis with patients. A focus group interview guide 
consisting of semi-structured questions will be used to elicit information regarding the process and 
content that multidisciplinary team members follow when discussing osteosarcoma with Zulu 
patients. 
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Objective 3: An integrative literature review which will be used to address the review question. Some 
topics that will arise may include: skills for cultural competence; models of cultural competence 
which have been used in cancer settings; evidence-based practice guidelines for cultural competence 
in healthcare settings. The integrative literature review allows for the inclusion of studies with diverse 
methodologies. It comprises a number of key stages: problem identification, literature search data 
evaluation, data analysis and presentation
61
.  
Objective 4: Develop an evidence-based practice guideline for culturally competent patient-provider 
communication with osteosarcoma patients based on the evidence collected.  
4. METHODS 
4.1. STUDY DESIGN FOR RESEARCH OBJECTIVE 1 
Objective 1: Qualitative semi-structured interviews will be used to explore and describe previously 
diagnosed patients’ understanding of the causes, symptoms, diagnosis and treatment of osteosarcoma, 
and patient experience of the patient-provider relationship throughout the illness experience. A 
qualitative exploratory descriptive study design will be used to achieve this objective. 
SETTING 
The Tumour, Sepsis and Reconstruction (TSR) Unit at Grey’s Hospital has a patient register of 
osteosarcoma patients treated at Grey’s Hospital. Permission to access this register will be obtained 
from the head of the TSR Unit. Patients will either be accessed when they attend their outpatient 
appointments at the Orthopaedic Clinic or when they attend the Oncology Clinic for chemotherapy. 
Patients that have completed their treatment could be telephonically invited to attend an interview at 
Grey’s Hospital. Their transport costs will be covered. Written informed consent will be obtained 
from each participant prior to commencement of the data collection (Appendix C). 
 
PARTICIPANT SELECTION 
Nonprobability purposive sampling will be used to select Zulu participants diagnosed with 
osteosarcoma from patient register held by the TSR Unit. The researcher will not include newly 
diagnosed patients in the study. Only outpatients that are receiving follow-up at Orthopaedic 
Outpatients or chemotherapy and follow-up at the Oncology Department will be included in the study. 
 
MEASUREMENTS 
A semi-structured interview schedule (Appendix E) guided by a literature review will be used to 
assess patients’ knowledge of the causes, symptoms, diagnosis and treatment of osteosarcoma. This 
schedule will also consist of a biographical section to be completed by the interviewer before 
commencement of the interview in order to gather biographical data about the patients. Patients’ 
experience of the patient-provider relationship will also be explored. Trained fieldworkers will 
conduct the interviews in Zulu. The interview schedule will be piloted on at least one Zulu speaking 
osteosarcoma patient before administering it to the rest of the participants. If no changes are made 
based on this pilot, the data will be included in the study for analysis. Interviews will be audio taped 







Data from the semi-structured interviews will be analysed using thematic analysis. Thematic analysis 
is a data analysis technique commonly employed in qualitative research for identifying, analysing, and 
reporting patterns within data
62
. There are a number of steps in thematic analysis: 
1. The first step involves familiarising yourself with your data. This entails transcribing data (if 
necessary), reading and rereading the data, and noting down initial ideas. 
2. The researcher then generates initial codes. This requires the researcher to code interesting features 
of the data in a systematic fashion across the entire data set, collating data relevant to each code. 
3. The researcher then searches for themes by collating codes into potential themes, gathering all data 
relevant to each potential theme. 
4. Themes are then reviewed and refined by checking the collated extracts for each theme and 
observing whether they form a coherent pattern (Level 1). Extracts that do not fit into a theme 
could be an indication that the theme is problematic and needs to be reworked or could mean that a 
new theme(s) has to be created for those extracts or alternatively that extracts have to be discarded. 
A thematic map is now generated of the themes and the researcher can move to Level 2 of this step 
which involvesconsidering the validity of individual themes in relation to the entire data set. 
5. Themes are then defined and named. This entails ongoing analysis to refine the specifics of each 
theme, and the overall story the analysis tells thereby generating clear definitions and names for 
each theme. 
6. The researcher then selects vivid, compelling extract examples, relating these back to the research 
question and literature and presenting a discussion of the findings.
62
 
Guba’s model of trustworthiness will be utilized
63
 in order to verify the accuracy of the findings. This 
model addresses four issues of trustworthiness, namely credibility, transferability, dependability and 
confirmability. In addressing credibility, the researcher and fieldworkers will use interviewing 
techniques and skills such as probing, reframing, clarifying and summarizing. The same semi-
structured interview schedule and procedures for interviewing will be used with each patient. 
Confidentiality of information gathered and anonymity in reporting of the results of the findings will 
be guaranteed and explained to participants during the consent process. Member checking will be 
used to verify the findings. Transferability will be addressed by saving the data analysis documents 
that will be used to generate the findings. Furthermore, the detailed descriptions of the research 
procedures followed will be documented. Dependability will be ensured by keeping a dense 
description of the research methods, processes and steps followed. Confirmability will be ensured by 
using an independent coder and member checking. 
SAMPLE SIZE 
Sample size will be determined by employing the guiding principle of the concept of saturation point 
which refers to the point at which no new information or themes are observed in the data.
64
 While 
there are no specific rules regarding sample size in qualitative research,
65
 it generally relies on smaller 
numbers. An experiment by Guest et al
64 
revealed that saturation could be achieved as early as 6 
interviews, with 12 interviews being sufficient according to their study on saturation. However, 
sample homogeneity, good quality data and specific rigorous inquiries are essential to limit the 
number of participants required for the study.
64
 This objective requires a homogenous Zulu patient 
population previously diagnosed with osteosarcoma. The objective is clearly specified and the 
interview questions will be piloted before they are administered to the participants.  
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4.2. STUDY DESIGN FOR RESEARCH OBJECTIVE 2 
Objective 2: Qualitative semi-structured interviews will be used to explore and describe the process 
and content of providers discussing osteosarcoma, its treatment and prognosis with patients. 
A qualitative exploratory descriptive study design will be used to achieve this objective. Focus groups 
will be organised in order to extract the process and content of discussing the diagnosis, treatment and 
prognosis of osteosarcoma with patients.The focus group is a qualitative research method for eliciting 
descriptive data from population subgroups.
66 
SETTING 
Health professionals in the Orthopaedic registrar programme and consultants are usually involved in 
sharing news regarding diagnosis, treatment and prognosis of osteosarcoma with patients. Registrars 
rotating through the TSR Unit and consultants will be interviewed. At the tertiary institution where 
the research will be conducted, a team approach is used to manage patients diagnosed with 
osteosarcoma. This team comprises dieticians, an occupational therapist, a physiotherapist, a social 
worker, a clinical psychologist, and registered nurses working in the outpatient orthopaedic clinic and 
the orthopaedic wards where these patients are admitted.  
PARTICIPANT SELECTION 
All members of the team as outlined in the previous section will be approached to participate in the 
study. Nonprobability purposive sampling will therefore be used to achieve this objective of the study. 
Inclusion criteria stipulates that participants must be members of the multidisciplinary team managing 
Zulu patients diagnosed with osteosarcoma and orthopaedic registrars that have worked or are 
working in the TSR Unit. Three separate focus groups consisting of the orthopaedic consultants and 
registrars, the nurses and allied health professionals respectively will be convened in order to collect 
the data for this objective. 
MEASUREMENTS 
A focus group interview guide (Appendix F) consisting of semi-structured questions will be used to 
elicit information regarding the process and content that multidisciplinary team members follow when 
discussing osteosarcoma with Zulu patients. The schedule will attempt to elicit whether there is a 
particular sequence of information provision that is followed and the nature of the content of 
information shared. The schedule will also attempt to tap into considerations of the team members 
regarding type of information shared. The interview schedule will be piloted on a colleague to ensure 
that the appropriate data is being elicited for the purpose of the study. 
DATA ANALYSIS 
Data from the focus groups will be analysed using thematic analysis as discussed in section 4.1. 
Guba’s model of trustworthiness will be utilized
63
 in order to verify the accuracy of the findings. 
Additional considerations in ensuring trustworthiness of the data gathering and data analysis refer to 
the fact that the researcher will conduct the focus groups. The process of bracketing
67
 will be used 
whereby the researcher is aware of own preconceived ideas and outcomes for the study as well as 
knowledge gained while reading in preparation for the study, and uses this awareness to minimise 
potential deleterious effects of these preconceptions on the research process.  
SAMPLE SIZE 
Usually eight to 12 members comprise a focus group.
66
 The researcher plans to constitute three focus 
groups: the orthopaedic consultants and registrars; the nursing staff comprising of registered nurses 
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working in the orthopaedic wards and orthopaedic outpatient department; and allied health 
professionals comprising of those individuals assigned to working with patients diagnosed with 
osteosarcoma. Saturation may not be possible with this objective as there are a limited number of 
individuals that can be invited to participate in the focus groups. All members of the team may not be 
interested in participating.   
4.3. STUDY DESIGN FOR RESEARCH OBJECTIVE 3 
Objective 3: An integrative literature review will be conducted to gather evidence from previous 
research. The integrative literature review allows for the inclusion of studies with diverse 
methodologies.
61
 It comprises a number of key stages: problem identification, literature search, data 
evaluation, data analysis and presentation as outlined in Whittemore and Knafl.
61
 
4.3.1 Problem identification 
The review question was formulated using the PICO guide.
68
 This guide divides each question into 
four components: 
Patients/population: which patients or population of patients are we interested in? How can they be 
best described? Are there subgroups that need to be considered? 
Intervention: which intervention, treatment or approach should be used? 
Comparison: what is/are the main alternative/s to compare with the intervention? This is the optional 
component in the PICO question as the researcher may only look at the intervention without exploring 
alternatives, and in some cases, there may not be an alternative.  
Outcome: what is really important for the patient? Which outcomes should be considered: 
intermediate or short-term measures; mortality; morbidity and treatment complications; rates of 
relapse; late morbidity and readmission; return to work, physical and social functioning and other 
measures such as quality of life; general health status; costs?
68 
The review question therefore based on PICO: 
Patients/population – The patient population focused on in this study are Zulu patients diagnosed with 
osteosarcoma. 
Intervention – The proposed intervention is culturally competent patient-provider communication. 
Comparison – no comparison or alternative intervention is proposed. 
Outcome – Improving treatment outcomes, either curative or palliative depending on disease stage at 
first presentation to the institution.  
Review Question: Among Zulu patients diagnosed with osteosarcoma, does culturally competent 
patient-provider communication improve treatment outcomes? 
4.3.2 Literature search 
A detailed search strategy will be devised to address the problem. Examples of databases that will be 
searched: EBSCOhost will be used to search across databases including MEDLINE, PsychINFO, 
CINAHL; PubMed; BioMed Central; Sabinet Online; National Guideline Clearinghouse website; 
Google Scholar; cancer, research and governmental organisations’ websites. Keywords used will 
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include but are not limited to: cultural competence, cancer, osteosarcoma, patient-provider 
communication. 
Inclusion criteria: All literature relevant to the problem will be included; English and Afrikaans data 
will be included as the principal investigator is fluent in these languages; all literature from 1982 
when the term cultural competence first appeared in the literature
69
 will be included. Grey literature 
which has been defined as "(t)hat which is produced on all levels of government, academics, business 
and industry in print and electronic formats, but which is not controlled by commercial publishers"
70
 
will also be included in the integrative literature review. Literature that duplicates information and 
that pertains to cultural competence in disciplines other than healthcare will be excluded from the 
review.  
4.3.3 Data evaluation 
Once all the relevant literature has been identified, evidence evaluation will be done by using a 
hierarchy system in order to rate the evidence. There are different levels of evidence depending on the 
type of study. The literature presents with a plethora of systems for evaluating evidence. The system 
proposed by Muir Gray
71
 is well-documented in the evidence-based practice literature and will be 
used to evaluate the quantitative evidence. This rating system is presented in Table 1. 
Table 1: Levels of Evidence for Quantitative Research 
Level I (strongest evidence) Strong evidence from at least one systematic review of multiple well-
designed randomised controlled trials. 
Level II Strong evidence from at least one properly designed randomised 
controlled trial of appropriate size. 
Level III Evidence from well-designed trials such as pseudo-randomised or non-
randomised trials, cohort studies, time series or matched case-controlled 
studies 
Level IV Evidence from well-designed non-experimental studies from more than 
one centre or research group or from case reports. 
Level V Opinions of respected authorities, based on clinical evidence, descriptive 
studies or reports of expert committees. 
 
A hierarchy of evidence for assessing qualitative health research as proposed by Daly et al
72
 is 
outlined in Table 2. 
Table 2: A Qualitative Hierarchy of Evidence-for-Practice 
Level I (strongest evidence) Generalisable studies  
Level II Conceptual studies 
Level III Descriptive studies  
Level IV Single case studies  
 
Once evidence has been identified and graded as previously described, critical appraisal tools will be 
used to “carefully and systematically examin(e) research to judge its trustworthiness, and its value and 
relevance in a particular context”.
73
 
Systematic reviews will be appraised using the AMSTAR which is a measurement tool to assess the 
methodological quality of the review.
74
 This has been shown to have good face and content validity.  
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Quantitative research will be appraised using the HCPRDU Evaluation Tool for Quantitative Studies 
developed by Long et al
75
 under the auspices of the Health Care Practice Research and Development 
Unit (HCPRDU) at the University of Salford, UK in a study regarding the feasibility of undertaking 
systematic reviews in social care. 
Qualitative research will be appraised using the Critical Appraisal Skills Programme (CASP) tool for 
assessing qualitative research.According to the National Collaborating Centre for Methods and Tools 
(NCCMT),
76 
CASP helped to develop an evidence-based approach in health and social care, working 
with local, national and international groups.  CASP tools assess internal validity, the results of the 
study and the relevance of the results to practice.
76 
Mixed method studies will be appraised using the HCPRDU Evaluation Tool for Mixed Method 
Studies developed by Long et al
75
 under the auspices of the Health Care Practice Research and 
Development Unit (HCPRDU) at the University of Salford, UK in a study regarding the feasibility of 
undertaking systematic reviews in social care. 
The grey literature will be critically appraised using the AACODS (Authority, Accuracy, Coverage, 
Objectivity, Date, Significance) checklist.
77
 This checklist has the flexibility to be applied to the 
widest range of resources.  
Evidence-based practice guidelines for cultural competency in health settings will be appraised using 
the AGREE II tool. The AGREE II tool was developed by an international team of guideline 
developers and researchers known as the Appraisal of Guidelines, Research and Evaluation (AGREE) 




To ensure the rigour of the literature search and data evaluation stages of the integrative literature 
review process, an independent reviewer will be used to minimise bias in selection of studies and to 
ensure that critical appraisal tools are accurately applied.
80
 
4.3.4 Data analysis 
The goals of this stage are a thorough and unbiased interpretation of primary sources as well as an 
innovative synthesis of the evidence.
61
 The process starts with data reduction and extraction. The 
reviewer has to decide on a classification system for managing the data from diverse methodologies. 
For the purposes of this research, type of evidence will be used to initially classify the data. Other 
subgroups may emerge depending on the data collected. The next step in data reduction involves 
extracting and coding data thereby organising it into a manageable framework. Data extraction is 
guided by the specific questions asked of the data. This is followed by data display which involves 
converting the extracted data from individual sources into a display that assembles the data from 
multiple primary sources around particular variables or subgroups. Data display leads to the next step 
in data analysis namely data comparison. The reviewer now has to compare the data in order to 
identify patterns, themes and/or relationships. This is followed by drawing conclusions and verifying 
the data. Patterns and processes are identified and conflicting evidence is highlighted and discussed. 
Typically a table is used so that systematic comparison of primary sources on specific aspects is 
possible.
61 
4.3.5 Data presentation 
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The data will be presented in the form of tables. This will be followed by a discussion of the main 
findings. Implications for practice, future research and policy development
61
 will be highlighted. 
4.4. STUDY DESIGN FOR RESEARCH OBJECTIVE 4 
Objective 4: Develop an evidence-based practice guideline for culturally competent patient provider 
communication with Zulu patients diagnosed with osteosarcoma based on the evidence collected from 
the semi-structured interviews with patients, the focus groups with providers and the integrative 
literature review. The guideline will be externally reviewed by an expert panel which will consist of 
people with expertise in clinical content; experts in literature reviews or guideline development, or 




There are a number of approaches to evidence-based clinical practice guideline development. Turner 
et al
81
 reviewed six evidence-based clinical practice guideline handbooks and advised that given the 
considerable agreement between these approaches, limited available resources should be spent on 
collating approaches as opposed to updating individual approaches. The NICE (National Institute for 
Health and Clinical Excellence) approach faired very well in this review. Similarly in a review of 
nineteen handbooks
82
, the NICE handbook scored the best. This approach is therefore proposed as a 
guide for developing the evidence-based practice guideline for this research. The steps suggested in 
the NICE handbook are briefly outlined and applied to this study.
68 
4.4.1 Topic Selection  
The topic for the guideline has already been selected based on clinical observations and literature 
findings (first step in guideline development). 
4.4.2 Scoping the clinical practice guideline (CPG) 
This step includes the following key tasks: considering the guideline remit; undertaking a preliminary 
literature search; identifying key aspects of care to be included; and reviewing the scope after 
consultation.
68
 All of these tasks have already been performed in the compilation of this protocol. 
However, reviewing the scope of the CPG is an ongoing process in consultation with the supervisors 
for this study. 
4.4.3 Formulating the Guideline Development Group (GDG):  
The GDG typically includes health professionals, those familiar with issues affecting patients and 
carers, and technical experts. Zulu patients diagnosed with osteosarcoma will be interviewed in order 
to achieve the first objective of this study. Health professionals involved with managing Zulu patients 
diagnosed with osteosarcoma will be interviewed to gather data for the second objective of this study. 
These health professionals will also be involved in member checking of that data and will be invited 
to comment on the CPG.  Furthermore, the supervisors of this research as well as technical experts on 
integrative literature reviews and CPG development will be consulted throughout the course of this 
research. 
4.4.4 Formulate the clinical questions  
This was achieved by using the PICO guide.
68
 The clinical question for this guideline is: Among Zulu 
patients diagnosed with osteosarcoma, does culturally competent patient-provider communication 
improve treatment outcomes? 
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4.4.5 Identify the evidence 
A search strategy will be developed and relevant databases will be searched using the inclusion and 
exclusion criteria set for the evidence. This step in the process will basically involve objectives 1 to 3 
previously discussed. 
4.4.6 Review and grade the evidence  
The levels of evidence for quantitative and qualitative evidence as well as the critical appraisal tools 
outlined in section 4.3.3 of Objective 3 will apply to this step of the CPG development.  
4.4.7 Create guideline recommendations 
Once the evidence has been critically appraised, the Grading of Recommendations, Assessment, 
Development and Evaluation (GRADE) system
83
 will be used to grade the quality of the evidence and 
the strength of guideline recommendations. This step also includes prioritising guidelines for 
implementation.
68
 The GRADE system is outlined in Table 3. 
Table 3: GRADE grades of evidence 
High Further research is very unlikely to change our confidence in the 
estimate of effect. 
Moderate Further research is likely to have an important impact on our 
confidence in the estimate of effect and may change the estimate 
Low Further research is very likely to have an important impact on our 
confidence in the estimate of effect and is likely to change the estimate 
Very low Any estimate of effect is very uncertain. 
 
4.4.8 Preparing the guideline 
This is an iterative process that involves at least two drafts of the guideline as well as review by the 
GDG or an expert panel convened for the purpose of reviewing the guideline before the final 
document is compiled.
68 
The expert panel will consist of people with expertise in clinical content; 
experts in literature reviews or guideline development, or both; and potential users of the guideline.
60
 
The AGREE II tool will also be used to evaluate the methodological rigour of how the clinical 
practice guideline was developed.
78,79 
The NICE guideline development process does not include the step of evidence transfer
56 
which 
relates to the careful development of strategies that involves packaging knowledge for the transfer to 
individual health professionals, health facilities and health systems globally by means of journals, 
other publications, electronic media, education and training and decision support systems. The 
information has to be understandable and actionable, be context specific taking into account the 
recipients’ needs; and delivered in a cost-effective manner.
56
 The data gathered will be published in 
peer reviewed journals for each of the objectives. Information will further be disseminated to the 
Department of Health KZN HOD in the form of a report. The information will also be made available 
to the professionals that participated in this study in order to improve practice with the study 
population. The hospital management and KZN Health Research and Knowledge Management will 
also receive a copy of the findings. 
5. ETHICAL CONSIDERATIONS 
A number of ethical considerations are important for the purposes of this study. 
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Informed consent 
Informed consent will be ensured in this study in that each prospective participant will receive an 
information sheet (Appendices C and D) explaining the nature and purpose of the study, who the 
researcher is, the issues of confidentiality and anonymity and a contact number should any questions 
arise. The researcher/fieldworkers collecting the data will provide a detailed explanation of the 
research, its duration and the issues of confidentiality and anonymity. The information sheet also 
contains the contact details for BREC should the participants be concerned that ethical violations 
occurred during the research. The information sheet for patients will be translated into Zulu once 
BREC approval has been obtained.   
Coercion 
Participants will be informed of their right to voluntary consent and their right to withdraw from the 
study at any time. Patient participants will also be reassured that their decision regarding participation 
in the study will not affect their access to healthcare in any way. 
Privacy and confidentiality 
The fact that the researcher will personally contact and make appointments with participants means 
that the participants will not be anonymous to the researcher. However, anonymity and confidentiality 
in reporting of the findings will be maintained at all times. 
Risk of Harm to Patients 
Zulu patients diagnosed with osteosarcoma will be approached for participation in the study. Patients 
will be asked about their illness as well as their experience of the healthcare system. Retelling their 
stories may evoke negative emotional responses in these patients. Counselling will be provided should 
patients require this as a result of participating in this study. It should be noted that osteosarcoma 
patients are referred to the Clinical Psychology Department before final diagnoses are made. These 
patients therefore receive ongoing psychological intervention from the time of work-up and 
throughout the treatment process should they agree to this service. In addition, many of these patients 
are serviced by the Social Work Department as well. The risk of harm noted is therefore minimal but 
will be taken into account nonetheless. 
Ethics Approval 
The study will be submitted for ethics approval to the UKZN Bioethics Research and Ethics 
Committee (BREC) and permission to conduct the study at the institution will be sought form the 












7. TIME LINES AND PROJECT MANAGEMENT 
Task Date 
BREC Approval January 2015 
Data collection from patients February to June 2015 
Data collection from health professionals February to June 2015 
Integrative literature review January to December 2015 
Development of the evidence-based practice guideline January 2015 to August 2016 
Compiling final document August to December 2016 
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DATE:   
Dear Dr Bilenge  
RE: Permission to Conduct Research at Grey’s Hospital 
I would like to request permission to conduct research at Grey’s Hospital. The research is for PhD 
degree purposes but also forms part of my job description and KRAs for EPMDS. The project is 
entitled:Culturally competent patient-provider communication as a means of improving health 
outcomes in Zulu patients diagnosed with osteosarcoma. The study entails the interviewing of Zulu 
patients previously diagnosed with osteosarcoma now receiving outpatient treatment. The study will 
also involve focus group interviews with health professionals involved in the multidisciplinary 
management of these patients. The research protocol will be submitted to the UKZN Biomedical 
research Ethics Committee (BREC) for ethics approval and your office will be furnished with the 
approval number and any correspondence from BREC. KZN Health Research and Knowledge 
Management will also be approached for permission to conduct the study and your office will once 
again be furnished with communiqué from this unit. The study will therefore only commence with 
your permission and once permission has been obtained from the entities as described. A copy of the 
research protocol is attached.  
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Appendix C: Information Sheets and Informed Consent: Patients 
Information Sheets and Informed Consent: Patients (English) 






























My name is Ottilia Brown and I am the principal clinical psychologist in the Clinical Psychology 
Department at Grey’s Hospital. My contact information is as follows: 
Email: Ottilia.Brown@kznhealth.gov.za 
Office telephone: 033 897 3135 
Pager: 137 
I would like to invite you to consider participating in a study that involves research on culturally 
competent patient-provider communication with Zulu patients diagnosed with osteosarcoma. The aim 
and purpose of this research is to develop a guideline for health professionals that help them to 
communicate with patients in such a manner that the patients feel like their cultural background is 
taken into account. The researcher cannot specify how many participants will be approached at this 
point because it will depend on the type of information that each participant offers the researcher. A 
fieldworker will conduct interviews in Zulu. Your interview will be recorded so that it can be written 
down word for word and translated into English so that the researcher can understand the information. 
Once the information has been looked at by the researcher, she will approach you again to make sure 
that she understood correctly what you were trying to convey in the interview. If you choose to 
participate in the study, you will be contacted on two occasions, first for the interview and secondly 
when the researcher checks that she understands the information correctly.  
You may be asked questions about the time when you were diagnosed with osteosarcoma and this 
may result in you remembering some unpleasant things linked to that time. The researcher will ensure 
that you have access to counselling should this be the case. While there may be no direct benefits to 
you from participating in this study, we hope that the guideline that will be developed in this study 
will help with successful management of patients diagnosed with osteosarcoma in the future. 
This study has been ethically reviewed and approved by the UKZN Biomedical research Ethics 
Committee (approval number_____). 
In the event of any problems or concerns/questions you may contact the researcher at 033 897 3135 or 
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BIOMEDICAL RESEARCH ETHICS ADMINISTRATION 
Research Office, Westville Campus 
Govan Mbeki Building 
Private Bag X 54001  
Durban  
4000 
KwaZulu-Natal, SOUTH AFRICA 
Tel: 27 31 2604769 - Fax: 27 31 2604609 
Email: BREC@ukzn.ac.za 
Participation in this research is voluntary and you may withdraw participation at any point. In the 
event of refusal/withdrawal of participation, you will not incur penalty or loss of treatment or other 
benefit to which you are normally entitled. If you decide that you do not want to participate in the 
study any longer, inform the fieldworker during the interview process or inform the researcher on 
033 897 3135 or on email as listed above. 
While you will not be paid for participation in the study, your transport costs to the hospital will be 
paid if you are being interviewed on a day that you are not at the hospital for other outpatient 
appointments.  
Please note that confidentiality will be maintained at all times. Codes will be used instead of patient 
names. Recordings will be stored with password protection on an electronic device. The recordings 
will only be used for the purposes of this research and will only be heard by the researcher, the 
transcriber and those supervising the study as well as the person that will be double checking that the 
researcher has analysed the information correctly (independent coder).  
--------------------------------------------------------------------------------------------------------------------------- 
CONSENT  
I _______________ have been informed about the study entitled: Culturally competent patient-
provider communication as a means of improving health outcomes for Zulu patients diagnosed with 
osteosarcoma by _________________. 
I understand the purpose and procedures of the study. 
I have been given an opportunity to answer questions about the study and have had answers to my 
satisfaction. 
I declare that my participation in this study is entirely voluntary and that I may withdraw at any time 
without affecting any treatment or care that I would usually be entitled to. 
I have been informed that I will receive counselling if I experience any negative emotions or reactions 
as a result of participating in this study. 
If I have any further questions/concerns or queries related to the study I understand that I may contact 
the researcher at 033 897 3135. 
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If I have any questions or concerns about my rights as a study participant, or if I am concerned about 
an aspect of the study or the researchers then I may contact: 
BIOMEDICAL RESEARCH ETHICS ADMINISTRATION 
Research Office, Westville Campus 
Govan Mbeki Building 
Private Bag X 54001  
Durban  
4000 
KwaZulu-Natal, SOUTH AFRICA 




____________________      ____________________ 
Signature of Participant                            Date 
 
 
____________________   _____________________ 
Signature of Witness                                Date 
(Where applicable)      
 
 
____________________   _____________________ 














My name is Ottilia Brown and I am the principal clinical psychologist in the Clinical 
Psychology Department at Grey’s Hospital. My contact information is as follows: 
Email: Ottilia.Brown@kznhealth.gov.za 
Office telephone: 033 897 3135 
Pager: 137 
 
Ngicela ukukumema ukuthi uzibandakanye ocwaningweni oluhlanganisa ukuxhumana 
komuntu osiza isiguli owaziyo ngamasiko oxhumana neziguli ezingamaZulu ezinesifo 
somdlavuza (osteosarcoma). Injongo nenhloso yalolu cwaningo ukwakha umhlahlandlela 
ozosetshenziswa abezempilo ozobasiza ukuxhumana neziguli ngendlela yokuthi iziguli 
zizizwe ukuthi amasiko azo akanyathelwa noma ayabhekelelwa. Angeke umcwaningi acacise 
ukuthi bangakhi abazozibandakanya okuzokhulunywa nabo okwamanje ngoba lokhu 
kuzoncika ohlotsheni lolwazi oluzonikwa ngozibandakanyayo enika umcwaningi. Ozobe 
eqoqa ulwazi uzoxoxisana nabantu ngesiZulu. Ingxoxo yakho izoqoshwa ukuze ibhalwe 
phansi igama negama bese ihunyushelwa eSingisini ukuze umcwaningi ezoluqonda ulwazi. 
Uma ulwazi selubukiwe umcwaningi, uyophinde akucele futhi ukuqinisekisa ukuthi 
ukuqonde kahle obewuzama ukukudlulisa ngesikhathi sokuxoxisana nozibandakanyayo. Uma 
ukhetha ukuzibandakanya ocwaningweni, kuyoxhunyanwa nawe kabili, okokuqala kuyobe 
kungokokuxoxisana bese okwesibili lapho umcwaningi esebheka ukuthi uluqonda kahle 
ulwazi.    
 
Ungabuzwa imibuzo ngesikhathi kutholakala ukuthi unomdlavuza (osteosarcoma) kanti 
lokhu kungaba nomphumela wokuthi ukhumbule izinto ezingezinhle ezenzeka ngaleso 
sikhathi. Umcwaningi uyoqinisekisa ukuthi uyokwazi ukwelulekwa ngokwqengqondo uma 
lokhu kwenzeka. Nakuba kungeke kubekhona imihlomulo eqondile eza kuwena 
ngokuzibandakanya kulolu cwaningo, sithemba ukuthi umhlahlandlela oyokwakhiwa kulolu 
cwaningo uyosiza ukuphathwa ngokunempumelelo iziguli okutholwe ukuthi zinomdlavuza 
(osteosarcoma) esikhathini esizayo.  
 
Lolu cwaningo selubuyekezwe laphinda lagunyazwa yi-UKZN Biomedical research Ethics 
Committee (Inombolo yokugunyaza_____). 
GREY’S HOSPITAL 
CLINICAL PSYCHOLOGY DEPARTMENT 
Private Bag X9001,PIETERMARITZBURG, 3200 
Town Bush Road, Chase Valley, 
PIETERMARITZBURG, 3201 







































                                                                                       
 
243 
Uma kungaba nezinkinga noma okukukhathazayo/imibuzo ungaxhumana nomcwaningi ku-
033 897 3135 noma i-UKZN Biomedical Research Ethics Committee, imininingwane 
yokuxhumana: 
 
BIOMEDICAL RESEARCH ETHICS ADMINISTRATION 
Research Office, Westville Campus 
Govan Mbeki Building 
Private Bag X 54001  
Durban  
4000 
KwaZulu-Natal, SOUTH AFRICA 
Tel: 27 31 2604769 - Fax: 27 31 2604609 
Email: BREC@ukzn.ac.za  
 
Ukuzibandakanya kulolu cwaningo kungukuvolontiya kanti ungahoxa ekuzibandakanyeni 
nanoma yingasiphi isikhathi. Uma unqaba ukuzibandakanya noma uhoxa, angeke 
uhlawuliswe noma ulahlekelwe wukwelashwa okade ukuthola noma eminye imihlomulo 
okufanele uyithole. Uma ukhetha ukuthi awusafuni ukuzibandakanya ocwaningweni, tshela 
lowo oqoqa ulwazi ngesikhathi nisaxoxisana noma utshele umcwaningi kule nombolo 033 
897 3135 no kwi-email njengoba ibhaliwe ngezansi. 
 
Nakuba ungeke ukhokhelwe ngokuzibandakanya ocwaningweni, izindleko zokugubela 
kwakho uya esibhedlela ziyokhokhwa uma kuyoxoxiswana nawe ngosuku oluyobe 
lungakudingi ukuthhi uye esibhedlela uyokwenza ezinye izinto.  
Sicela uqaphele ukuthi ubumfihlo buyogcinwa ngazo zonke izikhathi. Kuyosetshenziswa 
amakhodi esikhundleni samagama esiguli. Okuqoshiwe kuyolondolozwa nenombolo 




Mina _______________ ngazisiwe ngocwaningo olisihloko sithi: Culturally competent 
patient-provider communication as a means of improving health outcomes for Zulu patients 
diagnosed with osteosarcoma by _________________. 
 
Ngiyayiqonda inhloso kanye nenqubo yocwaningo. 
 




Ngiyasho ukuthi ukuzibandakanya kwami kulolu cwaningo kungukuvolontiya kanti 
ngingahoxa nanoma yingasiphi isikhathi ngaphandle kokuphazamiseka kokwelashwa kwami 
noma ukunakekelwa engijwayele ukukuthola. 
 
Ngithseliwe ukuthi ngizothola ukwelulekwa ngokwengqondo uma kwenzeka ngingaphatheki 
kahle ngokomphefumulo noma okuzokwenzeka ngenxa yokuzibandakanya kulolu cwaningo. 
 
Uma ngiseneminye imibuzo/okungikhathazayo okumayelana nocwaningo, ngiyaqonda ukuthi 
ngingaxhumana nomcwaningi kule nombolo  033 897 3135. 
 
Uma ngingaba nanoma emiphi imibuzo noma okungikhathazayo ngamalungelo ami 
njengozibandakanya ocwaningweni, noma uma ngikathazwa ingenye ethile yocwaningo 
noma abacwaningi ngakho ngingaxhumana ne: 
 
BIOMEDICAL RESEARCH ETHICS ADMINISTRATION 
Research Office, Westville Campus 
Govan Mbeki Building 
Private Bag X 54001  
Durban  
4000 
KwaZulu-Natal, SOUTH AFRICA 
Tel: 27 31 2604769 - Fax: 27 31 2604609 
Email: BREC@ukzn.ac.za  
 
 
____________________       _____________________ 
Kusayine ozibandakanyayo                             Usuku 
 
 
____________________     _____________________ 
Kusayine ufakazi                                Usuku 
(Uma kunesidingo)      
 
 
____________________     _____________________ 

































Dear Healthcare Professional 
My name is Ottilia Brown and I am the principal clinical psychologist in the Clinical Psychology 
Department at Grey’s Hospital. My contact information is as follows: 
Email: Ottilia.Brown@kznhealth.gov.za 
Office telephone: 033 897 3135 
Pager: 137 
I would like to invite you to consider participating in a study that involves research on culturally 
competent patient-provider communication with Zulu patients diagnosed with osteosarcoma. The aim 
and purpose of this research is to develop an evidence-based practice guideline for culturally 
competent patient-provider communication with Zulu patients about osteosarcoma. The researcher 
aims to conduct three focus groups; one with medical professionals, one with nursing staff and one 
with allied health professionals. The focus groups will be recorded so that they can be transcribed 
verbatim. Once the researcher has analysed the transcribed information, she will approach you again 
to make sure that she understood correctly what you were trying to convey in the interview. If you 
choose to participate in the study, you will be contacted on two occasions, first for the focus group 
and secondly when the researcher checks that she understands the information correctly.  
While there may be no direct benefits to you from participating in this study, we hope that the 
guideline that will be developed in this study will facilitate the successful management of patients 
diagnosed with osteosarcoma in the future. 
This study has been ethically reviewed and approved by the UKZN Biomedical research Ethics 
Committee (approval number_____). 
In the event of any problems or concerns/questions you may contact the researcher at 033 897 3135 or 
the UKZN Biomedical Research Ethics Committee, contact details as follows:  
BIOMEDICAL RESEARCH ETHICS ADMINISTRATION 
Research Office, Westville Campus 
Govan Mbeki Building 
Private Bag X 54001  
Durban  
4000 
KwaZulu-Natal, SOUTH AFRICA 
Tel: 27 31 2604769 - Fax: 27 31 2604609 
GREY’S HOSPITAL 
CLINICAL PSYCHOLOGY DEPARTMENT 
Private Bag X9001,PIETERMARITZBURG, 3200 
Town Bush Road, Chase Valley, PIETERMARITZBURG, 
3201 











































Participation in this research is voluntary and you may withdraw participation at any point without 
any negative consequence to you. If you decide that you do not want to participate in the study any 
longer, inform the researcher during the focus group process or inform the researcher on the contact 
information listed above. 
Please note that confidentiality will be maintained at all times. Codes will be used instead of 
participant names. Recordings will be stored with password protection on an electronic device. The 
recordings will only be used for the purposes of this research and will only be heard by the researcher, 
the transcriber, the independent coder and those supervising the study.  
--------------------------------------------------------------------------------------------------------------------------- 
CONSENT  
I _______________ have been informed about the study entitled Culturally competent patient- 
provider communication as a means of improving health outcomes for Zulu patients diagnosed with 
osteosarcoma by _________________. 
I understand the purpose and procedures of the study (add these again if appropriate). 
I have been given an opportunity to answer questions about the study and have had answers to my 
satisfaction. 
I declare that my participation in this study is entirely voluntary and that I may withdraw at any time 
without affecting any treatment or care that I would usually be entitled to. 
If I have any further questions/concerns or queries related to the study I understand that I may contact 
the researcher at 033 897 3135. 
If I have any questions or concerns about my rights as a study participant, or if I am concerned about 
an aspect of the study or the researchers then I may contact: 
BIOMEDICAL RESEARCH ETHICS ADMINISTRATION 
Research Office, Westville Campus 
Govan Mbeki Building 
Private Bag X 54001  
Durban  
4000 
KwaZulu-Natal, SOUTH AFRICA 






____________________      ____________________ 
Signature of Participant                            Date 
 
____________________   _____________________ 
Signature of Witness                                Date 
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Appendix E: Patient Demographic Information and Interview Schedule (English 


































Patient Demographic Information and Interview Schedule 
Patient Information 
Code  
Contact number  
Area of residence  
Age  
Gender □ Female 
□ Male 
Employment status □ Unemployed 
□ Self-employed 
□ Part-time employment 
□ Employed 
Occupation  





□ In a relationship 
Religious affiliation  
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1. How do you understand the diagnosis of osteosarcoma (cancer)? 
2. Can you provide details on how the diagnosis of osteosarcoma was given to you? 
3. What is your understanding of how this illness is treated? 
4. Can you provide details on how the treatment options were discussed with you? 
5. What information did you receive about the course of the condition/ the likely outcome of the 
condition (prognosis)? 
6. What are the cultural considerations that you had to take into account when you heard the 
diagnosis and had to decide on treatment? Some cues for this question include: 
a. Consulting the family 
b. Consulting a traditional healer 
c. Rituals 
d. Ancestors  
7. A number of different health professionals cared for you when you were diagnosed and treated. 
Can you give us some indication of what this experience was like for you? 
















Ishejuli yokuxoxisana nesiguli 
1. Ukuqonda kanjani ukuhlolelwa umdlavuza (osteosarcoma/cancer)? 
2. Unganikeza imininingwane ukuthi kwenziwa kanjani ukuhlolelwa umdlavuza kuwena? 
(osteosarcoma) 
3. Kuthini okwakho ukuqonda ngokwelashelwa lesi sifo? 
4. Unganikeza imininingwane ngokuthi kwaxoxiswana kanjani nawe ngezindlela zokwelapha 
ezikhona? 
5. Wathola oluphi ulwazi ngembangela yalesi simo/nanemiphumela yalesi simo? (prognosis). 
6. Eziphi izinyathelo mayelana nesiko okwafanele uziqaphele ngesikhathi uzwa ngokutholakala 
kwesifo kuwena futhi bese ukhetha ngohlobo lokwelashwa? Ezinye zezibonelo zalo mbuzo 
zihlanganisa lokhu : 
a. Ukuxhumana nomndeni 
b. Ukuxhumana nolapha ngesintu 
c. Imisebenzi efaka isiko 
d. Amadlozi  
7. Izisebenzi zezempilo zikunakekele ngesikhathi kutholwa ukuthi unalesi sifo futhi wanakekelwa. 
Ungasivezela ukuthi lesi sipiliyoni saba njani kuwena? 















































Provider Demographic Information and Interview Schedule 
Provider Information 
Code  
Contact number  
Age  
Gender □ Female 
□ Male 
Professional registration category □ Consultant 
□ Registrar 
□ Registered Nurse 
□ Occupational therapist 




Religious affiliation  
Traditional belief system  
 
Interview Schedule 
1. How do you go about discussing the diagnosis of osteosarcoma with the Zulu patient?  
a. Are there specific steps or processes that you follow? 
2. How do you usually discuss treatment options with this patient? 
3. How do you discuss prognosis with this patient?  
4. If you prefer not to discuss prognosis with patients, how do you respond when they ask about it? 
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Appendix G: Ethical approvals 
Ethical Approval from the Biomedical Research Ethics Committee (BREC) at UKZN 
Site Approval 
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Guideline aim: The aim of this guideline is to present healthcare providers treating Zulu patients 
diagnosed with osteosarcoma with evidence-based recommendations that can facilitate culturally 
competent communication regarding the diagnosis, treatment and prognosis of osteosarcoma.   
 
Methods and materials: The AGREE II (Appraisal of Guidelines, Research and Evaluation) 
appraisal instrument was used as a guide for developing the evidence-based practice guideline. An 
integrative literature review, focus groups with healthcare providers and in-depth interviews with Zulu 
patients were conducted to gather the evidence for the evidence-based practice guideline. The 
guideline wase reviewed by an expert panel using the AGREE II tool.  
 
Setting: This guideline was developed for healthcare providers communicating with adult Zulu 
patients diagnosed with osteosarcoma. The Zulu people are indigenous and reside in the 
predominantly rural South African province of KwaZulu-Natal. They speak isiZulu, one of South 
Africa’s 11 official languages. This province has an overall population of 10.9 million (of a total 
South African population of 54 956 900 million), the majority of which is classified as Zulu. The 
focus on osteosarcoma resulted from research findings indicating that the majority of patients 
presenting at the study site already have locally advanced or metastatic disease.The training hospital 
where this study was conducted is the referral centre for all patients with osteosarcoma from the 
western half of the province. 
 
Results: The guideline specifies generic aspects such as the awareness, knowledge, skills and 
provider attitudes required for culturally competent communication as well as the type of healthcare 
system that can support and cultivate such communication. The guideline then details specific 
recommendations for communicating the diagnosis, treatment and prognosis of osteosarcoma to Zulu 
patients. Cultural considerations and responses to these factors are described. 
 
Conclusion: Healthcare providers will require cultural competence and communication training in 
order to facilitate the implementation of the guideline. Some of the challenges identified in the focus 
group interviews are not addressed in this guideline leaving room for further development of the 
guideline. However, based on the integrative literature review, focus groups interviews with 
healthcare providers and in-depth interviews with Zulu patients, specific recommendations for 
culturally competent communication with this patient group regarding the diagnosis, treatment and 
prognosis of osteosarcoma were formulated. Evidence-based practice can contribute to improving 
culturally competent communication with cancer patients receiving treatment at culturally discordant 




Communicating the diagnosis and prognosis of cancer is widely documented as challenging tasks.
1-10
 
Furthermore, ensuring that patients understand their treatment options is considered good practice.
11
 
However literature in this regard tends to be limited. Performing these tasks in cross-cultural clinical 
settings complicates patient-provider communication.
12
 Culture plays a significant role in how 
patients’ health-related values, beliefs and behaviours are shaped, and affects how patients and 
communities approach the diagnosis and treatment of cancer as well as their trust in healthcare 
providers and institutions.
13,14
 Culture also affects professionals’ and institutions’ approach to 
minority patients and contributes substantially to disparities in access to healthcare for minority and 
underprivileged patients.
14,15
 An evidence-based practice guideline would contribute significantly to 
improving culturally competent communication with cancer patients receiving treatment at culturally 
discordant healthcare facilities.  
 
This guideline was developed for healthcare providers communicating with adult Zulu patients 
diagnosed with osteosarcoma. The Zulu people are indigenous and reside in the predominantly rural 
South African province of KwaZulu-Natal (KZN). They speak isiZulu, one of South Africa’s 11 
official languages. This province has an overall population of 10.9 million (of a total South African 
population of 54 956 900 million), the majority of which is classified as Zulu.
16 
The focus on 
osteosarcoma resulted from observations in clinical practice of the significant role that cultural factors 
play in the management of osteosarcoma. In addition, research findings indicated that the majority of 
patients presenting at the study site already have locally advanced or metastatic disease.
17
While late 
presentation of these patients for treatment can be partially attributed to misdiagnosis at community 
health centres or district hospitals,
17
 Zulu cultural practices including extensive familial, ancestral 
and/or traditional healing consultations and rituals before agreeing to certain treatment options may 
also play a role. Other observations in clinical practice related to delayed presentation included 
denialand/orunderestimationofthe seriousness ofthecondition. Our research with healthcare providers 
and Zulu patients at the study site confirmed that cultural considerations were paramount when 
treating Zulu patients diagnosed with osteosarcoma. 
 
Osteosarcoma is the most frequent primary solid malignancy of bone and is derived from primitive 
mesenchymal cells. Despite advances in treatment, survival is dependent on diagnosis prior to 
progression beyond localised disease.
18
 The late presentation of patients therefore limits treatment 
options and results in very poor prognosis.
17,19-22 
The treatment options are closely related to patients’ 
understanding of their prognosis and the outcomes resulting from various approaches to treatment. 
Healthcare providers in this setting are therefore expected to simultaneously inform patients of the 
diagnosis of osteosarcoma, the significant limitations with regard to treatment options, and prognostic 
considerations in a culturally sensitive manner that engenders cooperation in the patient while 
263 
allowing them the opportunity to fulfil their cultural obligations. Healthcare encounters at the study 
site are largely culturally discordant. This evidence-based practice guideline was therefore developed 
to provide recommendations for engaging in culturally competent communication with adult Zulu 
patients regarding the diagnosis, treatment and prognosis of osteosarcoma. The guideline is intended 
for use among doctors, nurses and allied health professionals communicating with Zulu patients about 
the diagnosis, treatment and prognosis of osteosarcoma. 
 
2. Methods and Materials 
The AGREE II (Appraisal of Guidelines, Research and Evaluation) appraisal instrument was used as a 
guide for developing the evidence-based practice guideline.
23 
The purpose of the AGREE II 
Instrument is to provide a framework for assessing the quality of guidelines; provide a methodological 
strategy for the development of guidelines; and inform what information should be reported in 
guidelines and in what manner.
24
 The original AGREE appraisal instrument was thoroughly 
investigated and modified to establish the AGREE II tool as the revised standard for guideline 
development, reporting and evaluation.
25,26
 The AGREE II is a 23 item tool comprising six domains. 
Domain five, applicability,pertains to the likely barriers and facilitators to implementation, strategies 
to improve uptake, and resource implications of applying the guideline. This domain also assesses 
whether the guideline presents monitoring and/or auditing criteria. This domain was beyond the scope 
of this guideline development process.  
 
2.1 Comments from the Expert Panel Reviewers 
An expert panel was selected to review the guideline and did not participate in developing the 
guideline. The AGREE II manual specifies that guidelines should be assessed by at least two 
reviewers but that four is preferable in order to increase the reliability of the assessment.
23
 Five 
reviewers agreed to appraise the guideline. The expert panel comprised of two nursing professors with 
extensive methodological knowledge, one of whom conducts research in KZN; one social work 
professor with methodological as well as field knowledge, having previously worked in public health 
in the province of KZN; one medical professor involved in training medical professionals in KZN; 
and one content expert – a clinical psychologist that had previously worked at the study site and had 
extensive knowledge of Zulu patients and the oncology environment. The AGREE II tool was used to 
review the guideline. Reviewers could rate each item according to a 7-point scale with response 
options ranging from strongly disagree to strongly agree. The scores for each domain were calculated 
as is described in the AGREE II manual.
23
 The reviewer comments are now discussed according to 





2.1.1 Scope and Purpose 
This domain is concerned with the overall aim of the guideline, the review question, and the target 
population. The guideline reviewers either agreed or strongly agreed that the aim of the guideline, the 
review question and the target population were clearly described. One of the reviewers suggested that 
the review question be improved in the following manner: ‘How is culturally competent patient-
provider communication best delivered by healthcare providers to adult Zulu patients diagnosed with 
osteosarcoma?’ It was proposed that the phrase ‘by healthcare providers’ be included. The review 
question was adapted accordingly. The domain score for this section was 92%. 
 
2.1.2 Stakeholder Involvement 
This domain focuses on the extent to which the guideline was developed by the appropriate 
stakeholders and represents the views of its intended users. The guideline reviewers’ scores ranged 
from neutral to strongly agree for this domain. One of the reviewers stated that the credentials of the 
guideline developer should be specified. The credentials of the developer have been included in 
section 2.2.2. One of the reviewers suggested that it be indicated whether the interview questions used 
to access the views and preferences of the target population addressed recommendations that were 
included in the guideline. This has been addressed in section 2.2.3.1.3. Three of the reviewers 
commented on the number of patients interviewed, one of whom enquired whether other audits or 
surveys had been done. The number of patients interviewed is a limitation of this guideline and is 
discussed in section 2.2.3.1.3 and 4.2. Two of the reviewers indicated that the target users of the 
guideline are clearly described but they requested more detailed information in this regard. A more 
detailed description of the target users is presented in 2.2.2. One of the reviewers suggested that 
specific recommendations are aligned to specific healthcare providers. The scope of the current study 
did not allow for healthcare provider specific recommendations hence this suggestion could be 
considered when further developing this guideline. The domain score for this section was 71%. 
 
2.1.3 Rigour of Development 
This domain relates to the process used to gather and synthesize the evidence, the methods to 
formulate the recommendations, and to update them. One of the reviewers suggested that the literature 
included as evidence should have included cross-cultural literature in general and should not have 
been limited to cancer literature. However, the review question was developed in line with the aim 
and objectives of the research and required a specific focus on cancer literature. Most of the reviewers 
rated this domain favourably. Three of the reviewers indicated that the strengths and limitations of the 
body of evidence were not clearly described. Section 4.2 has been added to address this concern. One 
of the reviewers indicated that the methods for formulating recommendations were not clearly 
described. This is addressed in section 2.2.3.2. The domain score for this section was 78%. 
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2.1.4 Clarity of Presentation 
This domain deals with the language, structure, and format of the guideline. The reviewers scored this 
domain well. One of the reviewers reported that the most critical recommendations should be 
highlighted as the recommendations are exhaustive. However, the recommendations are in line with 
the definition of cultural competence and also add context specific information that will aid in 
managing the Zulu patient diagnosed with osteosarcoma.Furthermore, the evidence did not prioritise 
recommendations. The domain score for this section was 87%. 
 
2.1.5 Editorial Independence 
This domain is concerned with the formulation of recommendations not being unduly biased with 
competing interests. Two of the reviewers scored this domain favourably. One of the reviewers 
indicated that funding and conflict of interest related to funding should be specified in the guideline. 
The suggestion was incorporated into the guideline. The domain score for this section was 80%. 
 
2.1.6 Overall Guideline Assessment 
The overall quality of the guideline was rated favourably. Two of the guideline reviewers 
recommended the guideline for use without modification and three reviewers recommended the 
guideline with modification. General comments made are now briefly outlined: 
 
Reviewer 1: 
This reviewer accepted the guideline with modification. Suggestions regarding a modification of the 
review question andan inclusion of credentials for the guideline developer were made. The relevance 
of the patient interview questionsin addressing the recommendations for inclusion in the guideline, 
and the number of patients interviewed wasqueried. More detail regarding the target users was 
requested and a summary of the strengths and limitations of the body of evidence was proposed. 
Clearer description of the methods for formulating the recommendations was also suggested. All of 
these comments have been integrated into the guideline.  
 
Reviewer 2: 
This reviewer accepted the guideline with modification. This reviewer reflected on the responsibility 
that the healthcare provider has in taking cognisance of the vast differences and nuances in treating 
Zulu speaking patients. The relevance of a guideline of this nature was emphasised. 
 
Reviewer 3: 
This reviewer indicated that the guideline was comprehensive and very well described. She made 
specific suggestions such as referring to the language as isiZulu and specifying the age group used as 
adult, which have been incorporated into the guideline. Content suggestions were also made with 
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reference to the recommendations. However these opinions could not be adhered to as the guideline is 
based on the evidence gathered.  
 
Reviewer 4:  
The guideline was well-accepted by this reviewer. This reviewer highlighted the importance of the 
role of family and community in managing African patients and how this diverges from westernized 
notions of clinical practice where the patient’s right to self-determination is usually in the foreground. 
The role of family is reflected in the guideline recommendations in sections 3.1.1.4, 3.1.2.4, 3.1.3.4, 
3.1.3.5 and 3.2.2.4. This reviewer also inquired about Zulu mysticism and African philosophy 
regarding limb disposal following amputation. The issue of clinical ethics in MDT functioning was 
also raised. The patients and healthcare providers interviewed in order to obtain stakeholder accounts 
did not raise these issues. 
 
Reviewer 5: 
The guideline was well-accepted by this reviewer. Content comments and a suggestion that 
recommendations take the link between patients, family and community into account were made. The 
link with family is firmly established in the recommendations. Further development of this guideline 
may explore community aspects.  
 
2.2 The Evidence-Based Practice Guideline 
This section provides details on the guideline development process according to the domains of the 
AGREE II instrument. 
 
2.2.1 Scope and Purpose 
This domain encompasses the aim of the guideline, the review question and the target population.  
 
2.2.1.1 Aim of the guideline 
Research has indicated that patients present at the study site when the disease has already 
metastasised.
17
 Although this is partially due to misdiagnosis at peripheral facilities,
17
 focus groups 
with healthcare providers at the study site and in-depth interviews with Zulu patients treated at the site 
confirmed observations in clinical practice that cultural health beliefs and practices also contribute to 
delays in treatment. The aim of this guideline is therefore to present healthcare providers treating 
adult Zulu patients diagnosed with osteosarcoma with evidence-based recommendations that can 
facilitate culturally competent communication regarding the diagnosis, treatment and prognosis of 




2.2.1.2 The review question 
The review question: How is culturally competent patient-provider communication best delivered by 
healthcare providers to adult Zulu patients diagnosed with osteosarcoma? 
 
2.2.1.3 Target group 
The targeted patient population are adult Zulu patients diagnosed with osteosarcoma. The adult age 
refers to patients 18 years and older. 
 
2.2.2 Stakeholder Involvement  
The guideline was developed by one of the members of the multidisciplinary team working with Zulu 
patients diagnosed with osteosarcoma. The developer is a content expert with methodological 
experience in both quantitative and qualitative research. The guideline development process was 
supervised by content and methodological experts.  
 
In addition, the healthcare providers working in a multidisciplinary team context with Zulu patients 
diagnosed with osteosarcoma participated in focus groups in order to ascertain their current 
approaches and their suggestions regarding how to engage in culturally competent communication 
with these patients. Zulu patients’ views and preferences were investigated using in-depth interviews.  
 
The evidence-based practice guideline was developed for use amongst healthcare providers working 
with Zulu patients diagnosed with osteosarcoma. These professionals include doctors, nurses and 
allied health professionals. The doctors working in the Orthopaedics Department are the first port of 
call for these patients. Nurses working in orthopaedic and oncology outpatient clinics and wards have 
the most contact with Zulu patients diagnosed with osteosarcoma. Allied health professionals working 
with Zulu patients diagnosed with osteosarcoma at the study site include physiotherapists, clinical 
psychologists, social workers, occupational therapists and dieticians. The guideline has not been 
piloted with the target group as this task is beyond the scope of the current research study.  
 
2.2.3 Rigour of Development  
This domain relates to the process used to gather and synthesize the evidence, the methods to 
formulate the recommendations, and to update them. 
 
2.2.3.1 Gathering and synthesising the evidence 
An integrative literature review was conducted to review the existing evidence. In addition, focus 
groups with healthcare providers and in-depth individual interviews with Zulu patients were 
conducted in order to contextualise the guideline. The approach taken therefore reflects the general 
consensus in the literature that evidence-based practice typically includes three key components 
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2.2.3.1.1 Integrative Literature Review 
An integrative literature review was conducted using Whittemore and Knafl’s approach.
29
 An 
experienced librarian assisted the primary author with selecting the keywords and databases, and with 
conducting the search. In the period February to May 2015, the following electronic databases were 
searched: PubMed, EBSCOHost, Emerald, JSTOR, Sabinet Online, SAGE, Cochrane, Science Direct, 
SpringerLink, Taylor and Francis, Web of Science, NEXUS and Sabinet (Thesis/Dissertations). 
Evidence-based practice guideline websites were also searched, including the National Guideline 
Clearinghouse, National Health and Medical Research Council (NHMRC), New Zealand Guidelines 
Group (NZGG), Registered Nurses’ Association of Ontario (RNAO), The National Institute for 
Health and Care Excellence (NICE), Scottish Intercollegiate Guidelines Network (SIGN), 
eGuidelines, Guidelines International Network, Turning Research into Practice (Trip) Database, 
Canadian Medical Association (CMA) Infobase and Joanna Briggs Institute (JBI) Evidence-based 








The following keywords were used in various combinations to conduct the literature searches: patient-
provider communication; doctor-patient communication; physician-patient communication; cancer; 
oncology; cultural competence; culturally competent communication; cross- cultural communication; 
multicultural communication; and transcultural communication. Various sets of keywords were used 
that were deemed suitable for the databases, to ensure that no relevant literature was missed. 
 
The following inclusion criteria were used: relevant literature from 1982 was included, as the term 
‘cultural competence’ first appeared in the literature in 1982.
30
 The literature on cultural competence 
had to pertain specifically to cancer or to cultural aspects of communication in the context of cancer 
care, and had to be available in English. Owing to the paucity of research documents available on the 
topic, non-research documents were also included when these were appraised as relevant to the review 
question.
31
 Regarding exclusion of records, literature that pertained to cultural competence in 
disciplines other than the context of cancer care was excluded from the review. Literature pertaining 
to paediatric oncology, cancer patient education not related to the interaction between patients and 
269 
healthcare providers, and cancer screening, were also excluded. Inclusion and exclusion of records 
was independently verified by the second author using the inclusion and exclusion criteria.  
 
Data evaluation entailed rating the evidence and critically appraising the records.  A comprehensive 
and frequently used hierarchy system (Table 1) was chosen to rate the evidence.
32
 Most of the 
documents were evaluated as level VII evidence (N=25), eight of the documents fulfil the criteria for 
level VI evidence, and two of the documents could be evaluated as level IV evidence. 
 




Level I (strongest evidence) Evidence from a systematic review or meta- analysis of all 
relevant randomized controlled trials (RCTs) 
Evidence from evidence-based clinical practice guidelines based 
on systematic reviews of RCT’s 
Level II Evidence obtained from at least one well-designed RCT 
Level III Evidence obtained from well-designed controlled trials without 
randomization (quasi-experimental study) 
Level IV Evidence from well-designed non-experimental studies (case-
control, correlational, cohort studies) 
Level V Evidence from Systematic reviews of descriptive or qualitative 
studies 
Level VI Evidence from a single descriptive or qualitative study 
Level VII Evidence from the opinion of authorities and/or reports of expert 
committees 
 
Critical appraisal tools were used to carefully and systematically examine the records in order to judge 
trustworthiness, value and relevance in a particular context.
33
 Documents were critically appraised 
independently by two reviewers to ensure rigour. Two quantitative studies were appraised using the 
Health Care Practice Research and Development Unit (HCPRDU) Evaluation Tool for Quantitative 
Studies.
34
 Four qualitative studies were appraised using the Critical Appraisal Skills Programme 
(CASP) tool for assessing qualitative research.
35
 Non-research records (N=29) were appraised using 
the Johns Hopkins Nursing Evidence-based Practice tool for Non-Research Evidence Appraisal.
31
 
After critical appraisal was done, thirty-five records were included for data extraction and synthesis.   
 
Data relevant to the review question were extracted from the included records. Data extraction and 
synthesis were also independently verified to improve the rigour of the data analysis. Data display 
matrices were developed to facilitate data comparison and synthesis. The researchers employed an 
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iterative process by repeating the data extraction and synthesis numerous times, in order to ensure the 
verification of the results.  
 
2.2.3.1.2 Healthcare provider focus groups 
Three separate semi-structured focus group interviews were conducted with orthopaedic 
consultants/registrars, nurses from the orthopaedic and oncology outpatient clinics and wards, and 
allied health professionals (N=23). The allied health professional focus group consisted of 
occupational therapists, physiotherapists, dieticians and a social worker. Interview questions focused 
on approaches that healthcare providers take when discussing osteosarcoma diagnoses, treatment and 
prognosis with Zulu patients and the cultural considerations pertaining to these discussions. The 
tertiary hospital where the guideline was developed uses a multidisciplinary approach hence all 
members of the team working with Zulu patients diagnosed with osteosarcoma were approached for 
participation in the focus groups (census sampling). Four Zulu healthcare professionals participated in 
the study. That the majority of the participants were not Zulu is an accurate reflection of the fact that 
patient-provider encounters are largely culturally discordant at this tertiary hospital. Data was 
independently coded and analysed using thematic analysis.
36
 Data was further reviewed by two 
independent qualitative research experts before consensus was reached on the themes. Guba’s Model 
of Trustworthiness was used to ensure rigour.
37
 The evidence derived from these focus groups can be 
classified as level VI evidence.   
 
2.2.3.1.3 Patient interviews 
Four in-depth interviews were conducted with Zulu patients diagnosed with osteosarcoma. Questions 
explored how diagnosis, treatment and prognosis were communicated to the patient; what patients 
understood about their diagnosis and treatment; their experience of the communication; and the role 
of culture in managing the condition. The questions were designed in order to elicit recommendations 
for inclusion in the guideline. Convenience sampling was used. There were a number of challenges 
with regard to locating patients for participation. In addition, distance from the study site also limited 
the number of patients that could participate. The interviews were conducted in isiZulu, transcribed 
and then translated for independent coding and thematic analysis by two experienced 
researchers.
36
Guba’s Model of Trustworthiness with its four criteria was utilized to ensure rigour.
37
 
This study can be classified as level VI evidence.   
 
2.2.3.2 Formulating the recommendations 
The recommendations were developed using content analysis. The guideline clearly links the 
recommendations to the evidence source. References are indicated next to each recommendation. The 
recommendations were formulated following careful review of the results of the integrative literature 
review, the focus group interviews and the patient interviews. Duplicate recommendations across 
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these three sources were grouped together. Generic recommendations were grouped together and 
recommendations specific for the communication of the diagnosis, treatment and prognosis of 
osteosarcoma with Zulu patients were presented separately. The guideline was reviewed by an expert 
panel and should be updated within the next two to three years. A guideline development group did 
not develop the guideline; however the guideline development process was supervised by experienced 
researchers and clinicians.  
 
2.2.4 Clarity of Presentation  
Care was taken to develop clear and unambiguous recommendations. Headings and subheadings 
clearly demarcate the different sections of the guideline. Appendix A provides a summary of the 
recommendations, the source of the recommendations and the associated levels of evidence. 
 
2.2.5 Editorial Independence  
There are no competing interests to report. The research was not funded hence there is no conflict of 
interest to report with regard to finding.   
 
3. Guideline Recommendations 
The recommendations are based on levels IV, VI and VII evidence from the integrative literature 
review, focus groups with healthcare providers and patient interviews (Appendix A). Cultural 
competence has varied definitions but seems to require the acquisition, integration and application of 
awareness, knowledge, skills and attitudes regarding cultural differences in order to effectively deliver 
expert care that meets the unique cultural needs of patients; to manage and reduce cross-cultural 
misunderstanding in discordant medical encounters; and to successfully negotiate mutual treatment 
goals with patients and families from different cultural backgrounds.
15,38-45
 The guideline first 
specifies generic aspects such as the awareness, knowledge, skills, and provider attitudes required for 
culturally competent communication as well as the type of healthcare systems that can support and 
cultivate such communication. The guideline then details specific recommendations for 
communicating the diagnosis, treatment and prognosis of osteosarcoma to Zulu patients. Where 
references are indicated, the recommendations are based on the integrative literature review.  
 
3.1 Generic requirements for culturally competent communication 
Evidence-based rationale 
Generic requirements for engaging in culturally competent communication include the development 
of awareness, the acquisition of knowledge, the acquisition and implementation of skills and strategies 
and fostering certain attitudes.
15,38
 The development and practice of culturally competent 
communication by individual practitioners and multidisciplinary teams is best fostered in the context 
of culturally competent healthcare systems. Culturally competent healthcare systems provide 
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linguistically and culturally appropriate services and supportive policies, strategies and resources that 
promote culturally competent communication.
46
 These generic requirements are now stipulated in 
clearly demarcated subsections.  
 
3.1.1 Healthcare provider awareness 
Different types of healthcare provider awareness are required for working in cross-cultural 
oncology settings. The acquisition, integration and application of awareness of cultural differences in 
cross-cultural oncology settings encompass more than just an awareness of self. The evidence 
revealed that HCPs have to develop contextual, self, and interpersonal awareness as well as an 
awareness of cultural expectations in the healthcare setting.  
 
3.1.1.1 It is recommended that healthcare providers develop contextual awareness of: 
 the country’s socio-political history47 
 the sociocultural factors that affect the patient-provider relationship48 
 patient demographics in the service area49,50 
 the role of gender in culture50,51 
 the role of religion in culture50,51 
 patients’ level of education52,53 
 patients’ experiences of discrimination in clinical settings54 
 dominant cultural narratives regarding health and illness55 
 culturally constructed myths about cancer56 
 cancer patients possibly combining allopathic and traditional medicine55 
 
3.1.1.2 It is recommended that healthcare providers develop self-awareness of own: 
 culture57 
 cultural beliefs58 
 belief systems59 
 spirituality60 
 cultural assumptions, biases and stereotypes14,48,57,59,61 
 
3.1.1.3 It is recommended that healthcare providers develop interpersonal awareness of: 
 inherent power differentials between patient and provider47 
 interaction between patient and provider’s culture57,62 
 communication differences between cultures51,63 
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3.1.1.4 It is recommended that healthcare providers develop awareness of cultural expectations in 
the healthcare setting related to the: 
 level of family involvement required59,64 
 role of family in cross-cultural clinical settings15,50,64,65 
 
3.1.2 Healthcare provider knowledge 
Culturally competent communication requires the acquisition, integration and application of 
knowledge regarding the context, the self, and the patient’s culture. 
 
3.1.2.1 It is recommended that healthcare providers acquire knowledge of broader contextual 
factors pertaining to: 
 racism, sexism, ageism58,66 
 socio-political barriers to accessing healthcare14,61,67 
 the impact of past and present racism61 
 the role of gender in the communication process14 
 the role of age in the communication process14 
 patients’ role expectations in the communications process14 
 socio-historical cultural context14 
 socio-cultural differences between self and patient61 
 
3.1.2.2 It is recommended that healthcare providers acquire context specific knowledge of: 
 the cultural groups attending services in the provider’s clinical setting49,61,63,65,67,68 
 serviced population’s disease profiles, health disparities and treatment outcomes44,63 
 cultural health-related needs and health-seeking behaviours61 
 cultural approaches to illness and treatment48 
 cultural meanings of cancer14 
 patients’ perception of their illness63 
 influence of culture on how patient interacts with healthcare system59 
 
3.1.2.3 It is recommended that healthcare providers acquire self-knowledge of own: 
 culture55,61,63,67 
 belief system61 




3.1.2.4 It is recommended that healthcare providers acquire knowledge of the patient’s culture, 
specifically: 
 the patient’s health belief systems54,64,67 
 the patient’s traditional health system64 
 the role of gender in decision-making49,64 
 the role of family in decision-making49,64 
 preferences regarding language used to discuss cancer15 
 nonverbal communication standards15 
 
3.1.3 Healthcare provider skills 
The healthcare provider is expected to acquire, integrate and apply a variety of skills in order to 
successfully deliver culturally competent patient-provider communication.  
 
3.1.3.1 It is recommended that healthcare providers deliver culturally and linguistically sensitive 
services by acquiring and applying the following cross-cultural communication skills: 
 Engage in culturally sensitive communication recognising the values beliefs and practices of the 
patient and presenting the communication accordingly
14,15,56,69
 
 Engage in culturally congruent communicationwhich recognises that cultural variations exist 




 Observe culturally appropriate nonverbal communication etiquette14 
 Use congruent verbal and nonverbal communication14,67 
  
3.1.3.1.1 It is recommended that healthcare providers ensure patient understanding by acquiring 
and applying the following communication skills and strategies:  
 Provide clear,64,67 accurate,64,67 open,53,54,60,70 flexible53 and transparent60 communication 
 Provide information in the patient’s language64 
 Learn the language64 
 Develop a vocabulary of terms familiar to the patient64 
o Include some basic isiZulu phrases in conversations [focus groups] 
 Use language that patients can understand [focus groups] 
 Use simple language47,52-54 [focus groups] 
 Encourage the patient to ask questions51 [focus groups] 
 Repeat information several times47 [focus groups] 
 Check patient understanding of information47,54,62-64,69 [focus groups] 
 Check what patients remember from previous explanations [focus groups] 
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 Do not use medical jargon [focus groups] 
 
3.1.3.2 It is recommended that healthcare providers manage differences in the patient-provider 
encounter:  
 Avoid stereotyping and generalisations14,44,48,61,63,64,67 [focus groups] 
 Do not make assumptions about patient race, nationality and language15 [focus groups and patient 
interviews]  
 Treat patients equally52,53 
 Encourage patients to raise concerns about discrimination54 
 Create a culturally safe and caring environment47,70 
 Individualise patient care48,70 
 
3.1.3.3 It is recommended that healthcare providers build the patient-provider relationship: 
 Invest time in the beginning49,63,71 
 Engage the patient67 
 Build rapport47,51 
 Gain patient trust38,51,53,56,67 
 Respond to patients’ emotions [focus groups & patient interviews] 
 Actively engage patients in decision-making51,63,69 [focus groups] 
 Encourage and empower patients to raise trust issues54 
 Address patients according to cultural preference67 
 Recognise inherent power differentials67 
 Be open about own cultural frame of reference55 
 Acknowledge own cultural background to patients15 
 Respond skilfully to cultural discordance67 
 
3.1.3.4 It is recommended that healthcare providers conduct a comprehensive patient assessment: 
 Assess patients’ specific communication needs71 
 Conduct a cultural assessmentbyactively exploring patients’ culture:60,62,71 
o Invite patients to describe their cultural backgrounds68 
o Explore views on family and community in the healthcare context68 
o Explore cultural67 and health beliefs59 
o Explore family expectations, feelings and concerns60 
o Explore level of family involvement required59 
o Determine who the main decision-makers are (patient or family?)48,49 [patient interviews] 
o Explore preferences for truth disclosure15,59,63 
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o Explore patients’ spiritual and religious beliefs15,60 
o Ask patients about their disease process [focus groups] 
 Use Kleinman’s eight questions38,68 
 
3.1.3.5 It is recommended that healthcare providers acquire and apply the skill ofaccommodating 
the patients’ family: 
 Invest in and gain family trust52,67 
 Communicate with extended family as per patient’s directive67 [focus groups] 
 Afford the family maximum control possible if this is a patient need60 
 
3.1.3.6 It is recommended that healthcare providers instil and maintain hope regardless of the 
disease stage by [focus groups]: 
 Emphasising what can be done 
o Inform patients that a palliative amputation could help with pain management 
 Reassuring patients of continued involvement of the multidisciplinary team 
 Differentiating the different problems that would be addressed  
 Explaining how the different problems would be addressed 
 Avoiding the provision of false hope 
o Do not inform patients that amputation could cure due to the possibility of disease 
recurrence 
 
3.1.4 Healthcare provider attitudes 
It is recommended that healthcare providers cultivate and integrate the following attitudes in order 
to facilitate culturally competent communication: 
 Take responsibility for cultural aspects of health and illness48 
 Take responsibility for combating discrimination in healthcare settings48 
 Take responsibility for learning about the Zulu culture [focus groups] 
 Be willing to learn from patients67 
 Be open to change and growth70 
 Be culturally sensitive15,48,70 
 Be willing to listen70 




 Demonstrate respect for patients’ spiritual and religious beliefs52 
 Develop an appreciation of different health belief systems66 
 Be willing to explore culture with individual patients63 
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 Validate different cultures68 




 Be willing to adjust behaviours and attitudes63 
 Reflect on own interaction with cultural groups in the clinical setting63 
 
3.1.5 Culturally competent healthcare systems 
Culturally competent healthcare systems are a requirement for the delivery of culturally competent 
communication. 
3.1.5.1 It is recommended that healthcare systems cultivate the following characteristics: 
 Are responsive to individual needs and to how cultures are perceived56,61 
 Promote and facilitate effective patient-centred communication61 
 Respect cultural differences, and support effective care for diverse populations61 
 Provide ethnic-specific services14 
 Convert an awareness of disease prevalence into practices and policies44 
 Develop and implement policies to support effective cross-cultural communication61,70 
 Link with culturally competent agencies and community organisations that provide bilingual and 
bicultural navigation, promotions, and community health outreach services
14
 
 Have adequate support services70 
 Include traditional healers in patient care [focus groups] 
 
3.1.5.2 It is recommended that healthcare systems employ the following cultural competence 
strategies: 
 Use patient navigators42,49,51,67,72,73 
 Use experienced and professional interpreters14,15,38,48,51,54,56,59,64,68 
 Use culturally sensitive print, visual, and audio-visual media and electronic communication51,54,69 
 Use images to assist providers when discussing cancer with patients47 [focus groups] 
 Monitor patient characteristics54 
 Translate written communications48 
 Provide language-concordant encounters54 
 Provide patient-centred care72 
 Consult communities on cultural needs47 
 Integrate community resources into cancer care14 
 Display images of people from cultural groups attending the service47 
 Have ethnically similar staff visible47 
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3.2 Recommended strategies for communicating the diagnosis, treatment and prognosis of 
osteosarcoma 
The focus groups and patient interviews revealed specific strategies for communicating the diagnosis 
of osteosarcoma to Zulu patients. General recommendations for discussing treatment as well as 
proposed strategies for managing cultural factors that affect treatment are outlined. Prognosis 
discussion recommendations are less extensive but still provide some guidance on how to approach 
this challenging task.  
 
3.2.1 Recommended strategies for communicating the diagnosis of osteosarcoma to Zulu patients 
Evidence-based rationale 
Communicating the diagnosis of cancer in cross-cultural clinical settings is documented as a 
challenging task.
74
 Results from the focus group interviews with healthcare providers highlighted 
distinctive factors that complicate communicating the diagnosis of osteosarcoma to Zulu patients. The 
Zulu people generally view the cancer diagnosis as an ancestral punishment or resulting from 
witchcraft and have been socialised to associate a cancer diagnosis with a poor prognosis. The isiZulu 
word for cancer reflects these cultural health beliefs and presents a significant barrier as the meanings 
associated with this word significantly complicates the diagnosis discussion especially when a good 
prognosis is possible. The isiZulu word for cancer is umdlavuza and refers to something that ravages, 
destroys, or cannot be stopped. Furthermore, language barriers present a significant challenge in this 
cross-cultural setting. The lack of availability of medical terms in isiZulu and the limitations with 
regard to the translatability of words into the patient’s language significantly impacts patient 
understanding. Language barriers further manifest in the lack of access to professional interpreters. 
Communicating the diagnosis of osteosarcoma to the Zulu patients therefore requires an 
understanding of cultural and health beliefs and incorporating this knowledge into diagnostic 
conversations.  
 
3.2.1.1 It is recommended that healthcare providers provide patients with factual information about 
their condition including [patient interviews]:  




3.2.1.2 It is recommended that healthcare providers set the stage for truth-telling by: 
 Starting the diagnosis discussion right from the beginning [focus groups] 
 Assessing how much the patient knows 
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 Warning patients a few times about possible cancer diagnosis [focus groups and patient 
interviews] 
 Giving patient incremental information as the diagnostic process unfolds [focus groups] 
 Informing patients of the reasons for diagnostic tests [focus groups and patient interviews] 
 Warning patients before delivering bad news when the diagnosis is confirmed [focus groups and 
patient interviews] 
 Warning patients by reminding them of earlier conversations of possible diagnosis [focus groups] 
 Checking patients’ readiness to receive the diagnosis [patient interviews] 
 Offering privacy when communicating the diagnosis [patient interviews] 
 Confirming diagnosis only once patient has been warned [focus groups and patient interviews] 
 
3.2.1.3 It is recommended that healthcare providers engage in patient-centred communication by: 
 Building a relationship with the Zulu patient (see 3.1.3.3) [focus groups] 
 Spending time with the patient [focus groups] 
 Offering the patient support [focus groups] 
 Demonstrating a personal interest in the patient [focus groups] 
 Assessing and addressing patient needs, emotions and coping [focus groups and patient 
interviews] 
 Responding to patient questions about the diagnosis [focus groups] 
 Assessing patients’ reactions to the diagnosis [focus groups] 
 Responding appropriately to patients’ reactions to the diagnosis [focus groups] 
 Managing the response of denial by [focus groups] 
 acknowledging that the diagnosis is difficult to accept  
 reinforcing the diagnosis  
 helping patients to accept the diagnosis 
 Mobilising support by having a psychologist present when patients are informed of the diagnosis 
[focus groups] 
 
3.2.1.4 It is recommended that healthcare providers engage in culture-centred communication by: 
 Taking responsibility for improving communication (see also 3.1.3.1.1) [focus groups] 
 Demonstrating an understanding of Zulu cultural health beliefs [focus groups] 
 Reassuring patients that their diagnosis is [focus groups]: 
o not due to anything that they have done  
o not a punishment 
o not due to bewitchment 
 Demonstrating a genuine interest in the Zulu culture by [focus groups]:   
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o Asking patients questions about  (see also 3.1.3.4) 
 their cultural practices 
 their religious practices 
 their understanding of the aetiology of the condition 
 how they want to manage the condition  
 their cultural health beliefs 
 Offering patients the best care possible regardless of language discordance [focus groups] 
 
3.2.1.5 It is recommended that healthcare providers facilitate understanding of the diagnosis by 
[focus groups]: 
 Using visual aids  
o Use images, pictures and information brochures 
 Explaining the stages of cancer   
o Educate patients regarding their stage of the disease  
o Educate patients about the effects of cancer in every stage 
 Using metaphors  
o Use metaphors to explain concepts like cells, organs, tumours and metastases 
o Use patient-initiated metaphors 
 
3.2.2 Recommended strategies for communicating the treatment of osteosarcoma to Zulu patients 
Evidence-based rationale 
Owing to the late presentation of patients for treatment at the study site (Ferreira), treatment options 
are limited and prognoses are often poor. Healthcare professionals (HCPs) consequently have to 
simultaneously inform patients of the diagnosis of osteosarcoma as well as the significant limitations 
with regard to treatment options. Late presentation means that most patients are not eligible for limb 
salvage and have to be informed about amputation.
17
 A number of cultural factors have been 
identified with regard to discussing the treatment option of amputation with Zulu patients. Healthcare 
providers reported in the focus group interviews that Zulu patients’ cultural beliefs dictate that they 
cannot become an ancestor if they have an amputation because their body is incomplete. The issue of 
post-amputation community exclusion was also raised. The patient interviews also revealed that 
cultural considerations become important when treatment, specifically amputation, is discussed. Focus 
groups and patient interviews also indicated other Zulu cultural and health beliefs that affect treatment 
such as the belief in traditional healing and the need to consult with cultural decision-makers before 
agreeing to treatment. The recommendations on how to communicate with Zulu patients regarding the 
treatment of osteosarcoma therefore take these cultural beliefs and practices into account.  
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3.2.2.1 It is recommended that healthcare providers provide patients with factual information 
pertaining to [focus groups and patient interviews]: 
 Surgical treatment options 
 Limb salvage is explained if this is an option 
 Amputation is discussed if it is the only option or in the case of borderline tumours 
 Chemotherapy  
 Its purpose 
 When and how it will be used 
 Side-effects of chemotherapy (emphasised in patient interviews) 
 Treatment of metastases (metastasectomies and/or chemotherapy)  
 
3.2.2.2 It is recommended that healthcare providers follow this process when discussing treatment 
with patients: 
 Delay providing treatment information until staging investigations are completed 
 Inform patients about the prognostic consequences of not treating the tumour, e.g. metastases, 
shortened life-span [focus groups and patient interviews] 
 Balance hope and honesty [focus groups] by 
 Communicating the urgency of intervening [patient interviews] 
 Offering patients reassurance [patient interviews] 
 Ensure patient understanding by (see also 3.1.3.1.1) [focus groups]: 
 Using analogies 
 Using the stages of cancer to explain disease progression and realistic treatment options. 
 Explore and manage patients’ emotions associated with amputation and chemotherapy [patient 
interviews] 
 
3.2.2.3 It is recommended that healthcare providers use these strategies for responding to cultural 
factors associated with amputation [focus groups]: 
 Time the treatment discussion to prevent the patient from signing refusal of hospital treatment 
(RHT) before diagnostic testing is complete.  
 When patients refuse amputation, offer patients other treatment options like chemotherapy and 
refer patients to other services like oncology, psychology, social work and dietetics. 
 Mobilise support by having a psychologist present when patients are informed of that an 
amputation is required 
 Expose patients to veteran osteosarcoma patients who have successfully adjusted to amputation 
 Show newly diagnosed patients a video of patients with successful outcomes  
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3.2.2.4 It is recommended that healthcare providers use these strategies for responding to cultural 
and health beliefs that affect treatment: 
 Initiate cultural discussions in order to fast track decision-making [focus groups] 
 Demonstrate an understanding of patients’ cultural beliefs by:  
o Acknowledging patients’ need to discuss treatment with their family [focus groups] 
o Encouraging patients to engage in their cultural traditions and rituals [focus groups and 
patient interviews] 
o Encouraging patients to combine Western and traditional approaches [focus groups and 
patient interviews] 
o Respecting patients’ cultural health beliefs and their desire to consult traditional healer 
[focus groups and patient interviews] 
 Liaise directly with family and cultural decision-makers where possible [focus groups] 
 Negotiate with patients to not go home and to rather invite a family member(s) to the hospital 
[focus groups] 
 
3.2.3 Recommended strategies for communicating prognostic information pertaining to 
osteosarcoma with Zulu patients 
Evidence-based rationale 
Given the late presentation of patients at the study site, HCPs have to communicate diagnostic and 
treatment information urgently. The treatment options are closely related to patients’ understanding of 
their prognosis and the outcomes resulting from various approaches to treatment. 
 
3.2.3.1 It is recommended that healthcare providers assess patient emotions and knowledge by: 
o Enquiring about patients’ thoughts, fears, and impressions of the future [focus groups] 
 
3.2.3.2 It is recommended that healthcare providers inform patients of the prognostic consequences 
of not treating the osteosarcoma [focus groups and patient interviews]: 
 Inform patients of the likelihood of metastases if the osteosarcoma was not treated. 
 Inform patients of the effect on survival if the osteosarcoma was not treated.  
 
3.2.3.3 It is recommended that healthcare providers inform patients of treatment limitations:  
 Explain the nature of osteosarcoma to patients and inform patients that this type of cancer is not 
curable [focus groups] 
 Inform patients that even with surgery the cancer could recur [focus groups and patient 
interviews] 
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 Inform patients that they have to return within six months and then annually to check for cancer 
recurrence [focus groups and patient interviews] 
 
3.2.3.4 When patients have metastases, it is recommended that healthcare providers inform patients 
that: 
 That they have metastases [focus groups and patient interviews] 
 The condition is not curable but that amputation could help with pain [focus groups] 
 Treatment options are limited due to the metastases [focus groups] 
 
3.2.3.5 It is recommended that healthcare providers inform patients of poor prognoses: 
 Inform patients about the terminal nature of the disease if the osteosarcoma is reasonably 
expected to result in the death of the patient within a short period of time [focus groups] 
 Normalise death [focus groups] 
 Do not inform patients of the life expectancy [focus groups] 
 
3.2.3.6 It is recommended that healthcare providers use a staged approach to communicating about 
prognosis [focus groups]. Given the late presentation of patients at this tertiary hospital, a staged 
approach may be more useful for patients that present with localised or metastatic disease that is 
amenable to surgical management. 
 Communicate about immediate treatment goals and if the disease progresses, communicate about 
adjustments in treatment goals to for example palliative care.  
 If treatment is working and cancer is remitting, communicate with patients about rehabilitation 
and resuming normal everyday activities. 
 
4. Strengths and Limitations of the Body of Evidence 
4.1 Strengths 
The strengths of the body of evidence are reflected in the actions taken to ensure scientific rigour 
while collecting the data. With regard to the integrative literature review, an established approach was 
used to conduct the review.
29
 In addition, an independent reviewer experienced in the integrative 
literature review methodology verified the inclusion and exclusion of records, independently 
appraised the documents, and verified the data extraction and content analysis of the data extracted 
from the included documents. Guba’s Model of Trustworthiness was used as a guide to ensure the 
scientific rigour of the studies conducted with the healthcare providers and the Zulu patients.
37
 The 
focus group interviews were conducted by an experienced qualitative researcher in order to minimise 
bias as the primary investigator is part of the MDT that treats Zulu patients diagnosed with 
osteosarcoma. The focus group interviewer and the primary investigator independently coded the data 
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which was further reviewed by two qualitative research experts. The data analysis process was 
extensive and iterative. The interviews with Zulu patients were conducted by Zulu fieldworkers and 
the consent form was also available in isiZulu. Patients were encouraged to express themselves freely 
and also advised that they could withdraw from the study at any time without any recourse. The data 
from these interviews were translated into English and back translated to ensure accuracy of 
translation. Data was independently coded by a qualitative research expert and themes were then 
agreed upon. The research designs and methodologies for all the studies were described in detail and 
allows for replicability of the work.  
 
 
4.2 Limitations of the Study 
The evidence derived from the integrative literature review was mostly low level evidence (Level VII) 
and hence the results had to be interpreted with caution.
32
 Furthermore, most of the studies that met 
the inclusion criteria for inclusion in the integrative literature review were international. With regard 
to the focus groups with healthcare providers, all those that were eligible to participate were 
approached but some MDT members were not available at the time of data collection. Our use of 
discipline specific focus groups likely enhanced our ability to explore issues common to each 
professional group, however it may have restricted our opportunity to assess the inter-professional 
functioning of MDT members, which is likely an important factor given the high pressure 
environment in which the study was conducted. Our results may have been enhanced had other 
qualitative data gathering techniques been used to complement the focus group interviews.With 
regard to the patient interviews, patients were asked to provide retrospective accounts of their 
experiences and the interviews were conducted at one point in time and not as the disease process 
unfolded. Furthermore, the challenges experienced with regard to locating participants limited the size 
of the sample. Although a Zulu interviewer ensured that patients could express themselves in their 
own language, the interviewer already knew what patients meant with regard to some of the cultural 
aspects that were discussed and hence these were not further explored. Zulu patients’ accounts of how 
prognosis was communicated were limited in comparison to the healthcare providers’ descriptions of 
the prognosis communication. 
 
5. Implementation and Further Development of the Guideline 
Healthcare providers will require cultural competence and communication training in order to 
facilitate the implementation of the guideline. Focus group interviews highlighted competency issues 
and lack of training with regard to communicating diagnosis, treatment and prognosis with patients. 
Furthermore, some of the challenges identified in the focus group interviews are not addressed in this 
guideline as specific recommendations pertaining to these challenges did not emerge from the data. 
These challenges included: competency and training deficits with regard to culturally competent 
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communication of diagnosis and prognosis; lack of clear documentation as to previous patient 
communication;delays in patient queries being addressed; attendance and continuity of MDT 
meetings which was particularly difficult due to resource constraints; lack of access to professional 
interpreters; and nursing time constraints; lack of agreement regarding informing and timing of 
prognostic information; and lack of knowledge of disease progression in allied health professional 
staff. Although most of these challenges are organisational in nature, further development of this 
guideline could include recommendations for addressing these challenges. One of the reviewers 
enquired about patient satisfaction surveys or audits. This may be a method for obtaining patient 
feedback at the time of their visit to the hospital thereby circumventing retrospective accounts and 
difficulties with access to patients at a later stage. This method could also increase the number of 
patients interviewed. One of the reviewers also proposed that recommendations may be aligned to 
specific healthcare providers for ease of implementation.  
 
6. Conclusion 
Communicating with patients about cancer in cross-cultural clinical settings is widely recognized as a 
challenging task. The focus on Zulu patients diagnosed with osteosarcoma stems from the fact that 
these patients present late for treatment and are then faced with making significant treatment decisions 
which are often viewed as culturally discordant. Zulu cultural and health beliefs affect the speed at 
which health professionals can intervene and necessitates the appropriate communication with Zulu 
patients in order to achieve the best cultural and medical outcome. 
 
This evidence-based practice guideline was developed based on evidence derived from an integrative 
literature review, focus groups with healthcare providers that work with Zulu patients diagnosed with 
osteosarcoma, and interviews with patients diagnosed with osteosarcoma. The AGREE II tool was 
used to guide the development of the guideline. Further development of the guideline is needed in 
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Generic requirements for culturally competent communication 
Guideline Recommendations Source of 
Recommendation 
Levels of Evidence 
Healthcare provider awareness Develop contextual awareness ILR Level IV, VI, VII 
Develop self-awareness ILR Level VI, VII 
Develop interpersonal awareness ILR Level VI, VII  
Develop awareness of cultural expectations in the healthcare setting ILR Level VI, VII 
Healthcare provider knowledge Acquire knowledge of broader contextual factors ILR Level VI, VII 
Acquire context specific knowledge ILR Level VI, VII 
Acquire self-knowledge ILR Level VII 
Acquire knowledge of the patient’s culture ILR Level VII 
Healthcare provider skills Acquire and apply cross-cultural communication skills ILR Level VII 
Ensure patient understanding ILR, FG Level IV, VI, VII 
Manage differences in the patient-provider encounter ILR, FG, PI Level IV, VI, VII 
Build the patient-provider relationship ILR, FG, PI Level IV, VI, VII 
Conduct a comprehensive patient assessment ILR, FG Level VI, VII 
Source of Recommendation Key: 
Integrative literature review – ILR 
Focus groups with healthcare professionals – FG 
In-depth interviews with patients - PI 
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Accommodate the patients’ family ILR, FG Level VI, VII 
Instil and maintain hope regardless of the disease stage FG Level VI 
Healthcare provider attitudes Take responsibility for cultural aspects of health and illness  ILR Level VI 
Take responsibility for combating discrimination in healthcare settings  ILR Level VI 
Take responsibility for learning about the Zulu culture  FG Level VI 
Be willing to learn from patients  ILR Level VII 
Be open to change and growth  ILR Level VI 
Be culturally sensitive  ILR Level VI, VII 
Be willing to listen  ILR Level VI 
Develop and demonstrate respect for cultural diversity, for the patient’s 
culture and their cultural values  
ILR Level IV, VI, VII 
Demonstrate respect for patients’ spiritual and religious beliefs  ILR Level VII 
Develop an appreciation of different health belief systems  ILR Level VII 
Be willing to explore culture with individual patients  ILR Level VII 
Validate different cultures  ILR Level VII 
Engage in continual self-examination and self-reflection to examine 
one’s own values and assumptions  
ILR Level VI, VII 
Be willing to adjust behaviours and attitudes  ILR Level VII 
Reflect on own interaction with cultural groups in the clinical setting  ILR Level VII 
Culturally competent healthcare 
systems 
Cultivate the characteristics of culturally competent healthcare systems ILR, FG Level VI, VII 
Strategies employed by culturally competent healthcare systems ILR, FG Level IV, VI, VII 
Recommended strategies for communicating the diagnosis, treatment and prognosis of osteosarcoma 
Guideline Recommendations Source of Levels of Evidence 
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Recommendation 
Recommended strategies for 
communicating the diagnosis of 
osteosarcoma to Zulu patients 
Provide patients with factual information PI Level VI 
Set the stage for truth-telling FG, PI Level VI 
Engage in patient-centred communication ILR, FG, PI Level IV, VI, VII 
Engage in culture-centred communication ILR, FG Level IV, VI, VII 
Facilitate understanding of the diagnosis FG Level VI 
Recommended strategies for 
communicating the treatment of 
osteosarcoma to Zulu patients 
Provide patients with factual information FG, PI Level VI 
Follow a specific process when discussing treatment ILR, FG, PI Level IV, VI, VII 
Strategies for responding to cultural factors associated with amputation FG Level VI 
Strategies for responding to cultural and health beliefs that affect 
treatment 
FG, PI Level VI 
Recommended strategies for 
communicating prognostic 
information pertaining to 
osteosarcoma with Zulu patients 
 
Assess patient emotions and knowledge FG Level VI 
Inform patients of the prognostic consequences of not treating the 
osteosarcoma 
FG, PI Level VI 
Inform patients of treatment limitations FG, PI Level VI 
Inform patients regarding metastases and treatment limitations result 
from the metastases 
FG, PI Level VI 
Inform patients of poor prognoses FG Level VI 
Use a staged approach when patients have non-metastatic or minimally 
metastasised disease 
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AGREE II Items for the Five Domains that were used to Score the  
Evidence-Based Practice Guideline 
 
Each item is scored according to a 7-point scale with response options ranging from strongly disagree 
to strongly agree. 
DOMAIN 1: SCOPE AND PURPOSE 
1. The overall objective(s) of the guideline is (are) specifically described 
2. The health question (s) covered by the guideline is (are) specifically described  
3. The population (patients, public etc.) to whom the guideline is meant to apply is specifically   
    described  
DOMAIN 2: STAKEHOLDER INVOLVEMENT 
4. The guideline development group includes individuals from all relevant professional groups 
5. The views and preferences of the target population (patients, public, etc.) have been sought 
6. The target users of the guideline are clearly defined 
DOMAIN 3: RIGOUR OF DEVELOPMENT 
7. Systematic methods were used to search for evidence 
8. The criteria for selecting the evidence are clearly described  
9. The strengths and limitations of the body of evidence are clearly described 
10. The methods of formulating the recommendations are clearly described 
11. There is an explicit link between the recommendations and the supporting evidence  
12. The guideline has been externally reviewed by experts prior to its publication 
DOMAIN 4: CLARITY OF PRESENTATION 
13. The recommendations are specific and unambiguous.  
14. Key recommendations are easily identifiable 
DOMAIN 5: EDITORIAL INDPENDENCE 
15. The views of the funding bodies have not influence the content of the guideline 
 
OVERALL GUIDELINE ASSESSMENT  
1. Rate the overall quality of the guideline 
2. I would recommend this guideline for use:  
Yes 
Yes, with modification 
No 
 
NOTES 
 
 
 
 
 
